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Two Applications of Microwave Therapy: Psoriasis and Varicose Veins
Abstract
An introduction to the use of microwaves for medical applications is given, with a 
comparison between different modalities for heating tissue, such as radio-frequency 
and laser based techniques. The background to the design and construction of 
applicators using finite element packages is also explained and this knowledge is 
demonstrated in the design, construction and testing of novel systems to treat psoriasis 
and varicose veins. The psoriasis treatment system is hyperthermia based, whilst the 
varicose veins treatment employs ablation, thus giving an insight into two different 
means of inducing a therapeutic effect using heat. Thermal analysis of the heat 
induced by the applicators is demonstrated by numerical solution of the diffusion 
equation by finite difference approximations and Green’s function analysis, with the 
results being validated against bench models. The results of testing of the psoriasis 
system on three patients are given, including the first quantitative assessment of the 
relationship between skin temperature and blood perfusion levels for both psoriatic 
and healthy skin at hyperthermic temperatures. The varicose veins treatment is 
minimally invasive, and is the first microwave based treatment for varicose veins.
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Chapter 1: Introduction and background
1.1 Introduction
Heating tissue can have a variety of effects depending on the temperature and the 
length of time for which that temperature is held. It can temporarily stop cell 
replication (Herman, 1977), coagulate blood vessels (Carbonell, 2003), cause tissue 
shrinkage (Trembly & Keates, 1991) and, of course, induce cell death (Borelli, 1990). 
The resulting cell death, and the effects resulting from further heating, such as 
carbonisation and vaporisation, are commonly referred to as ablation (LeCarpentier, 
1993), and are useful for treating a wide variety of complaints. Some of the modalities 
available to achieve heating in tissue include direct contact heating, (Chung, Xiao & 
Ryan, 2002), heating induced by laser beams (Navarro, 2001), ultrasound induced 
heating (Tyreus, Nau & Diederich, 2003), the direct application of radio-frequency 
(RF) electromagnetic waves (Scott, 2001) and the application of RF energy via an 
argon plasma (Miyazawa, 2000).
Achieving the desired effect on the tissue relies on producing a particular temperature 
profile within the tissue for a given length of time. The fact that each modality 
delivers energy to the tissue through a different method of action means that each 
modality will lend itself to producing different temperature profiles over different 
timescales. Different modalities are therefore inherently suited to producing different 
effects, and hence for the treatment of different conditions. In addition, the use of a 
particular modality has an impact on the engineering of the device and system used to 
deliver the heating, which can also be an important consideration in where and how 
the treatment system can be used. A review of the most commonly used modalities, 
together with their features and advantages and disadvantages are given in sections
1.2.1 to 1.2.6. A summary is given in table 1.1. The majority of these modalities have 
been reviewed by Williams and colleagues (2004).
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1.2 Thermal medical treatment modalities
1.2.1 Contact heating
Possibly the superficially simplest method of achieving tissue heating is through 
contacting the tissue to be heated with a hot surface or hot fluid. Thermal conduction 
is then relied upon to carry the heat into the tissue. This has the advantage of being 
likely to be relatively easy to implement in terms of system engineering, as the 
technology required to achieve heating of fluids or surfaces is unlikely to be as 
complex as that required for other heating modalities. In addition, the maximum 
temperature rise in the tissue will not exceed the temperature of the fluid or surface 
used, due to the fact that thermal conduction alone is used to carry heat through the 
tissue. This means that an accurate upper limit on tissue temperature can be set if the 
surface temperature is known. This differs from other heating modalities where the 
heating is induced in the tissue itself, making the maximum tissue temperature more 
difficult to accurately predict. This effect can be important for treatments that have 
tight safety limits on temperature, such as treatments that must not produce steam, or 
must achieve cellular damage without causing cell death.
The fact that contact heating relies on thermal conduction alone also has significant 
disadvantages. Above all, it cannot produce ablations of significant depth without the 
use of very high surface temperatures and is slow to create deep ablations compared 
to other modalities such as microwaves and RF. A major limiting factor in this regard 
is the level of blood perfusion, which has the effect of cooling the tissue and hence 
limiting ablation depth even more. In addition, if  a surface is used to provide this 
heating, any small gaps between the surface and the tissue will result in significantly 
less transfer of heat and so result in a significantly smaller ablation depth than 
predicted by thermal analysis. This problem can be overcome through the use of a 
fluid, but this introduces the difficulty of safely delivering the hot fluid to the 
treatment site without causing collateral damage, containing it once in place and then 
removing it again. One example of the use of contact heating in medicine is in 
removing the lining of the uterus, called the endometrium, by inserting a hot saline 
filled bag into the uterine cavity (Baldwin, 2001). Removal of the endometrium using 
heat is called endometrial ablation.
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1.2.2 Laser
Lasers light with wavelengths of between 1000-3OOOnm are typically used for heating 
tissue. Lasers heat the tissue directly, and very superficially, leading to difficulty in 
assessing and controlling the maximum tissue temperature achieved. However, they 
offer potentially superficial heating at high temperatures over a small treatment area. 
The minimum depth of ablation is around 20pm according to LeCarpentier et a l 
(1993) with maximum ablation diameters of between l-3cm if heating is maintained 
(Iizuka, 2000). In addition, no contact with the tissue is required to achieve the 
heating and the energy can be delivered down very narrow (600pm) optical fibres 
with minimal losses.
On the other hand, the small size of the heated area of tissue makes ablating large 
areas slow, as this can only be achieved by passing the heated spot over the surface to 
be treated. It is therefore not ideal for treating large areas due to the significant time 
that is required. The fact that the power delivery is from a virtually point source also 
means that carbonisation of the tissue can result when trying to achieve large ablation 
volumes (Iizuka, 2000), due to the maintenance of very high temperatures in a small 
volume of tissue, followed by a reliance on thermal conduction to carry the heating 
out further. As with direct contact heating, this reliance on thermal conduction limits 
ablation volumes compared to ultrasound, RF and microwave based modalities and 
leads to the need for very high superficial temperatures to try and achieve a larger 
depth of thermal penetration within an appropriate length of time, if  required for an 
application that necessitates large ablation volumes such as tumour ablation. Some 
examples of lasers being used in medicine are their use in eye surgery due to their 
very focussed heating, their use to cause veins to occlude by causing localised damage 
to the vein wall, and in cancer treatment, where they have been used to ablate 
tumours.
1.2.3 Ultrasound
Ultrasound is very widely used in imaging, but high intensity ultrasound can also be 
used to produce significant tissue heating. Frequencies of between 1-15 MHz are 
typically used with heating over depths of up to 5cm (Tyreus, Nau & Diederich,
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2003). Higher frequencies are absorbed more readily, so giving smaller depths of 
penetration, with lower frequencies resulting in deeper penetration. This ability to 
vary the depth of over which the tissue is heated means that there is significantly more 
flexibility in determining the required therapeutic temperature profile, as thermal 
conduction alone is not relied upon to deliver the heat. In particular, heating over a 
significant depth of tissue means that large ablation volumes are theoretically possible 
without the need for the development of extremely high temperatures, as thermal 
conduction is not the only method of delivering heat into the tissue. This means that 
ultrasound heating is well suited for the ablation of tumours.
Unfortunately, ultrasound applicators have difficulty maintaining efficiency as the 
probe heats up, even for relatively modest temperature rises. Direct contact with the 
tissue is also needed to deliver the ultrasonic waves and the use of a coupling medium 
(such as ultrasound gel) can be required to achieve efficient coupling between the 
ultrasonic transducer head and the tissue. Both of these effects lead to a significant 
lack of efficiency and high reflected powers, particularly as the probe temperature 
rises due to heating of the surrounding tissues. This limits ablation volumes to around 
3cm diameter. Also, relatively large applicators of around 2.2 to 4mm diameter are 
required to create these significant ablation volumes (Tyreus, Nau & Diederich, 
2003), which is large in comparison to RF and laser applicators which are generally 
around l-2mm in diameter. An additional disadvantage is that ultrasonic absorption is 
directly related to tissue protein content, which can vary significantly between tissues. 
It will therefore selectively heat some tissues more than others, such as bone, nerves 
and scar tissue. This makes ultrasonic ablation impossible in areas close to bone.
1.2.4 Radio-frequency
Radio-frequency based heating is the most widely used method of heating tissue. 
Alternating currents at frequencies of around 450 - 1000 kHz are used to cause 
heating due to the passage of the current through the tissue. This means that two 
electrodes are required to allow currents to run between them. In a bipolar system, the 
two electrodes are placed near each other on the applicator, so the current is relatively 
well confined to the region around the applicator. In a monopolar system, currents run
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between the applicator and a large pad attached to the patient, often located on their 
thigh. The current is most intense at the applicator, and becomes increasingly diffuse 
for tissue closer to the pad. This therefore limits heating to the area around the 
applicator.
The relatively low frequencies used, when compared to microwave frequencies, 
means that wires can be used to deliver the energy, and this has significant advantages 
from an engineering point of view. Applicators can be made very narrow and with 
minimal energy losses on route to the treatment site. The heating induced by the 
currents is less superficial than that produced from lasers, but significantly shallower 
than heating from ultrasound, making it potentially suitable for treating a wide range 
of conditions.
However, the more limited heated volume of tissue that results when compared to 
ultrasound induced heating means that ablation volumes are intrinsically smaller than 
those available from ultrasound induced heating. This is due to the greater reliance on 
thermal conduction to expand the ablation, and the need to limit power delivery to the 
applicator to prevent excessive temperatures and charring around the applicator. In 
addition, tissue desiccation resulting from prolonged heating causes the impedance of 
the tissue to change in the tissue surrounding the applicator. This has the effect of  
lowering energy delivery to the tissue, so limiting ablation volume. In an attempt to 
remedy this and expand the ablation volume, multiple electrodes have been used 
emerging from a single applicator. This has resulted in unpredictable larger ablation 
volumes and leads to recurrences when used to treat cancerous tumours as the entire 
tumour has not been successfully ablated (Scott et al., 2001).
1.2.5 Argon plasma coagulation
An extension on the use of radio-frequency heating is the combination of radio­
frequency heating with an argon plasma. The plasma allows conduction between the 
electrode and the tissue without the need for direct contact of the electrode on the 
tissue. This expands the region of heating whilst still allowing the use of a small 
probe. This gives very shallow, even bums of around 400pm according to Miyazawa
Chapter 1: Introduction and background Page 5
Two Applications of Microwave Therapy: Psoriasis and Varicose Veins
(2000) without vaporisation of tissue. Naturally, this also means that it does not lend 
itself to ablating large volumes, and it is primarily used to stop bleeding from surface 
blood vessels.
1.2.6 Microwave
Microwaves offer many of the advantages for heating tissue that other modalities 
offer, due to the fact that it can heat both large and small volumes (Swift, 2003). In 
this respect it is similar to ultrasound, but does not have some of the major drawbacks 
associated with the use of ultrasound. Despite this, it has been used surprisingly 
infrequently. This may be due to the difficulties in producing efficient antenna 
designs. In fact, microwaves applicators have the potential to offer very efficient 
designs that can produce uniquely large ablations (Wonnell et ol., 1992). As with 
ultrasound, the depth of tissue heating can be altered through altering the frequency of 
operation. Frequencies of around l-10GHz are used with tissue penetration depths 
between several millimetres and several centimetres. In addition, the absorption of  
energy by tissue due to microwaves is relatively uniform as it is dominated by the 
water content of the tissue, which is relatively uniform across tissues. This greatly 
reduces selective heating effects, allow heating in areas much closer to bone than is 
possible with ultrasound. Finally, direct contact between the applicator and the tissue 
is not a necessity to ensure efficient microwave radiation into the tissue.
There are some potential drawbacks however. In particular, large applicators are 
generally required to achieve efficient designs (2-5mm in diameter). This is 
considerably larger than many RF and laser applicators. Also, as with radio-frequency 
ablation, tissue desiccation due to extended treatment times can result in a reduction 
in energy delivery due to changes in tissue properties. However, careful antenna 
design can minimise or eliminate this effect and ensure good efficiency throughout a 
treatment.
Microwaves have the potential to be used to treat many different conditions. 
Possibilities include tumour ablation, coagulation of blood vessels and endometrial 
ablation.
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Contact Laser Ultrasound Radio-frequency Argon plasma Microwave
Method of 
action
Thermal conduction Absorption of 
photons
Mechanical agitation 
of tissue caused by 
ultrasonic waves
Resistive heating 
induced by the 
impedance of the 
tissue
Application of high 
frequency current via 
ionised argon gas
Agitation of polar 
molecules such as water
Typical
frequencies
n/a 1000-3000nm 1 -1 5  MHz 450 - 1000 kHz Radio frequency 1 -10 GHz
Advantages Simpler technology 
required 
Maximum tissue 
temperature known if 
surface temperature 
known
Very targeted heating 
Energy deliverable 
via narrow fibres 
No contact with 
tissue required 
Minimal losses en 
route to treatment site
Large volumes 
ablation
Depth of penetration 




Power deliverable via 
narrow wires 
Widely used and 
accepted
Creates very shallow, 
even bums - 400pm. 
Coagulated material 
remains in place 
Small probe 
Direct contact not 
required 
Compact system
Efficient and quick 
Large ablation volumes 
possible
Depth of microwave 
penetration can be 
controlled by frequency 
Predictable heating 
patterns
Disadvantages Difficult to deliver 
heat to treatment site 
Slow
Only small ablation 
volumes possible 
If hot saline used to 
deliver the heat, 




Virtually point source 
can lead to 
carbonisation when 
trying to achieve 
larger ablation 
volumes
Small heated spot 
size makes ablating 
areas slow
Large applicators 
required for optimal 
performance 
Energy absorption 
related to tissue type 








Large ablations not 
possible
Cannot cope with high 
levels of blood loss
Large applicators 
required compared to RF 
and laser to deliver 
significant power levels 
Tissue desiccation can 
result in impedance 




Endometrial ablation Eye surgery 
Venous occlusion 
Treatment for thread 
veins and acne










1.2.7 Table 1.1: A summary of the major thermal medical treatment modalities
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1.3 Introduction to microwaves
Microwaves are electromagnetic waves in the frequency range from around 300 MHz 
to 300 GHz, with corresponding wavelengths in vacuum of around lm  to 1mm. For 
medical purposes, frequencies of around 1 to 10 GHz are used with wavelengths in 
tissue of about 1cm. Much of the electromagnetic spectrum (figure 1.1) is routinely 




0 0 4  U b  496 mENERGY 0 000000248
1 cm « 10 000 000 nanometers
Figure 1.1: The electromagnetic spectrum 
www.spacetoday.org/DeepSpace/Telescopes/GreatObservatories/Chandra/ChandraSpectrum.html
Microwave heating is fundamentally controlled by the degree of attenuation o f the 
waves. Since our bodies are mostly water and there is relatively little variation in 
water content between different tissue types, microwave heating is predictable (see 
section 2.2.3). Microwaves can also be used at different frequencies to give different 
depths of penetration and with different shaped antennas to give different field 
patterns. The absorption efficiency of the microwaves by water also means that 
relatively low powers can be used to produce large ablation volumes relative to other 
techniques for heating tissue.
1.4 The history of electrosurgery
The possibility of heating tissue using high frequency currents was first noted by 
Thompson (1889), who noticed heat in his wrists when currents from his early high
Chapter 1: Introduction and background Page 8
Two Applications of Microwave Therapy: Psoriasis and Varicose Veins
frequency generator were passed through his hands after they were immersed in 
saline. Jacques Arsene d'Arsonval (1891 & 1893) applied various high frequency 
currents to human subjects in 1891, and found that frequencies in excess of 10kHz did 
not produce neuromuscular stimulation, thus allowing the use of high frequency 
currents to heat tissue in-vivo. D'Arsonval’s equipment was modified by Oudin to 
create sparks that would cause superficial tissue destruction. Riviere (1900) used this 
equipment to successfully treat an ulcer in 1900, and Pozzi (1909) reports successful 
use of the equipment to treat skin cancer, claiming that the modality could selectively 
destroy tumour cells. Doyen (1909) reports the successful use of a return path 
electrode that was connected to the patient. This produced a more penetrating and 
effective current. Clark (1911) achieved the first desiccation of tissue, once again with 
the Oudin current generator, but with a multiple set of electrodes in order to create a 
multiple set of sparks, rather than a single electrode. The most major advance 
undoubtedly came from William Bovie (1928). He successfully worked with Harvey 
Cushing, a neurosurgeon, to create an electrosurgical device that gained widespread 
acceptability (Goldwyn, 1979).
The use of both bipolar and monopolar radio-frequency has advanced steadily since 
then, with many medical devices based on the use of radio frequency currents. The 
use of even higher frequencies was not possible until the development of the 
magnetron during World War n. Since then the possibility of heating tissue using 
microwave ovens has been widely exploited. The use of microwaves for medical 
treatments is also becoming more widespread. The principles of operation of four 
commercial systems are given below. These demonstrate four successful ways of 
applying microwave therapy.
1.5 Current microwave therapies
1.5.1 Microwave endometrial ablation (Microsulis® MEA™ - “MEA”) 
This treatment is for a condition called menorraghia, which is heavy menstrual 
bleeding experienced by up to 19% of women of reproductive age (Snowden & 
Christian, 1983). This condition frequently leads to a hysterectomy, which is an 
operation that carries a high degree of morbidity (7% according to Kelly, 1998) and
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even mortality (Baldwin, 2001). MEA uses high frequency microwaves to ablate the 
lining of the uterus, called the endometrium. This has been a highly successful 
treatment and to date has been used in approximately 36,000 operations. Some major 
aspects of the treatment design are given below.
In figure 1.2 is the applicator. This has an 8.5mm diameter shaft which is designed to 
be able to be inserted into the uterine cavity through the cervix. It has a metal handle 
that is held by the surgeon, into which are connected a coaxial cable and a data cable. 
The coaxial cable delivers microwaves from a microwave generator to the applicator, 
with the data cable feeding back treatment data from the applicator to the treatment 
system.
Figure 1.2: The MEA applicator showing the handle with connections for microwaves and data, the 
shaft that delivers microwaves from the handle to the tip, and the tip itself.
When the treatment is started microwaves at 9.2 GHz are delivered to the applicator 
causing microwaves to radiate from the tip. The depth of penetration of the 
microwaves at this frequency is around 2mm, as shown by the plot of microwave 
tissue absorption around the tip, shown in figure 1.3. This is chosen specifically in 
order to target the endometrium, by ensuring that power is deposited over the depth of 
the endometrium. The depth of heating is therefore tailored to the treatment 
requirements, and this depth of heating is determined by the choice of microwave 
frequency. The exact radiation pattern of the microwave tip is determined through
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computer modelling of the interaction between the applicator and the surrounding 
tissue, giving results such as those shown in figure 1.3. The use of computer 
simulation packages also allows the development of efficient applicator designs.
Figure 1.3: A microwave tissue absorption plot o f  the MEA applicator tip. The tip diameter is 8.5mm, 
with significant microwave absorption over the first 2mm o f tissue
Once an efficient applicator has been designed and the radiation pattern assessed by 
computer simulation, prototype applicators can be built. The actual heating pattern 
that the applicator produces can then be assessed in tissue phantoms, such as those 
described in section 2.5.5. The heating pattern over time for a stationary MEA 
applicator is shown in figure 1.4.





Figures 1.4a-e: The heating 
pattern o f  an MEA applicator 
evolving over time. The 
applicator is bedded in a clear 
tissue phantom gel called PAG, 
with added surfactants that turn 
the gel opaque at a pre­
determined temperature.
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In order to ablate the whole lining of the endometrium, the applicator needs to be 
swept around the inside of the cavity. This is controlled by the surgeon attempting to 
maintain a temperature of between 75°C and 85°C at the tip. This temperature is fed 
back from the applicator to a system, where the temperature is displayed on an 
attached screen (Cronin & Sharp, 1995). A typical temperature profile and the 
concurrent progress of the treatment are shown in figure 1.5.
Figure 1.5: The MEA treatment procedure including a typical temperature profile as seen by the
surgeon, and the treatment progress
In order to minimise patient risk considerable efforts are made to characterise 
applicator temperature profiles, together with their resulting effects. For the case of 
MEA this means simulating the temperature profiles that will result from surgeons 
using the temperature feedback described above. The temperature is measured by a 
thermocouple located at the tip, as shown in figure 1.6. Safety is ensured by limiting 
the maximum potential bum depth through setting an upper limit on temperature, and 
this has been shown to limit the maximum possible bum depth to 8mm. In the event 
that the temperature exceeds 90°C the system cuts microwave power to the applicator, 
and before every treatment the wall thickness of the uterus is measured using 
ultrasound to ensure that it is greater that 8mm.
Powe
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Figure 1.6: A simulated MEA applicator tip showing the position o f  the thermocouple
This treatment has effectiveness ratings comparable with surgical removal of the 
endometrium (Bain, Cooper and Parkin, 2002), but is faster and has considerably 
lower complication rates. A typical treatment takes around 3 minutes.
1.5.2 Microwave tissue ablation (Microsulis® MTA™ - “MTA”)
MTA is currently in use for the treatment of liver cancer, but could potentially be used 
to treat other cancers. These initial trials are being conducted in liver because liver has 
the advantage that it can re-grow. A tumour in the liver can therefore be ablated along 
with a safety margin of surrounding tissue. The entire area will then necrose (Swift, 
2001), and be replaced over time. Moving on to treat tumours located in other areas 
will require more care, as the bum will need to be carefully controlled in order to 
minimise damage to adjacent healthy tissue.
Figure 1.7: A close-up o f  the MTA 6.4mm 
applicator Clegg (2002)
SAR F 1 e 1 d [W /k g ]











9 . 3750e*001 
6 2500e-001 
3 . 1250e*001
Figure 1.8: MTA predicted microwave tissue 
absorption Clegg (2002)
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The applicator consists of a radiating monopole antenna, shown in figures 1.7 and 1.8, 
that is surgically inserted into the area to be ablated. Power is then applied. The 
resulting ablation can be monitored in real time through ultrasound, or by temperature 
measurement at the edge of the volume to be treated. The frequency used is 2.45 GHz, 
which gives a depth of microwave penetration of around 2cm. This is in order to give 
a large possible ablation volume. Ablation volumes can be up to around 7cm in 
diameter, with a typical ablation lasting 5 minutes. An ablation in ex-vivo liver is 
shown in figure 1.9. Three different monopole antenna applicators are shown in figure
1.10, together with a flat-ended applicator that is used to treat tumours that have 
reached the liver’s surface. The flat end of this applicator can be applied to the tumour 
on the surface to ensure that no surface tumour cells are spared during a treatment, as 
may have been the case if the tumour had been treated from the inside using a 
monopole antenna.
Figure 1.9: A 4cm microwave induced liver ablation Figure 1.10: Several microwave MTA applicators 
Clegg (2002) Clegg (2002)
1.5.3 Microwave treatment of thread veins (Veinwave™)
This treatment consists of a fine needle that is inserted into thread veins. These are 
common swollen superficial veins that can be unsightly, as shown below in figure
1.11. Veinwave is therefore a cosmetic procedure. The needle is pushed vertically 
through the skin, and through the vein. Once the needle is in position, microwave 
power at 18GHz is applied for around 1 second. This causes coagulation of the blood 
at the part of the vessel where the needle is located and thereby occludes it at that
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point. This causes the whole vessel to disappear as blood can no longer be carried 
through the vein. A small red mark will appear where the needle was inserted, which 
will disappear over time.
1.5.4 Microwave treatment for benign prostatic hyperplasia 
(Prostatron®)
Benign prostatic hyperplasia (BPH) is a chronic enlargement of the prostate. 
Enlargement of the prostate over a man’s lifetime is very common with 20% of men 
in the 40-50 age group, rising to 80% of 70-80 year olds showing at least microscopic 
evidence of BPH. According to Kang (2004), 25-50% of these present clinical 
symptoms. This generally occurs when the size of the prostate results in occlusion of 
the urethra. The current gold standard treatment for this is to surgically resect parts of 
the prostate trans-urethrally, called TURP. This can result in chronic bleeding and 
therefore carries with it a high level of morbidity including a 6.8-10% incidence of 
deep venous thrombosis and a 0.2-2.2% reported incidence of pulmonary embolus 
according to Bell and colleagues (1999). The prostatron aims to reduce the volume of 
the prostate by ablation. The applicator is inserted into the urethra and guided up to 
the relevant position. Microwave power is then applied at a frequency of 915 MHz for 
28.5mins. In order to ensure sparing of the urethra, the shaft of the applicator is water- 
cooled. The maximum tissue temperature reached is reported as being around 65°C. 
Both rectal and urethral temperatures are monitored throughout the treatment to 
ensure they are spared.
Figure 1.11: Thread veins
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Chapter 2: Microwave and thermal analysis
2.1 Introduction
Chapter 1 described the advantages that microwave heating can offer for heating 
tissue compared to other methods. Despite this, and perhaps surprisingly, microwave 
based treatments have been used relatively infrequently. This may be because of the 
difficulty in designing and building efficient applicators that can reliably and 
accurately deliver their energy. Overviews o f some of the few microwave based 
treatments currently in clinical use were described in section 1.5.
As mentioned in the review of MEA (in section 1.5.1), considerable efforts need to be 
made to accurately characterise the temperature profiles resulting from any treatment. 
This is because of the need to minimise potential risks to patients, as well as to be able 
to demonstrate to regulatory healthcare authorities how the treatment achieves its 
effects, and how potential risks have been mitigated. Computer simulations and bench 
testing provide the major means of achieving this.
The use of computers starts with the use of finite element packages to design the 
applicator and ensure high efficiency with minimum power reflected. Optimising the 
efficiency of the applicator is important because it maximises the treatment effects 
available for a given microwave power and enhances safety by ensuring that 
applicators will not be able to deliver more power to the tissue than expected. This is 
because they are already delivering all or very nearly all, the energy supplied to them. 
An efficient applicator is described as being “well matched”, as the match of the 
applicator is the degree to which it delivers the energy supplied to it into the tissues.
The use of the finite element package also allows the pattern of microwave absorption 
in the tissue to be characterised. The thermal profile resulting from this absorption can 
then be simulated using various methods. Finite difference simulations, Green’s 
function simulations and the use of finite element packages are described in this work. 
Finite difference simulations (described in section 2.5.2) offer a quick method of 
simulating temperature rises, particularly for simple geometries that only require 
simulation in 1 dimension such as planes, infinitely long cylinders, and spheres. They
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are used in chapter 3 to simulate the thermal profile resulting from microwave heating 
of skin, and in chapter 4 to assess the thermal profile resulting from heating of a vein. 
Green’s functions (described in section 2.5.3) offer the ability to model more complex 
microwave absorption patterns, but assume a homogenous, isotropic environment of 
infinite extent. This is applicable for treatments where temperature rises are 
sufficiently small that significant changes in tissue properties will not occur as the 
tissue heats up, and especially where the applicator is removed from the tissue once 
the heating has occurred. This is because the effect of the applicator itself on the 
thermal profile will be minimised in this case. A Green’s function is used in chapter 4 
to modelling the heating of a microwave applicator inside a vein. Finally, the use of 
finite element packages (described in sections 2.5.4, 2.5.5, 2.5.6 and 2.5.7) allows a 
much more comprehensive thermal analysis to be performed, incorporating the effect 
of the applicator itself and changing tissue properties. The effects of temperature 
measurement devices themselves can even be incorporated. A finite element thermal 
model is used in chapter 4 to assess how effectively a temperature measurement probe 
can measure the temperatures surrounding it. However, such thorough analyses can be 
complex to set up, computationally expensive and do not generally lend themselves 
well to moving applicators.
Once the thermal analysis has been performed, the tissue damage that is predicted to 
result from the simulated temperature profile can be assessed through application of 
the Arrhenius equation to the predicted temperatures at a given location in the tissue. 
This is described in section 2.6 and is used in chapter 4 to quantify thermal damage as 
a result of tissue heating in a vein heated by a microwave applicator.
At all stages the results of the simulations can be validated through bench testing as 
described in section 2.7. For example, the efficiency of the applicator can be checked 
using reflected power measurements and calorimetry. Also, after the temperature 
profile has been simulated, the model can be validated by comparing measured and 
predicted temperatures at specific points around the applicator. Finally, following the 
application of the Arrhenius equation to the temperature profile, the predicted degree 
of tissue damage can be assessed. For temperatures sufficient to cause cell death, the
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region of cell death can be validated against liver obtained from a butcher. Cellular 
damage can also be evaluated through microscopic examination of cellular structure, 
as well as staining to show the presence or absence of enzymes required for cellular 
survival. Examination of the cellular structure is known as histology, and the major 
relevant aspects are described in section 2.7.9.
All the simulations naturally rely on good material properties data to provide 
successful predictions. The relevant microwave and thermal tissue properties used in 
this work are given in sections 2.2.3 and 2.4.4 respectively.
Section 2.2 gives an introduction to how electromagnetic radiation can cause heating 
in tissue and how the interaction between the electromagnetic radiation and the tissue 
is characterised at microwave frequencies.
2.2 Complex permittivity
2.2.1 Introduction
The interaction between microwaves and the media through which they pass is of 
crucial importance in hyperthermia. The effect on electromagnetic (EM) waves of 
propagating through various media can be described by solution of Maxwell’s 
equations for a plane wave. A comprehensive analysis is available from Sadiku 
(2001).
The relevant properties of the medium are specified by the permittivity £, permeability 
fi and conductivity cr. It is usual to express permittivities and permeabilities in terms 
of relative permittivities Sr and permeabilities /u. This is the ratio o f the permittivity 
or permeability o f the medium to the permittivity So or permeability /jq of free space. 
Since none of the media considered in this work have magnetic properties, the relative 
permeability can be left as 1. Relative permittivity is also known as the dielectric 
constant. For this analysis a plane wave propagating through free space, as well as in a 
lossless dielectric, in a good conductor and in a lossy dielectric, will be considered.
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Assuming a linear isotropic homogenous uncharged medium, Maxwell’s equations 
can be expressed as,
— —* d H
V # £  = 0 2.1 Vx £  = - / / —  2.2
dt
—  —  — pjf
V * H  = 0 2.3 V x H  = <tE + £ — . 2.4
a/
Taking the curl of equation 2.2,
V X (V X E) = X g g . = - n  ^ V * g }  .
a/ ar
and substituting in equation 2.4 and applying the identity 
V x ( V x 3 )  =  V ( V » 3 ) - V 23 ,
gives,
V(V • E ) - V 1E = - u — (aE  + s — ).
dt dt
The medium is uncharged, so using equation 2.1 and rearranging gives,
„ 2 -  dE  d 2E  .V E - ju a ------- u s— — = 0.
^  dt ^  d t2
In one dimension this can be expressed as,
d 2E dE d 2 E — ------ us— r-  = 0. 2.5
dz2 *  dt ^  d t2
Assuming linearly polarised plane wave solutions o f form,
E = E„e,(M-b}i . 2.6
where m = 2nf and k=2nlX then,
dE . B d 2E  2 ?  d2E , 2B
—  = ia>E — T- = -a> E  — t- = - k E .
dt d t 2 dz2
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Substituting into equation 2.5 gives, 
- k 2E -  icocrjuE + £fico2E = 0
k 2 = -ifAGCO + SjUO)2
2.7
This result leads to different outcomes for each case of the four media given above.
1. Free space
In free space the medium is non-conducting therefore tr= 0.
Therefore from equation 2.7,
k 2 =£(16)2.
Since group velocity is give by a/k and £ =  £o then,
co _  1 _ 1
* V£o-“o
The speed of the wave is therefore . - , which is the speed of electromagnetic
V*oA>
radiation in free space, called c. As there is no imaginary component to k the wave 
does not decay, unlike in situations 3 and 4 below. Free space is therefore lossless.
2. Lossless dielectrics
A medium where the relative permittivity is real and greater than unity is a lossless 
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Since e  = £o&, then
co
k 4eoVo
The speed of the wave is therefore reduced by —i= ffom  c. Since the frequency is
V*r
constant, the wavelength is also reduced by a f a c t o r .
3. Good conductors
If the medium is a good conductor then cr~ oo, therefore k is now complex and heavily 
dominated by the -ijuaco term. Splitting k into real and imaginary parts,
k = kR + ikj 
and substituting into equation 2.6 gives,
= EQeK°*-kRZ\e~klZi .  2.8
Therefore, any degree of conductivity in the medium causes the wave to decay 
exponentially with distance.
4. Lossy dielectric
A lossy dielectric is a medium which may be partially conducting, with 0. It may 
also be an insulator at low frequencies, yet still cause electromagnetic wave 
attenuation at high frequencies, such as Teflon at optical frequencies. This is because 
of the loss mechanisms that can occur when an EM wave passes through a lossy 
dielectric medium that are frequency dependent.
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As shown by the case of a good conductor, any medium that allows a net movement 
of charge will decay a plane EM wave. However, as the frequency increases 
attenuation is also caused by the excitation of various microscopic modes in the 
medium. For tissue at microwave frequencies, the overriding effect is that as the field 
varies, the polar molecules of which water is made up attempt to orientate themselves 
with the oscillating electric field. The frictional forces that result cause energy to be 
lost as heat. At higher frequencies still, bound charges are excited by the waves, also 
causing oscillation and causing energy to be lost as heat. At yet higher frequencies, 
quantum effects become increasingly import as photon energies become sufficiently 
high to cause electron promotions. Since all o f these losses are over and above any 
losses directly attributable to movement of free charges, the lossiness of the medium 
at microwave frequencies is represented by making the relative permittivity complex, 
so £r = e'-is". Since s  is now complex, k is also complex, once again leading to 
equation 2.8, even in the absence o f net charge movement. Complex permittivity 
together with conductivity therefore encapsulates all the losses in the medium.
Conductivity here is low frequency conductivity, interpreted in tissues as that due to 
ionic conduction through extracellular space (Duck, 1990). Some authors use an 
alternative description in which the losses due to conductivity are subsumed into the 
complex permittivity. However, this prevents a distinction being made between ionic 
conduction, which is important for the heating caused by currents at RF frequencies, 
and losses due to the mechanisms given above at higher frequencies such as 
microwave frequencies.
Due to the fact that the various factors that influence EM wave attenuation are 
frequency dependent, complex permittivity values are not constants and vary with 
frequency and temperature. Some typical variations for complex permittivity values 
with frequency are given below in section 2.2.3.
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As demonstrated above, there is an exponential decrease in wave amplitude with 
distance travelled in a lossy medium. Ignoring time dependence and assuming that the 
frequency is sufficiently high that losses due to ionic conduction in tissue may be 
ignored gives
where Eo is the magnitude of the electric field at distance 0, Ez is the magnitude o f the 
electric field at distance z, and a is a constant given by,
as derived by Sadiku (2001: pp418-419). a  is the attenuation coefficient and the 
imaginary component o f k. 1/a gives the 1/e amplitude attenuation depth, i.e. the
For a plane wave the power penetration depth is therefore half that o f the amplitude 
penetration depth.
Since the distinction between a good conductor and a lossy dielectric is not easy to 
make, a distinction is made through reference to the solution of the EM wave 
equation. Equation 2.7 above is
E ^ E o e -0*,
2.9
point at which the wave has attenuated to 36.8% of its initial value. Since the power 
of a wave is given by the amplitude squared,
Pz = Poe '2oa 2.10
k 2 = - ifiac) + EfiQ)2.
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For a good conductor a ~ oo, therefore the - ijL ia c o  term dominates k2 and eco «  o. 
Conversely, for a good dielectric a «  eco. Taking the ratio of a and eco defines tan 0 
(Sadiku, 2001: pp421-422), where tan 0 is known as the loss tangent and is given by
tan 9 = —  .
cos
A small loss tangent therefore describes a good (low-loss) dielectric, whilst a large 
loss tangent describes a good conductor or highly lossy dielectric. The loss tangent 
can also be shown to be equal to the ratio of the imaginary to real parts of the complex 
permittivity (Sadiku, 2001: p422). So,
2.2.2 Measurement of complex permittivity
A variety of techniques have been used to measure complex permittivity at 
microwave frequencies. Waveguide techniques are popular for the measurement of 
permittivity generally, but are not necessarily very well suited to the study o f tissue 
since they require the placing of a sample of known thickness within the waveguide, 
as performed by Hagmann and Gandhi (1982), Dudeck and Buckley (1992), 
Abdulnour, Akyel and Wu (1995) and Sphicopoulos, Teodoridis and Gardiol (1985). 
As the sample must make firm contact all around the waveguide and the thickness of 
the sample must be accurately known, this is not an ideal measurement technique for 
biological samples, particularly since biological tissues tend to be very lossy, hence 
requiring thin films. Alternatively, it is possible to contain the samples in a cell 
(Szwamowski and Sheppard, 1977), or place the sample at the end of an open ended 
waveguide as performed by Alekseev and Ziskin (2000), but this is still not ideal.
Another commonly used technique is measurement of the perturbation o f the 
resonance of a cavity, as described by Raveendranath and Mathew (1996). This has 
the disadvantage that measurements can only be made at a single frequency.
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The technique that lends itself best to the measurement of tissue complex permittivity 
is through characterisation of the reflection from the end of a coaxial line probe in 
contact with the medium to be analysed. This has been used by Raicu, Kitugawa and 
Irimajiri (2000) on skin, Hoshi and colleagues (1998) on teeth, Staebell and Misra 
(1990) on a variety of tissues, and Clegg (2002) on a variety o f tissues. This technique 
is particularly convenient as it requires little or no sample preparation, and can be 
carried out in-vivo. The probe needs to be calibrated before use (Misra, 1990), and the 
measurement is dominated by the material in very close proximity to the tip (Tofighi 
and Daryoush, 2000). This tends to prevent its use on hard surfaces, but it is ideally 
suited to most biological tissues.
One additional technique that is not widely used is the free space technique. This was 
used by Ma and Okamura (1999) to measure the complex permittivity of sawdust in a 
container at 9.4GHz. This requires planar samples of known constant thickness that 
are large enough to intercept an entire microwave beam.
2.2.3 Complex permittivity values
Some complex permittivity measurements o f interest made by Clegg (2002) using the 
flat ended coaxial cable technique are given in figure 2.1. As can be seen in figure 2.1, 
the real and imaginary parts o f the relative complex permittivity for all tissue types 
and the tissue phantom gel PAG, are relatively similar. This is because they are all 
primarily composed of water. Fat, on the other hand, has significantly different 
complex permittivity values. The attenuation depths that these complex permittivity 
measurements give are shown in figure 2.2 and table 2.1, calculated using equations 
2.8 and 2.9. This figure and table show that microwave absorption increases with 
frequency over the range l-10GHz, and that the minor differences in tissue complex 
permittivity values between the non-fat tissue types shown in figure 2.1 has a limited 
impact on microwave tissue absorption. Fat, on the other hand, does have a 
significantly different complex permittivity and a much reduced degree of microwave 
absorption compared to other tissues, with a corresponding increase in attenuation 
depth between the frequencies of l-10GHz.
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Figure 2.1: Real and imaginary parts o f complex relative permittivity for the tissue phantom 
polyacylimide gel (PAG) and several tissue samples. The real parts are positive and the imaginary parts 
are negative. Clegg (2002)
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Figure 2.2: 1/e penetration depth for the tissue phantom polyacrylimide gel (PAG) and several tissue 
samples Clegg (2002)
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2.45 GHz 7 GHz 9.2 GHz
PAG 12.14 mm 2.22 mm 1.48 mm
Porcine Aorta 9.75 mm 2.69 mm 1.84 mm
Human Skin 9.07 mm 2.27 mm 1.51 mm
Porcine Fat 17.33 mm 6.96 mm 5.22 mm
Porcine Liver 10.04 mm 2.85 mm 1.92 mm
Table 2.1: 1/e penetration depth values for the tissue phantom polyacylimide gel (PAG) and several 
tissue samples Clegg (2002)
2.3 Waveguide modes and coupling
Waveguides channel electromagnetic waves along predetermined paths. The 
waveguides used in the work described in this thesis are coaxial cable and hollow 
metal pipe. Coaxial cable consists of a centre conductor surrounded by a dielectric 
and clad in an outer metal sheath. In a coaxial cable both the electric and magnetic 
fields are at right angles to the direction of propagation, as shown in figure 2.3. This is 
called the transverse electromagnetic or TEM mode. Only waveguides with two or 
more conductors can carry this mode and unlike modes carried by other waveguides, 
it has the advantage that it has no low frequency cut off. However, in theory although 
it can carry any frequency, it becomes increasingly lossy as the diameter of the 
coaxial cable goes down and as the frequency increases.
Figure 2.3: The electric field (shown in red) and magnetic field (shown in green) o f  coaxial cable 
carrying the TEM mode in axial and longitudinal cross section.
The metal pipe is generally either rectangular or circular and can be filled with a 
dielectric. It can only operate in either transverse electric TE or transverse magnetic 
TM form. This means that either the magnetic or the electric fields are perpendicular
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to the direction of energy travel, but not both. This is because at the surface o f any 
good conductor the tangential component of the electric field must be zero and the 
normal component of the magnetic field must be zero. This cannot be true for both the 
top and side walls as would need to be the case if propagating a wave in TEM mode. 
Therefore either the electric or magnetic fields can be transverse. Not being able to 
carry a TEM mode also means that these waveguides have a low frequency cut-off 
point. Frequencies below this point cannot propagate, and the excitation dies away 
exponentially with distance down the guide.
For a circular waveguide, the wave equation can be solved in cylindrical polar 
coordinates to yield a general solution which is in terms of the Bessel equation, and 
therefore has an infinite number o f roots, and is of a particular order n (see Cronin, 
1995). Any particular solution of order n and root / is called a mode. In addition to 
this, Bessel’s equation has two independent solutions, so there are two sets of modes 
of the same orders and roots. One set describe the TE modes and one the TM modes. 
These are denoted by TE„/ or TM„/. n equates to the number of full wave patterns 
around the circumference of the guide, whilst / refers to the number of half wave 
patterns across the diameter. As an example, the electric field patterns of the TMoi 
mode are shown in figure 2.4.
Figure 2.4: The electric field (shown in red) and magnetic field (shown in green) o f  circular metal pipe 
waveguide carrying the TMoi mode in axial and longitudinal cross section.
One important reason for visualising the fields of waveguide modes is because a 
waveguide is usually fed or excited by another waveguide such as a coaxial cable. In 
order to achieve good coupling and minimal reflection when two different waveguides
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are connected, E and H fields need to be produced by the driving waveguide in the 
second waveguide that are similar to the E and H fields of the mode that is intended to 
be excited in the second waveguide. For example, this means that a coaxial cable will 
naturally couple effectively into a circular metal pipe waveguide if the centre 
conductor is positioned such that it will excite the TM oi mode in the metal pipe 
waveguide. This is because the fields patterns produced by the centre conductor when 
positioned protruding into the metal pipe as shown in figure 2.5 will naturally tend to 
excite the T M oi mode.
Figure 2.5: The electric (shown in red) and magnetic fields (shown in green) at the transition between a 
coaxial cable and a circular metal pipe waveguide. The diagram furthest to the left shows the field 
pattern o f  the TEM mode in a cross section o f  coaxial cable. In the centre is shown the extension o f  the 
centre conductor into the circular metal pipe waveguide and the resulting electric fields in longitudinal 
cross section. On the right are shown the electric and magnetic fields o f  the T M oi mode in the circular 
metal pipe waveguide. The similarity o f  the field patterns and orientation o f  the centre conductor in the 
metal pipe allows good coupling to be achieved between the two waveguides.
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2.4 Thermal analysis
2.4.1 Thermal models of biological tissue
Thermal conduction is described by the diffusion equation. For the 3 dimensional case 
where temperature is a function of position and time, T(x,y,z,t), the diffusion equation 
is
v 2r - ^ ^ = - ^ ,  2.11
k dt k
where k is the thermal conductivity, p  is density, c is the specific heat capacity and P 
is the source term measured in Wm‘ . The derivation o f this equation for the one­
dimensional case is given in appendix 1.
For the thermal analysis of clinical microwave heating, the source term, P, can now be 
broken into three parts. Firstly there is the deposition o f microwave power. This is 
commonly expressed in W/kg, and is described as a Standard Absorption Rate or 
SAR. Secondly, there is blood cooling. Finally there is the internal heat generation 
due to metabolic processes, which gives,
P = p ,S A R -p ,p bcbm (T -T b) + p ,Q , 2.12
where p t is the density of the tissue, p b is the density o f blood, Cb is the specific heat
capacity of blood, m is the volumetric flow rate of blood per unit mass of tissue, Tb is 
the temperature of the perfusing blood and Q is the metabolic heat generation, 
measured in W/kg. Multiplication o f the metabolic heat generation and SAR by p t 
converts the power gain per kg of tissue to power gain per cubic metre o f tissue. 
Similarly, p tp bcb is required to convert the units o f m(T-Tb) into power loss per cubic 
metre of tissue.
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Inserting equation 2.12 into 2.11 and re-arranging gives Pennes’ (1948) bio-heat 
equation, which for the 3-dimensional case is,
= V2J  -  PtPbC>’m (T -T b) + — SAR + .
k dt k 4 k k
Pennes’ equation was first developed through his study of temperature in the resting 
forearm of human subjects. Thermocouples were passed through the arms in order to 
measure temperature as a function of depth within the arm. Anaesthetic was not used 
in order that it would not affect the results. Pennes showed temperature differences of 
3-4 °C between the skin and interior of the arm. His model proposed that metabolic 
heat generation is homogenous throughout the tissue. Blood perfusion was also taken 
to be homogenous and the perfusing blood simply heats or cools the tissue through the 
micro-vasculature in proportion to its temperature difference with the local tissue. 
There is assumed to be no energy transfer either before or after the blood passes 
through any point. Chato (1980), Chen and Holmes (1980) and Lemons, Weinbaum 
and Jiji (1987), have all questioned the validity of Pennes’ model, as he makes the 
assumption that blood enters the micro-capillary bed at arterial blood temperature, and 
effectively that no heat exchange occurs in the arteries. Alternative models have been 
developed by Wulff (1974), Klinger (1974), Chen and Holmes (1980) and Weinbaum, 
Jiji and Lemons (1984). These all attempt to take into account the vascular 
architecture. The first three models propose that larger vessels are modelled separately 
from smaller vessels and tissue alone. Weinbaum, Jiji and Lemons attempt to model 
the vasculature based on anatomical observation.
Despite the development of other more complex models, Pennes’ original bioheat 
equation remains very widely used, particularly since it allows analytical solutions to 
be sought. Wissler (1998) returned to look at Pennes’ original data in order to re- 
evalute his work. Although he demonstrated some flaws in Pennes’ work, he 
demonstrated that with improved computations, Pennes’ model was a very good fit to 
the experimental results. Arkin, Xu and Holmes (1994) assessed Pennes’ model in 
different regions of vascular architecture and concluded that it was effective in
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regions of numerous small, but thermally significant, vessels. Xu, Chen, Holmes and 
Arkin (1991) found in a comparison between Pennes’ model, the Chen-Holmes and 
the Weinbaum-Jiji model,, that the Chen-Holmes and Pennes results were virtually 
identical, which leads to the recommendation of the use of Pennes’ model due to its 
greater simplicity. All the other models suffer from additional complexity and the 
need to evaluate additional parameters. Chamey (1992) provides a comparison of all 
the major bioheat transfer models.
A major simplification is possible if the heated volume is small relative to the body. It 
can be assumed that the metabolic processes are sufficient to maintain homeostatic 
equilibrium at body temperature before heat is applied. The temperature o f the blood 
is also assumed to be fixed at this initial temperature. Since the heated volume is 
small relative to the body as a whole, the metabolic processes can be neglected and all 
temperature rises are relative to the initial body temperature with blood circulation 
acting to return the tissue to body temperature. The absolute temperature can therefore 
be characterised purely in terms o f a relative temperature rise.
2.4.2 Temperature dependent properties
All the differences between the various models are related to differences in their 
handling of blood perfusion. However, there are other temperature related factors that 
also need to be taken into account. At temperatures above approximately 60°C (Iizuka 
et al., 2000), coagulation will cause cooling through blood perfusion to be stopped. At 
higher temperatures, steam generation starts to become important. This has two 
effects. Firstly, it helps limit the maximum temperature reached in the tissue due to 
the latent heat of vaporisation of the water. Secondly, it can also actively push hot 
water and steam out through blood vessels, which may possibly extend the bum 
relative to model predictions.
The tissue specific heat and thermal conductivity will also change with temperature 
(Valvano and Chitsabesan, 1987), and is likely to change quite radically as the tissue 
begins to dessicate at high temperatures. In terms of the heat input to the tissue, the
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applied SAR and match o f a microwave applicator is also likely to change as the 
dielectric constant o f the tissue changes as a result o f the tissue heating up.
2.4.3 Measurement of thermal properties
Values for the key properties o f specific heat capacity and thermal conductivity are 
commonly derived through the use of thermal probes such as thermistors that act both 
as a heat source and a temperature sensor (Balasubramaniam and Bowman, 1977 and 
Valvano, 1984). The thermistor is placed at the tip o f a plastic catheter. It is then 
inserted into the tissue and heated (Chen, 1981), Holmes and Chen (1983) and 
Valvano, 1983). Both the electrical power delivered and the resulting temperature rise 
are simultaneously measured. The resulting temperature profile is a function of the 
thermal conductivity, specific heat capacity, power delivered and the blood perfusion, 
and unfortunately it is not possible to calculate all the required unknowns directly. 
Either the perfusion or the specific heat or the thermal conductivity is required in 
order to calculate the others (Arkin, 1986). In-vitro experiments are performed to 
allow the specific heat and thermal conductivity to be derived, or the blood supply 
must be occluded in-vivo. This allows the specific heat capacity and thermal 
conductivity to be derived in the absence of blood perfusion. The perfusion can then 
be derived.
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2.4.4 Thermal tissue properties
Some thermal tissue properties are given below in table 2.2.
Density
- P






1050 -1070 kgm"3 
Duck (1990)
Human
3600 J kg'1 K'1
Cooper & Trezek (1972)
Bovine
3370 J kg'1 K'1 
Robinson (1972)
Human
0.467-0.527 W m ’K '1 
Bowman (1981)
Bovine
0.488 W m’K'1 
Poppendiek et al. (1966)















3150,3280 J kg'1 K*1 
(dermis) Robinson (1972) 




Hensel & Bender (1956) 
0.385-0.393 W m 'K '1 
Van der Staak et al. (1968) 












3528 J kg'1 K'1 
Valvano & Chitsabesan 
(1987)
Derived from thermal 
diffusivity 1.27 x 10’7m 2 s’1
Human Aorta 
0.476 Wm-’K'1 
Valvano & Chitsabesan 
(1987)
0.444 Wm-'K'1 
Van Gemert et al. (1986)
Fat
Human Breast 
917- 939 kgm'3 
Duck (1990)
Porcine
2250,2400 J kg'1 K'1 
Henriques & Moritz (1947) 
2600 J kg'1 K'1 
Lehmann & Johnson (1958) 
2680-3920 J kg*1 K'1 
Robinson (1972)
Human
0.200-0.246 W m 'V
Bowman (1981)
Silica 2200 Kgm*3 740 J kg'1 K'1 1.38 Wm^K'1
Plastic (polythene) 940 Kgm'3 1900 J kg'1 K'1 0.47 Wm-'K'1
Table 2.2: Thermal properties of relevant materials
As can be seen, there are quite significant differences between published results for 
both specific heat capacity and thermal conductivity even in the same tissue types. 
This is likely to be due to the difficulties in obtaining accurate measurements for the 
reasons described in section 2.4.3. However, as with complex permittivity values, 
thermal property values appear to be fairly similar across tissue types, bearing in mind 
the uncertainty inherent in the measurements themselves. This is with the exception of 
fat, which is consistently reported as having lower thermal conductivity, specific heat 
capacity and density values than other tissue types.
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2.5 Simulations
2.5.1 Introduction
Unfortunately, the electromagnetic field pattern is not the heating pattern. Thermal 
conduction carries heat away from the region being heated and blood cooling will also 
alter the degree of heating. This transfer of heat is governed by the diffusion equation. 
This can be solved using a variety o f methods including analytical techniques, finite 
element and finite difference methods. Finite element solutions require specialist 
computational analysis programs, but a quick and quantitative estimation of 
temperature in both space and time can be achieved using simple finite difference 
techniques.
2.5.2 Finite difference simulations
Finite difference methods simply approximate differentials by calculating gradients 
numerically. The gradient at any point in x can be estimated by evaluating the 
absolute value of that equation at points on either side of the chosen point at a 
distance of +h and —h. The approximate gradient will, o f course, be the difference 
between the values of the function evaluated at these two points divided by 2h. This is 
called a centred approximation. This naturally means that finite difference 
approximations are based on grids. In this case the grid spacing is h. As h gets larger, 
the approximation becomes less accurate. The error in this approximation will be of 




Tu  = T(X,> t j ) and xMJ = xu  + h
Double differentials can also be approximated numerically using
i
dx2 h
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The centred approximation relies on being able to evaluate the function on either side 
of x  Boundary conditions are therefore required. These specify the value, or the 
gradient of the function, at the extreme edges of the grid i.e. x = 0 and x = L when the 
grid runs from 0 to L. These effectively set the reference frame for the rest o f the 
approximations.
Since this is a system that evolves in time, time is also represented on the grid with a 
spacing of n. The temperature profile at any point t + n is governed by the 
temperature profile at t. However, the temperature profile at / + 2n is as yet unknown 
when the profile at t + n is approximated. A simpler approximation is therefore used. 
This simply evaluates the temperature difference between points t + n and t and 
divides by the step size n. This requires an initial temperature profile at t = 0 rather 
than boundary conditions in order to give a temperature profile to start from. Since the 
gradient is evaluated over fewer points the error increases relative to a centred 
approach and is of the order o f n. The approximation is therefore,
&Tt , 1
- i r ' — P w -T u )  dt n
where,
T,j  = T (*,, tj  ) and f U+1 = tu  + n .
This numerical description is called a forward time centred space approach.
Not only does the error increase as h and n increase, but the errors can reach a point 
where they make the algorithm unstable. This is important since there is a trade-off 
between accuracy and speed. As h and n increase, the speed of the approximation 
increases since there are now fewer points in the grid, at the expense of accuracy. 
Fortunately computers are now sufficiently powerful to run the algorithms used for 
the temperature calculations in this thesis quickly, even with small grid spacings. The
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stability requirement according to Chapra and Canale (2002) for this simple forward 
time centred space approach is given by
1 kn
2 > V
where k is the thermal conductivity. This requirement also ensures convergence.
2.5.3 Green’s function simulations
Another common method for the solution of PDEs, such as the diffusion equation, is 
by the use o f Green’s functions, as described by Courant and Hilbert (1953).
The SAR applied to the tissue can be visualised as a set of impulse heat sources, or 
“source points”. Each impulse heat source will cause a temperature rise at a point in 
space that is a function of the tissue properties, time and the distance between the heat 
source and the point where the temperature is measured. The point at which the 
temperature rise is required is the “field point”. Let G( d, t )  denote the temperature 
rise o f the tissue at any distance d  from the source point at time t, where t is measured 
from the impulse. This is the Green’s function kernel, which is effectively a solution 
for the case in which the medium is assumed to be homogenous except at one point.
For the case of a infinite homogenous medium, the Green’s function G(d, t) as 
described by Yeung (2001), is given by
G (d,t)= ap\ 
k(4 nat)
kwhere a is given by — , and u is a lumped perfusion parameter given
pc
by ^ p tp bcbm /k  . m is the volumetric flow rate o f blood per unit mass of tissue. The
•y
factor p tp bcb is required to convert m into units of W m '.
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Once the Green’s function kernel is obtained, linearity is then assumed and this allows 
superposition of the solutions from single impulses to give solutions for the defined 
heat source distributions over the required time. The total temperature rise at a point 
in space caused by a source distribution SAR is therefore given by the volume integral 
of G over the full range of source points in the region SAR, taking into account that 
the magnitude of the point source heating described by G is a unit magnitude. The 
SAR therefore needs to be convolved with G in order to give the correct magnitude o f 
heating. This gives the temperature rise from a single impulse of heat with the 
distribution SAR. The entire expression then needs to be integrated over time to give 
the temperature rise that will be induced by the SAR being applied for a length of 
time. For the case in which the applied SAR is defined in cylindrical polar coordinates, 
the temperature rise AT(ro, t )  at a point in space ro after a length of time t ’ during 
which the SAR has been applied, is given by
t
AT(r0,t') = J ^ \G {rQ\r',t)SAR{r,9, z)rdQdzdrdt
0 v
where ro is the field point located in space at (ro, 0, zq), r ’are the source points located 
at (r, 6, z), and ro\r ’ is the distance between the source points and the field point.
Due to the complexity of the resulting integrals, a numerical solution method can be 
required. The commercial program Mathcad® can be used to generate the solution.
2.5.4 Finite element (FE) simulations
Correctly matching the applicator to the tissue at the chosen treatment frequency and 
ensuring the correct field pattern is extremely difficult without the help o f a finite 
element package such as Ansoft HFSS (High Frequency Structure Simulator, 2003) or 
ANSYS version 8.0 (2003). Theory gives guidelines as to the approximate shape to 
make the applicator, whilst the fine tuning is conducted by building and testing the 
applicator in the computer, as, for example, in figure 2.6. The results from a particular 
simulation allow the design to be altered and improved. This saves making and testing 
each particular design, and hence saves time. Furthermore, all the dimensions of a 
design can be parameterised. This allows either automated optimisation of the design
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dimensions, or a batch analysis with the dimensions stepping through a range between 
pre-determined limits.
It is also possible to perform finite element thermal analyses, including mapping of 
the heating induced by an applicator generated by an electromagnetic solution into a 
thermal solution, or even coupling of the two solutions in ANSYS. This allows both 
the microwave properties and the thermal properties to be optimised.
Figure 2.6: A varicose veins applicator modelled and meshed in HFSS
FE analysis involves four underlying steps. Firstly, the region to be solved is divided 
into a finite number of subdivisions, or elements. The governing equations for the 
elements are then derived. All the elements are then assembled into a matrix which is 
finally solved to obtain the required unknowns for each element. The procedure for 
generating and solving a FE simulation is described below.
2.5.5 Initial decisions
There are three initial decisions to be made:
a) What to model
There is always a trade-off between computation time and model completeness. The 
more detail that is included the longer the simulation takes, but the greater the chance 
of obtaining a solution that is an accurate reflection of reality. It is therefore very
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important to assess correctly what is required, and what can be approximated or 
ignored.
b) How to model it
It is often possible to take advantage of symmetry when modelling. In order to take 
advantage of this, the geometry, loading conditions and material properties need to be 
symmetric. There are four different types of symmetry that can be applied. 
Axisymmetric, rotational, reflective and repetitive. Axisymmetric means complete 
symmetry around a central axis, so that model can become two dimensional. 
Rotational means that there are repeated segments around a central axis. Reflective 
means that one half of the model is the mirror image of the other half. Finally, 
repetitive means that segments are repeated along a straight line.
c) Choice of element type
This is partly governed by the point above. Depending on the different degrees of 
symmetry in the model, different element types need to be used. A two dimensional 
axisymmetric model would require two dimensional axisymmetric elements that take 
this symmetry into account. Naturally, the correct element type for the dimensionality 
of the problem needs to be chosen, such as whether to use line elements, shell 
elements, two dimensional or three dimensional elements. The element shape can also 
be determined. For example, the elements can be brick shaped, tetrahedral, 
quadrilateral or triangular. In addition, the element type must be suitable for solving 
the problem, for example, thermal, electromagnetic or structural.
2.5.6 Preprocessing
In general the following five steps are required:
a) Creating the model geometry 
This can be approached in two basic ways -  bottom-up, and top-down. Bottom-up 
means defining keypoints in space. These are then joined by lines, which in turn are 
linked together to form areas and volumes. In the top-down approach, basic volumes 
called primitives are defined through a minimal set o f commands. These are then 
operated upon using Boolean operations, to create the required geometry. Both 
approaches can be combined in the course of creating a particular geometry.
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b) Defining the materials
This simply means applying the relevant properties to all the volumes in the 
geometry. These can have temperature dependence in ANSYS. It is important to use 
the same units as those used in the creation of the model, as definition of the units is 
not required to obtain a solution.
c) Meshing the model
This is an important step in the creation of the model as the model geometry created 
earlier plays no part in the actual solution. Only the mesh created within the geometry 
will be used to generate the solution. The greater the mesh density the more likely it is 
for the solution to be accurate. However, this has to be set against the additional 
computation time required when solving larger matrices. In order to assess the areas 
that need refinement and maximise accuracy, the mesh density can be increased in 
areas o f importance after an initial trial solution has been obtained, as shown in 
figures 2.7a & b. This can be done manually or automatically. In a thermal solution, 
areas of high thermal gradient are the areas that may benefit most from mesh 
refinement. In a HF solution, areas of high field intensity will benefit most from a 
finer mesh. Automatic mesh generation and refinement saves time in the short term 
when generating the model, but may well cause refinement in areas that are not 
required, adding significantly to the computation time.
1 iteration 1063 tetrahedra 6 iterations 2817 tetrahedra
Figures 2.7 a & b: Increasing number o f  elements in the dielectric o f  a varicose veins applicator 
modelled in HFSS as the mesh is refined
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d) Applying loads
These are the model constraints and boundary conditions. For high frequency 
solutions typical loads are port excitations and radiation boundary conditions. For 
thermal solutions, heat flux, fixed temperature areas, adiabatic surfaces, radiating 
surfaces, convecting surfaces and internal heat generation loads are often used.
e) Solving
The solution of an ANSYS model is performed in loadsteps. This is defined as one set 
of loading conditions for which a solution can be obtained. For a thermal solution a 
loadstep lasts for a given time. Within each load step the solution is broken down into 
substeps. So for a thermal solution a new solution would be generated at each substep. 
Once again there is a trade-off between computation time and solution accuracy. More 
substeps will give a more accurate result, but result in longer solution times. At the 
end o f each loadstep different loading conditions can be applied. For example, in a 
thermal solution, the SAR of an applicator can be removed after a given time period 
in order to allow both heating and cooling to be modelled. The thermal properties of 
the tissue can also be made temperature dependent.
It is also possible to change the solution type from one loadstep to another. For 
example, once the SAR and match of an applicator have been derived from an 
electromagnetic solution, ANSYS allows the SAR to be directly mapped into a 
thermal model. This transfer of data from one solution to another is applicable when 
the two interactions are loosely coupled. This means that one of the simulations is 
considerably less influenced by the changes induced from the results o f the other one 
than vice versa. This situation can be iterated, though, so that the thermal changes can 
be used to alter the SAR and match, which in turn are fed back into the next thermal 
analysis. In other words the microwave properties o f the tissue have been made 
temperature dependent.
2.5.7 Post-processing
Once a solution has been generated, the results generated need to be filtered to obtain 
only the information of interest. This is typically achieved through the use o f contour
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plots on cross sections, animations and graphs of relevant data at points o f interest. 
Correct interpretation of the results is crucial and it is, o f course, always important to 
relate the model output to reality. It may be necessary to re-examine the 
implementation of the model.
2.6 Use of the Arrhenius equation to estimate cel! damage
2.6.1 Introduction
The degree of damage to the cell is a function of both temperature and the length of 
time for which the temperature is maintained. A higher temperature for a shorter time 
is therefore equivalent to a lower temperature for a longer time. The influence of 
temperature and time on cell damage has been studied by Borelli (1990) in tests on 
baby hamster kidney (BHK) cells between 43.5°C and 57°C. It was concluded that as 
a general rule of thumb, a decrease in temperature of 1°C requires a 1.8-fold increase 
in heating time to achieve the same percentage of cell survival. The absolute level of 
cellular damage for a particular length of time at constant temperatures of 43.5, 46, 
50,54 and 57°C were also given by Borelli.
In reality, the temperature experienced by tissue at any given point is not constant, but 
is a function of time T(t). In this case the degree of thermal damage can be quantified 
by use of the Arrhenius equation, as first performed by Moritz and Henriques (1947) 
using
where Q(x) is the degree of tissue damage at time x, E is an activation energy, R is the 
universal gas constant (8.314 J/mole/K) and A is a rate parameter. T(t) is in Kelvin 
and C(x) is the proportion of cells surviving at time x.
This equation is widely used for quantifying the progress of chemical reactions and
tissue damage. In chemistry, the activation energy is the minimum energy required by
E /RT(t)
has been used almost without modification for quantifying hyperthermia induced
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a molecule to react with another molecule. The e~E 1 RT(t) term comes from the 
Maxwell-Boltzman distribution and gives the likelihood that the two molecules will 
be carrying this minimum energy. As is to be expected, this probability rises with 
temperature. The rate parameter can be visualised as giving a likelihood that the two 
molecules will successfully meet to allow a reaction to take place. A comprehensive 
introduction to the Arrhenius equation and its use in quantifying the progress of 
chemical reactions is given by Zubay (1993).
An important assumption of the Arrhenius equation is that for a constant temperature 
the decrease in surviving cells as a function of time will be an exponential decay since
/ ]Ae~E
C(t) = C(0)/
For a fixed temperature, activation energy and rate parameter Ae~E will be a 
constant. In this case letting R = A e~E 'RT{t) will give
C(r) = C(0)/eR*.
This model therefore assumes that at a fixed temperature cellular survival decays 
exponentially, and the rate of this decay is a function of the temperature and the 
chosen activation energy and rate parameter. There are two problems with this 
approach. Firstly, for quantifying tissue damage the values of E and A have no 
physical meaning. Secondly, as shown in section 2.6.2, cellular survival has been 
shown to decrease at a greater than exponential rate at a fixed temperature, bringing 
into question the validity o f this approach to quantifying thermally induced tissue 
damage. However, the Arrhenius equation is very widely used and there are no 
commonly accepted alternatives.
E and A are parameters that need to be determined from data such as Borelli’s, such 
that omega is unity at the point of irreversible tissue damage. This is taken to be when 
cell survival rates are at 37%. Published values include E = 430,000 (+/- 85,000)
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Jmole"1 and A = 5.6 x 1063 (+/- 8 x 1012)s_1, used by Baldwin (2001). Iizuka (2000) 
uses values of E — 506,400 Jmole'1 and A = 2.984 x 1080 s'1. The wide variation in 
values means that a very wide range of possible conclusions for bum depth can be 
drawn. Indeed, even the uncertainties on the values for A and E given by Baldwin 
(2001) are so large as to render the given values as meaningless.
2.6.2 Fitting Arrhenius equation parameters to published data
Since published values for A and E are so highly variable, values of A and E for use in 
this work were found from looking back at the original data on cell survival over time 
at fixed temperatures from Borelli. Borelli’s results are plotted below in figures 2.8a- 
e, with the fraction of cells surviving plotted on a log scale on the y axis in blue, 
against time. The increasing gradient of the line shows that the rate of cell death does 
in fact increase faster than exponentially over time. As mentioned earlier, this means 
that the Arrhenius equation cannot therefore be made to fit the entire curve, no matter 
what values o f A and E are chosen. However, since the most important part of the 
curve is the upper part, which is where the vast majority of the cell death takes place, 
values for A and E can be chosen to most accurately describe this part o f the curve.
C  »7Q
Using values for E o f 5.064 x 10 and A of 8.5 x 10 gives the pink lines in figures 
2.8a-e. This shows that there will be a slight overestimate in the percentage o f cell 
death up until the point at which cell survival reaches approximately 37%. If heat is 
applied for longer that this, then cell death rates increase dramatically relative to the 
Arrhenius predictions. This therefore fits well with 37% cell survival representing 
tissue death, as any slight degree of heating beyond this point will cause a greater 
level of tissue death than predicted by the Arrhenius equation using the chosen values 
for E and A. There is a good agreement between the Arrhenius predictions and all the 
experimental data available, which is over the range of temperatures from 43.5°C to 
57°C. This represents agreement over three orders of magnitude in terms of time.
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Figure 2.5a: Experimental cell survival data (blue) compared to the fitted Arrhenius equation (pink) at 
43.5°C




Figure 2.5b: Experimental cell survival data (blue) compared to the fitted Arrhenius equation (pink) at 
46°C







Figure 2.5c: Experimental cell survival data (blue) compared to the fitted Arrhenius equation (pink) at 
50°C
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Figure 2.5d: Experimental cell survival data (blue) compared to the fitted Arrhenius equation (pink) at
54°C




“ BorreSi 57C 
-Arrhenius
Figure 2.5e: Experimental cell survival data (blue) compared to the fitted Arrhenius equation (pink) at 
57°C
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2.7 Bench testing
2.7.1 Introduction
A variety of bench test models are used to characterise applicators, including the 
tissue phantom polyacrylamide gel (PAG), gelatine based gels, egg white, foam and 
water loads, ex-vivo animal liver and ex-vivo human samples. Histology can then also 
be performed on the ex-vivo animal and human samples. All of these have very 
similar microwave dielectric properties, thus allowing the match to be tested using the 
network analyser and in all cases except for the foam load, the heating pattern to be 
visualised. They cannot, of course, take into account the effects of blood cooling, but 
they are an extremely valuable tool for the development and testing of applicators.
2.7.2 Temperature logging
In conjunction with these models, temperature logging is often required. This is 
performed in two ways. For temperature measurements outside of the microwave field 
standard thermocouples, such as those shown in figures 2.6 and 2.8, have been used. 
These are connected to an analogue to digital converter to allow temperature-logging, 
as shown in figure 2.7, which interfaces with a computer to log the data. For 
measurements inside the microwave field, Luxtron® optical fibre temperature 
measuring probes have been used in conjunction with Luxtron’s 3201 and 720 data 
collection systems. Once again, these are interfaced with a standard PC in order to log 
the data.
Figure 2.9: Thermocouples Figure 2.10: Thermocouple A to D Figure 2.11: Thermocouples
converter bedded in PAG around an
MEA applicator handle
Fibre optic temperature sensors are not affected by the microwave field as the probes 
contain no metal parts, but in regions of rapidly changing field intensity, there can be 
a slight delay in their response, as explained in section 4.8.4.
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2.7.3 Calorimetry
A definitive measurement o f the output power of a device can be made through 
calorimetry. The applicator is placed in a known volume of water held in an insulated 
container and power applied for a known time. The temperature rise is measured. 
Knowing the specific heat capacity of water together with the volume heated, the 
length of time that heat is applied for and the temperature rise, allows the power 
output of the applicator to be calculated. The volume of water surrounding the 
applicator needs to be sufficient to prevent significant levels of microwave leakage. 
The penetration depth of the microwaves at the frequency being used therefore needs 
to be taken into account in the design of the calorimeter. If the power input to the 
applicator is known, the efficiency of the applicator can also be calculated.
2.7.4 Network analyser measurements
A network analyser compares the microwave signal that leaves the analyser and is 
incident on a test device with either the signal that is transmitted through the test 
device, or the signal that is reflected from its input. Of most importance for the work 
in this thesis is the reflection coefficient, called “SI 1”. This consists of both a 
magnitude and phase. For characterisation of applicator efficiency only the magnitude 
is required and this is commonly referred to as the “match”. For calculation o f the 
complex permittivity of materials, accurate measurement o f magnitude and phase is 
required. The ratio o f the magnitude of reflected to incident power is generally 
displayed in dB. An applicator with an S ll o f -lOdB therefore reflects 10% of 
incident power. This is normally the minimum required for an applicator to be 
described as “well matched”. Such a level is, o f course, arbitrary.
2.7.5 Polyacrylamide gel (PAG)
Initial testing of applicators is often performed in PAG. This is a transparent, jelly- 
like, high water content gel that is clean, easily storable, reusable and has similar 
dielectric and thermal properties to tissue (Andreuccetti, 1988). It can also have 
surfactants added to it that become opaque at a predetermined temperature (Yamura, 
1982). This enables heating patterns to be visualised, as shown in figures 2.12a and 
2.12b. It has a major advantage over other phantom materials in that it can stand the
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temperatures that are achieved during microwave ablation without melting. Appendix 
2 gives details of the process used to make PAG.
Figures 2.12a & b: Applicator heating patterns being tested in PAG Clegg (2002)
2.7.6 Egg white
Egg white has been a commonly used microwave tissue phantom material. It has the 
advantage that it is non-toxic and gives a very visible white heated volume. On the 
other hand it is difficult to prepare large quantities and is therefore only useful for 
heating small volumes. Another disadvantage is that convection is possible, which 
distorts the perceived heating pattern. However, it can be ideal for presentations.
2.7.7 Foam and water loads
These consist of open cell foam that is moistened until wet, but not sodden. This 
means that the applicator surroundings are wet, but the water cannot convect, so 
allowing the temperature of the water surrounding the applicator to rise. It is ideal for 
testing the temperature response of applicators and also allows the match to be 
assessed.
2.7.8 Ex-vivo animal liver
Liver has the useful property of blanching at a temperature of around 50 °C, as shown 
in figure 2.13, in addition to possessing the correct dielectric properties and thermal 
properties. This makes it ideal for evaluating the likely size of the bum in-vivo. The
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liver is typically warmed in a water bath to 37°C, after which the experiment is carried 
out. Pig’s liver is typically used due to its lack of vessels. Unfortunately it consists of 
relatively thin lobes of around 3cm in thickness. This is insufficient for large bums 
and experiments conducted at low frequencies. It also makes it difficult to section into 
thin slices and there is also the possibility that surface cooling will influence the 
result. Ox liver is available in large pieces, but the vascular architecture is of greater 
calibre, which often results in less clear-cut results than otherwise would be available.
C 
0
Figure 2.13: A well defined bum in liver
2.7.9 Ex-vivo human samples and histology
Human tissue that has been removed from consenting patients can also be used to 
perform tests. These have the advantage that they will replicate in-vivo conditions as 
closely as possible, with the exception of course, of blood perfusion. Also, if it is still 
within 10-15 minutes of being removed, the tissue will still be alive. The bum can 
then be induced, followed by fixation of the sample in liquid nitrogen. The resulting 
histology that can be performed should give a realistic idea of the likely extent of the 
bum in-vivo. If the tissue sample is already dead, then a bum can still be done and 
histology performed, but it is likely to be an underestimate of the likely bum in-vivo, 
since only the gross destruction of cells will be recorded.
For investigation of gross damage to cells, loss of collagen birefrigence is commonly 
used, as described by Thomsen (1989). Polarised light is shone through a thinly 
sectioned piece of tissue, and examined under a microscope. Thermally undamaged 
tissue with high collagen content appears bright, as shown below in figure 2.14, whilst 
damaged tissue appears dark, as shown in figure 2.15.
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Figure 2.14: Vein cells exhibiting no loss o f  Figure 2.15: Vein cells exhibiting loss o f
collagen birefringence (Metcalfe, 2004) birefringence after thermal insult (Metcalfe,
2004)
Unfortunately, microwaves are a well-known method of fixing tissue (Kok and Boon, 
1990 and Yamashiki et al., 2003), and the changes that result in a change in collagen 
birefringence, also require a threshold level of time and temperature. This means that 
the changes that may be expected to be observable to demonstrate cell death are only 
visible after much higher levels of thermal damage than are required to kill the cell. A 
more subtle, but still common technique checks for the activity of a mitochondrial 
enzyme called succinic dehydrogenase (SDH) (Swift, 2003 and Yamashiki, 2003). 
Succinic acid and a stain called nitrotetrazolium blue is added to the tissue, and in 
areas where the enzyme is still functioning the enzyme catalyses a reaction to convert 
the stain to an insoluble pigment. The stain is then washed away with water, but 
remains fixed in the areas of viable tissue. The live areas are therefore left stained 
blue, as shown below in the uterus in figure 2.16.
Figure 2.16: A uterus that has undergone MEA in-vivo followed by histological assessment for SDH 
activity, showing the thermally damaged areas
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Certain cells are low in SDH, such as veins, so an alternative, but similar test is used 
to check for the viability of another enzyme called NADH. Once again, 
nitrotetrazolium blue is used to check the outcome of the test. A typical outcome is 
shown in figure 2.17. The vein on the right was not thermally damaged, whilst the one 
on the left was.
Figure 2.17: A thermally damaged vein (left), alongside a non thermally damaged one (right)
(Metcalfe, 2004)
It is important to recognise that whilst the viability test demonstrates the degree of 
damage inflicted upon a particular enzyme, this does not prove cell death since it is 
impossible to be sure that the cell cannot recover.
Chapter 2: Microwave and thermal analysis Page 53
Two Applications o f  Microwave Therapy: Psoriasis and Varicose Veins
C hapter 3: P soriasis
3.1 Introduction
3.1.1 Background
Psoriasis is a chronic skin inflammation caused by abnormally quick skin cell 
reproduction. Ortonne (1996) has shown that the cell cycle is reduced from 311 hours 
to 36 and the skin cell transit time, which is the length of time it takes for the skin 
cells to travel from the base of the epidermis to the surface, is decreased from 28 days 
to just 4. Psoriasis presents in a variety of forms, but around 80% of sufferers have 
plaque psoriasis, such as that shown in figure 3.1, which leads to red thickened areas 
with silvery scales. It also presents differently in different individuals, and ranges 
from very mild intermittent attacks to the severe and chronic. It can even change from 
one type to another over a patient’s lifetime. It tends to appear on the elbows, knees, 
small o f the back and other areas that are regularly flexed, such as the hands and feet 
(Ashcroft, Po & Griffiths, 2000). Fortunately for sufferers, it tends not to appear on 
the face, except in the most serious cases.
Figure 3.1: Chronic plaque psoriasis
The exact cause is unknown but it appears to be due to a damaged immune system 
response that manifests itself cutaneously. Psoriasis often appears aggressively at 
around 20 years of age, but can appear at any time. It can also appear later on in life at 
around 60, at which point it tends to be less aggressive (Ashcroft, Po & Griffiths, 
2000). There is a large genetic component to the disease. Children with no psoriatic 
parents, but first-degree relatives who do suffer from the disease, have a 4% chance of
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inheriting it. According to Swanbeck and colleagues (1997), if  one of the parents is a 
sufferer then the risk rises to 28% and if  both parents are sufferers then the risk rises 
to 65%. The disease is therefore likely to be caused by multi-site genetic defects. 
There are several proposed genetic linkages with one in particular standing out. The 
marker Cw6 was present in 85% of individuals with early onset psoriasis in a study by 
Tilikainen and colleagues (1980). Monozygotic twins, however, only have a 72% 
chance of sharing the condition (Farber & Nall, 1971), so genetics is certainly not the 
only culprit. Stress, physical injury, infection and the use of drugs are also known 
contributory factors (Ashcroft, Po & Griffiths, 2000).
Psoriasis is a surprisingly widespread disease with around 1-2% of the population 
affected, according to the results of a questionnaire survey in the US by Farber and 
Nall (1974). This means that there are around 1 million sufferers in the UK and 
around 4-5 million in the US. It is also an extremely unpleasant affliction. Rapp and 
colleagues (1999) found in their study that “Patients with psoriasis reported a 
reduction in physical and mental functioning comparable to that seen in cancer, 
arthritis, hypertension, heart disease, diabetes and depression.” Despite being so 
common and unpleasant there is relatively little research interest as it is both non-life 
threatening and notoriously difficult to treat. There is no cure at present, and treatment 
therefore focuses on limiting the disease. Current treatments can be divided into three 
basic categories -  topical agents, phototherapy and systemic agents. Topical means 
that the treatment is restricted to the skin, whilst systemic means that the treatment is 
applied throughout the body. Creams are therefore topical agents, whilst drugs that are 
injected or taken orally are systemic.
3.1.2 Current psoriasis treatments
First-line treatments are generally topical. The simplest treatment is simply an 
emollient. This aims to reduce the itchiness and scaliness o f the plaque. Steroidal 
creams, coal tar and anthralin are commonly used for patients with mild to moderate 
psoriasis. They tend to be messy and ineffective however, with a response rate of 
around 50%. For more serious cases of psoriasis UV therapy (PUVA) and oral anti- 
cancer drugs such as Methotrexate are given (Boreham, Gasmann and Mitchel, 1995). 
However, these more effective treatments also have potentially more serious side
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effects. The dangers of UV radiation are well known (Ashcroft, Po & Griffiths, 2000), 
and psoriatics can only have a limited number of courses of treatment over their 
lifetime. Since psoriasis is a disease involving cellular proliferation, anti-cancer drugs 
provide the most effective treatment, but they are also the most harmful, with possible 
serious and long-term side effects (Duhra, 1993).
3.1.3 Hyperthermia for the treatment of psoriasis
Hyperthermia means heating tissue to sub-lethal temperatures, and is a promising 
candidate for psoriasis treatment. It was extensively tested in the 1970s and 1980s 
when attempts were made to heat psoriatic plaques to between 42°C and 45°C with 
ultrasound (Orenberg, 1980), infrared radiation (Westerhof, 1987), water (Orenberg, 
1986) and exothermic pads (Urabe, 1981). These temperature levels are sufficient to 
induce a response, whilst still being below the pain threshold. This is reported as 
being 46°C by Cook (1952) who heated subjects using microwaves at 3GHz. 
Microwave therapy would provide another treatment option for small, and also 
possibly larger, area chronic plaque psoriasis, and remove the need for patients to be 
exposed to high doses of potentially carcinogenic UV radiation.
The mechanisms that produce a response to hyperthermia are unknown, but excessive 
heat is well known to prevent cell replication by inhibiting DNA, RNA and protein 
synthesis (Westerhof, 1987). Heating produces heat shock proteins such as p53 
(Conner, 1977) that are known to slow the cell cycle. Another possibility is that 
localised heating may have an effect on the immune system, thus directly altering an 
underlying cause of the psoriasis. It could be that both effects are important in treating 
psoriasis. Cancer is also a hyperproliferative cell disease, like psoriasis, and 
hyperthermia has been shown to be a clinically effective cancer treatment in mice by 
Herman (1977).
Skin cells are formed at the base of the epidermis, the stratum basale, (indicated in 
figure 3.2) and move up from there to form the other layers of the epidermis. Psoriatic 
cells do not appear to adequately respond to spatial limitations. They therefore end up 
effectively producing what would be a large sheet o f cells in the relatively small area
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of the plaque. This leads to an even more irregular base than in healthy skin. The 
cross section through a psoriatic plaque shown in figure 3.2 shows just how irregular 
the epidermis can be. The heating needs to penetrate down to the base of the 
epidermis in order to be as effective as possible. This undulation makes delivering the 
heat effectively more difficult, since there is high blood flow in these folds, and the 
pockets of skin that hang down will be well cooled by the blood flow surrounding 
them. In fact, cutaneous blood flow in plaques is around ten times higher than in 
healthy skin according to Kemp and Staberg (1983).
Stratum
basale
Figure 3.2: A cross section through a psoriatic plaque. The stratum basale is arrowed in the picture and 
is visible as a thin layer o f  dark purple cells. The epidermis starts at the stratum basale and includes all 
the layers from the stratum basale to the surface, (http://www.jichi.ac.jp/usr/path/athos/gifs/i90853.gif)
In order to maximise treatment effectiveness, the superficial 3mm of the skin needs to 
be heated to a therapeutic temperature according to Orenberg (1986). This is typically 
between 42 and 45°C. However, if  the skin surface is maintained at a therapeutic 
temperature, hyperthermia induced by simple hot pads, water contact and infra-red 
heating hyperthermia systems can result in insufficient heat conducting down to 
ensure a therapeutic effect over the crucial 3mm (Orenberg, 1986).
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Ultrasound does induce heating in the tissue and appears to produce an improved 
therapeutic response compared to exothermic pads. Urabe and colleagues (1981) 
produced a clinical response in 16-45 days using pads at temperatures of 42-43°C, 
whilst an ultrasound hyperthermia system produced a response in an average of six 
treatments given over a two week period at a temperature of 43°C (Orenberg, 1980). 
Since microwaves also deliver heat directly into the tissue, they offer the opportunity 
to replicate, or perhaps even improve upon, the results achieved by ultrasound 
heating. Microwave hyperthermia was demonstrated by Keddy-Grant (1990), who 
treated three volunteers with microwaves at 2.45 GHz. One was successfully treated, 
and remained psoriasis free during the three-month follow-up period. The other two 
volunteers withdrew from the trial due to uncomfortable deep heating. The promise of 
microwave therapy therefore appears to have been demonstrated, but only at an 
inappropriate frequency that will cause significantly deeper heating than is required. 
As shown in table 2.1, the 1/e penetration depth of microwaves at 2.45 GHz is 9mm. 
This is significantly greater than the 3mm of heating that is thought to be optimum. It 
should therefore be possible to perform a very similar treatment to those o f Urabe and 
Keddy-Grant, but using microwaves at a more appropriate frequency. This should 
replicate their results with similar efficacy but with less side-effects.
On the other hand, given the apparent success o f hyperthermia for treating psoriasis, it 
is unclear why research appears to have been discontinued. The results o f the 
ultrasound trial by Urabe and colleagues (1981) in particular appear to be very 
promising. One possibility is that the production of a commercial treatment system is 
not economic due to the complexity required of such a system. In addition, the fact 
that only a limited area can be treated by ultrasound therapy would make this 
treatment modality too time-consuming to be used in the case of most patients. This is 
because psoriatics are likely to have multiple plaques located all over the body. The 
same may also be true of microwave based treatments, but additionally, the 
withdrawal of 2 out o f 3 subjects in the only published microwave based trial would 
almost certainly discourage further research in this direction. It is also possible that all 
the studies were very careful in their patient selection, and hyperthermia would not 
prove to be as effective as other interventions in a randomised controlled trial.
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3.2 Aims of the research
It should be possible to maintain the advantages of a microwave treatment whilst 
preventing the problem of deep-heating that occurred for Keddy-Grant, by altering the 
frequency used in the treatment to a higher value than 2.45GHz and so reducing the 
penetration. The aim o f this work therefore consists o f three fundamental parts. 
Firstly, to assess the most appropriate frequency at which to conduct a treatment using 
a thermal model. Secondly, to develop a system that will be able to provide a 
treatment at this frequency. Finally, to test the system in psoriatic volunteers which 
should allow an assessment of whether the chosen higher frequency can eliminate the 
problem of painful deep heating, and hence possibly provide an improved treatment 
for psoriasis.
3.3 Finite difference modelling
33.1 Introduction
The amplitude of an electromagnetic wave decays exponentially as it passes through 
tissue. The rate at which the decay occurs is determined by the chosen frequency and 
the complex permittivity of the tissue as explained in section 2.2. At 2.45 GHz the 
field intensity has dropped to around one third of its initial value after 18mm in 
human skin. It is therefore understandable that any hyperthermia treatment conducted 
at this frequency could induce painful deep-heating.
3.3.2 Model development
In order to study the influence of microwave frequency on the heating induced in the 
skin, a thermal analysis of the problem was conducted by numerical solution of the 
bioheat equation given in section 2.4.1 in one spatial dimension. The equation that 
was solved was
k dt dx k k
where T is the temperature of the tissue in °C, p t is the density of the tissue, p b is the 
density of blood, Cb is the specific heat capacity of blood, m is the volumetric flow
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rate of blood per unit mass of tissue, 7* is the temperature of the perfusing blood and 
SAR is the microwave induced heating, measured in W/kg. Values for the various 
tissue properties involved in the model are therefore required as given in section
3.3.2.1-a, including a value for blood perfusion as given in section 3.3.2.1-c. In 
addition, values for the microwave power deposition are required as given in section
3.3.2.1-b.
This is equation differs from the pure bioheat equation due to the fact that metabolic 
heat generation has been neglected. This is because the heated volume is sufficiently 
small that any effects on metabolic heat generation are assumed to be negligible. 
Furthermore, metabolic processes are assumed to be sufficient to maintain
homeostatic equilibrium at body temperature before heat is applied. The initial
temperature is therefore assumed to be the subcutaneous tissue temperature.
This allowed the expected temperature profile at different microwave frequencies to 
be predicted by using a finite-difference discretisation in time and space, and a 
forward-time-centred-space approach, as given in section 2.6. The grid spacing was 
selected to be 0.1mm in space, which imposed a constraint on the spacing in time to 
be less than 0.044s in order to ensure stability. For simplicity, the spacing in time was 
chosen as 0.01s. A fixed temperature boundary condition was placed at a depth of 
5cm with the temperature set at the subcutaneous temperature. At the surface a 
symmetry boundary condition was used, with an extra term to account for power loss 
due to surface cooling through convection. This cooling term also requires
characterisation, and this is described in section 3.3.2.1-d. It does, of course, assume
that the heated area is an infinite flat plane. This model is given in detail in appendix 3 
and all the key tissue properties used in the model are given in table 3.4.
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33.2.1 Parameter derivation
a) Tissue properties
The tissue properties given in table 3.1 were taken from Duck (1990) for use in the 
model.
Tissue property
Density p  = 1133 kgm'3
Specific heat capacity C  = 3417.5 Jkg^K 1
Thermal conductivity k = 0.360 Wm^K1
Table 3.1. Tissue properties used for the computer modelling (Duck, 1990)
b) Microwave heating
The microwave heating was described by an exponential decay, the rate of which was 
determined by the complex permittivity o f the tissue, and the frequency, as described 
by Sadiku (2001). The complex permittivity of skin at different frequencies is given in 
figure 2.2. The relationship between power absorption and depth is therefore
Px=Poe2ax,
where Po is the power absorbed per unit volume at the surface, Px is the power 
absorbed per unit volume at depth x, and a is the attenuation coefficient defined in 
section 2.2.1.
The total power input per unit area (Pt ) is therefore given by
p, = \p xdx.
0
Plotting e'2ax for human skin at 2.45, 7 and 9.2GHz gives the graph of normalised 
SAR against depth shown in figure 3.3, which is equivalent to power absorbed per 
unit volume since the power absorption is normalised and the density is a constant.
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Figure 3.3: Power absorbed as a function o f  depth in human skin at three frequencies 
c) Blood cooling
The blood cooling was simply described by a uniform rate of heat loss that was 
directly proportional to the temperature difference between the blood temperature and 
the tissue temperature. Using Klemp and Staberg’s (1983) blood perfusion value for 
psoriatic skin of 63.5ml 100g'lmin'1 and Duck’s (1990) value for the density of human 
skin of 1133 kg m'3 gives
where T is the temperature of the tissue in °C and Tb is the constant blood temperature,
d) Surface cooling
It would theoretically be possible to calculate the degree of heat loss at the skin’s 
surface if the surface temperature were known and the perfusion level known. Since, 
however, in-vivo perfusion levels are uncertain, it is not possible to use temperature 
measurements of skin to evaluate the degree o f heat loss. Therefore a tissue phantom
= -0 .0 \2 x (T  - T b) ,
ot
i) Introduction
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was used to try and evaluate the rate o f heat loss that would occur on the patient’s 
skin, assuming that the skin was in contact with air at an ambient temperature, as the 
tissue phantom has zero perfusion. PAG tissue phantom (described in section 2.10.1) 
was used as its surface is naturally slightly damp, and can be expected to have similar 
thermal properties to the surface of sweating human skin.
ii) Method
A round sheet of PAG tissue phantom of 2cm thickness and 20cm in diameter was 
immersed in a water bath at 37°C until warmed through. It was then raised to the 
surface until the surface was just above the water level, and a Luxtron temperature 
measurement optical fibre was taped to the centre of the surface of the PAG disc. The 
temperatures were then logged as the surface cooled. This approach was taken as it 
meant that the situation could be closely modelled using the ID finite difference 
thermal model, with the heat loss coefficient (defined in equation 3.1) as the only 
unknown parameter. The properties o f PAG used in the evaluation are listed in table
3.2. The model therefore consisted of a 2cm thick layer of PAG with the lower end 
having a fixed temperature boundary condition of 37°C. The starting temperature of 
the entire layer was 37°C. Surface cooling was assumed to follow Newton’s Law, 
which states that the rate of heat loss is assumed to be directly proportional to the 
temperature difference between the surface and the ambient temperature, and is 
directly proportional to the surface area. This is valid for both forced and natural 
convection according to Jones (2000) and can be expressed as
q = hA (Ts - T^, 3.1
where q is the heat lost from the surface, A is the area, Ts is the temperature of the 
surface, T» is the bulk temperature of the fluid and h is the constant o f proportionality 
called the heat transfer coefficient.
The surface cooling heat transfer coefficient was then adjusted manually to give the 
best possible fit to the logged temperature cooling data.
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Polyacrylam ide gel
Density (Bini, 1984) p -  1030 kg m'3
Specific heat capacity (Bini, 
1984)
C = 4187 Jkg 'K'1
Thermal conductivity (Bini, 1984) £ = 0.41 Wm-'K’1
Complex permittivity (7 GHz) 
(Clegg, 2002)
4 8 .2 - /2 1 .8
Table 3.2. PAG properties used for the computer modelling
An analysis was also made of the effect of forced air cooling on the heat transfer 
coefficient in exactly the same way as for natural convection alone. As before, a flat 
sheet o f PAG was heated in a water bath, then raised just above the water line and the 
surface temperature fall measured. However, this time air was blown onto the surface 
from a small fan as shown in figure 3.4.
Figure 3.4: Experimental set-up for relating heat transfer coefficients to forced air cooling rates
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The rated airspeed through the fan was 0.849ms'1 at a voltage of 12V. The airspeed 
was assumed to vary in direct proportion to the fan speed cubed, as described by 
Graebel (2001), the resistance of the fan was assumed to be a constant, and the 
airspeed was assumed to vary in direct proportion to the power input, as shown in 
table 3.3. Several different voltages were applied to the fan and once again, the heat 
loss at the surface was evaluated by best fit to the measured data. The aim was 
therefore to allow a quantitative relationship between airflow speed and the heat loss 
through surface cooling to be derived.
Voltage applied to fan Power input (arbitrary 
units)
Fan speed (arbitrary 
units)
Air flow speed 
(m/s)
0 0 0 0
3V 0.0625 0.39685 0.337
6V 0.25 0.63 0.535
9V 0.5625 0.825 0.7
12V 1 1 0.849
Table 3.3: Air flow speec derivation
iii) Results
0 1In the absence of forced air cooling, using a value of 224.3 Wm' K‘ for the heat 
transfer coefficient in the model gave the result shown in figure 3.5. This provides a 
good fit to the experimental data and therefore provides a value for the likely surface 
heat loss o f sweating human skin through convection alone.
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Figure 3.5: Comparison between modelled and measured rate o f  temperature fall on the surface o f  PAG
As can be seen, the value of 224.3 Wm^K'1 gives a good fit over a considerable 
length of time during a transient response, giving confidence in the value. For the 
forced air-cooling, the best fits between the model and the experimental results that 




Measured 0 m/s 
Modelled 224 W/mA2/K 
Measured 0.337 m/s 
Modelled 776 W/mA2/K 
Measured 0.535 m/s 
Modelled 1467 W/mA2/K 
Measured 0.7 m/s 
Modelled 1941 W/mA2/K 
Measured 0 849m/s 
Modelled 2588 W/mA2/K
Figure 3.6: Comparison between modelled and measured surface cooling data
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Once again, a good degree of concurrence was possible between the modelled and 
measured results. Plotting the air flow speeds against the fitted heat transfer 


















Figure 3.7: Airflow speed over tissue phantom against surface cooling coefficient. The confidence 
intervals are based on the maximum and minimum surface cooling coefficients that can reasonably be 
fitted to the measured data shown in figure 3.6
This allows the airflow speed that would be required to obtain a given heat transfer 
coefficient to be estimated. This therefore gives meaning to the values for heat 
transfer coefficient and in particular gives meaning to the results o f the thermal 
modelling given in section 3.3.4 that predict an optimum heat transfer coefficient to 
try and obtain the most effective thermal profile.
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e) Model parameters summary
In summary, the properties given in table 3.4 were used in the modelling.
Tissue (Skin)
Density* p =  1133 kgm'3
Specific heat capacity* C = 3417.5 Jkg^K'1
Thermal conductivity* £ = 0.360 Wm^K'1
Blood perfusion* co -  63.5mllOOg ’min"1
Complex permittivity (2.45 GHz)§ 56.3 - *16.3
Complex permittivity (7 GHz)5 49.2-/21.6
Subcutaneous temperature 36.5°C
Surface cooling (convection only) h = 224.3 Wm^K'1
Table 3.4: Tissue properties used for the finite difference thermal modelling of psoriatic skin 
(#Duck, 1990, §Clegg, 2000, *Klemp and Staberg, 1983)
33.3 Solution optimisation
Initially an optimum solution was sought using a hill-climbing algorithm. (Given in 
appendix 4). This simple algorithm was tried first due to its simplicity and due to the 
problem only requiring optimisation of three parameters -  the power, frequency and 
surface cooling coefficient. It compares the solutions that result from using different 
sets o f parameters against a pre-set target solution (Goldberg, 1989). A value is then 
assigned to each trial solution, which is given by the sum of differences between the 
pre-set optimum and the target squared, as given by equation 3.2.
The object of the program is to minimise this value. It starts with a trial solution and 
finds the value associated with that solution. It then varies these starting parameters 
slightly and finds the value associated with the new solution, whilst also retaining the 
original parameters. The parameters out o f the two possibilities that give the better 
solution survive to the next generation. These surviving, more appropriate, parameters 
are also varied slightly, and then their value compared again to their parent
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parameters. Once again, the more suitable parameters survive to the next generation, 
and so on. The value attached to a given trial solution is therefore
n 2
Value = £  (T°p"m"m -  T ‘n°') , 3.2
0
where T, is the temperature at each point in the finite difference grid and n is the 
number of grid points in the spatial dimension
In order to speed up program execution, the algorithm starts with a temperature 
profile that is the target solution. In other words, the initial conditions for the 
simulation are set as the target. The simulation is then run for one cycle, which is 10 
milliseconds of simulation time. If the parameters were perfect, then the temperatures 
would not deviate from the optimum in any way, since the target is the required 
solution in the steady state. The greater the change over this one cycle, the less 
appropriate this set of parameters would be. This method greatly speeds up program 
execution times. Rather than starting at body temperature with each trial solution and 
waiting several minutes for the steady state to be reached, the suitability o f any 
solution can be found in one cycle.
For the treatment of psoriasis, the optimum solution would be a step function with a 
temperature of 43°C over the superficial 3 millimetres and normal body temperature 
below that, which is impossible to achieve. Setting the target as a step function results 
in the algorithm either tending towards zero power, or infinite power with a very low 
frequency. In order to get a useful result from the algorithm the target needs to be at 
least approximately achievable.
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The target was set using a best fit approximation using Microsoft Excel, by picking 
the surface to be 43°C, the temperature at 1.5 mm to be 44°C and the temperature at 
3mm to be 43°C, with a rapid drop in temperature down to body temperature after 
that. This gave the equation shown in figure 3.8 for temperature as a function of 
depth, which is
T =  1.S6 * Iff9x ? - 8.08* Iff7x4 + 0.000147x?-0 .0 1 0 9 x? + 0.21x + 42.968, 3.3
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Figure 3.8: Target temperature profile
This is clearly unrealistic at depths of below 10mm, but this is unimportant since the 
parameters that the algorithm varies will have little to no influence so deep below the 
surface. The lower boundary condition of 36.5°C also prevents the algorithm from 
being able to try to approximate the profile below 10mm in depth. Closer to the 
surface however, the profile is appropriate, and it is this that the algorithm 
approximates the trial solutions to.
In order to check that the solution was converging to a consistent set of parameters, 
the algorithm was run several times starting with various different values.
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3.3.4 Results
a) Optimum solution with surface cooling
The optimum parameters were consistently found to be a power input of 3875Wm' at
- i  1
a frequency of 5GHz, with a heat transfer coefficient of 330 Wm' K' with the air at 
20°C. The value for surface cooling of 330 Wm'2K"' is equivalent to an air speed of 
only around 0.5ms'1. It is interesting to note, however, that most of the improvement 
in the error came from the extra air cooling as shown in figure 3.9. Variations in 
frequency and power had a smaller effect. 3875Wm'2 equates to a power input o f 15W 
for the applicator described in section 3.4.3. The surviving parameters in each 
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Figure 3.9: Optimisation o f  frequency, power and surface cooling parameters over 3000 generations
The temperature profile after 5 minutes starting from body temperature using the 
optimised parameters is shown below in figure 3.10. This is very close to the required 
profile.
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Figure 3.10: Simulated temperature profile using optimised parameters after 5 minutes of heating
b) Optimum solution without surface cooling
Since the degree of air-cooling required to obtain the required profile is minimal, an 
investigation was then conducted without this parameter. Figure 3.11 shows the 
predicted profile that would be induced by heating due to simple thermal conduction 
from surface heating, compared to that induced by heating at both 2.45 GHz and 7 
GHz. A frequency of 7 GHz was chosen because it was predicted to give a 
temperature of 42°C at a depth of 3mm. This should therefore give a therapeutic 
treatment over the top 3mm of the skin, whilst not being therapeutic at below 3mm, 
and not requiring any form of extra surface cooling. The likely effectiveness o f the 
treatment compared to simple thermal conduction should be increased because o f the 
higher temperatures reached below the surface. It also should reduce the likelihood of 
causing unnecessary pain due to heating below the epidermis when compared to a 
treatment at 2.45GHz, due to the more targeted heated depth.
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Figure 3.11: The predicted temperature profiles in psoriatic skin produced by contact heating compared 
to those produced by microwave hyperthermia at 2.45 GHz and 7 GHz.
3.4 The treatment system
3.4.1 Introduction
In view of the additional complexity that would be entailed by incorporating a forced 
air-cooling system, together with the limited effect that it was predicted to have, the 
decision was made not to incorporate forced air cooling into the treatment system. A 
system was therefore required to safely heat human skin to a pre-set hyperthermic 
temperature using the predicted optimum frequency of 7GHz. The design that was 
settled on was based on readily available equipment linked together, with a custom 
made applicator and custom feedback control. The overall system configuration is 
shown in figure 3.12, with a description of the system components given in section
3.4.2.
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Figure 3.12: The components o f  the psoriasis treatment system together with their interconnections
The temperature of the skin was measured using the Luxtron fibre optic thermometer, 
the tip of which was taped onto the skin. The measured temperature was then fed back 
to the computer where a feedback algorithm would alter the power of the source to 
maintain the set-point temperature. A travelling wave tube amplifier then amplified 
this source output, which was connected to the applicator through a standard coaxial 
cable. The power meter simply provided a check on the output power of the amplifier. 
The mains supply to all components was delivered through an isolation transformer in 
order to meet medical electrical equipment safety standard EN60601.
3.4.2 System components
The microwave source consisted of an oscillator to generate low power microwaves at 
the required frequency, as shown below in figure 3.13. The microwaves were then 
amplified by an amplifier, shown in figure 3.15. The surface temperature was 
measured using a fibre optic temperature sensor (figure 3.14) taped to the skin. The 
measured temperature was fed back to a standard PC, which altered the power output 
from the source using a feedback algorithm. The program also logged the skin 
temperature and source power output. The feedback and control algorithm was
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created in Agilent Vee, which is a commercially available data acquisition and 
instrument control program.
Figure 3.13: The source Hewlett-Packard HP8350B Figure 3.14: The Luxtron fibre optic
sweep oscillator combined with a HP83592A RF plug-in thermometer -  model 3201
Figure 3.15: The amplifier - an ETM SC band travelling wave tube
Since the power output at the applicator was determined by the power input from the 
source, the power output at the applicator needed to be characterised for the source 
and amplifier combination over the range of output of the source, and for various 
appropriate levels of amplifier gain, as shown in figure 3.16.
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Figure 3.16: Source power output against actual power output. Data was only logged at the marked 
points. The continuous lines are the functions that were used to interpolate between the available data 
points.
The power output from the source was logged along with the set-point temperature 
and the actual skin temperature by the PC. Figure 3.16 therefore allowed the power 
available to the applicator to be derived from the logged power outputs recorded for 
the source.
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3.4.3 The applicator
Since the computer modelling showed that 7 GHz seemed the optimum frequency to 
choose, an applicator needed to be designed that would deliver microwave radiation at 
this frequency. It also needed to fulfil a variety of design criteria. It had to be tolerant 
to movement relative to the surface and needed to give predictable, preferably even, 
heating over the aperture, whilst ideally allowing the skin to be in contact with air. 
This was modelled using the finite element package HFSS (High Frequency Structure 
Simulator).
The fundamental applicator design chosen was basically an air filled metal pipe 
waveguide. The edges of the metal cylinder can be placed on the skin to prevent 
radiation leakage, and since the heated area will only be in contact with the air, 
potential allergy related problems and perspiration build-up between the applicator 
and the skin should be minimised. It also allowed the design to retain the possibility 
of being adapted to incorporate forced air-cooling if later required.
The applicator was designed to use the TMoi mode because this mode is easily excited 
when fed by a coaxial cable, as described in 2.3. This is because o f the similarities 
between the field patterns of the TEM mode of coaxial cable and the TMoi o f the 
waveguide. To successfully excite the TMoi mode the centre conductor of the coaxial 
cable needs to be extended into the waveguide in line with the waveguide, and in the 
centre. This therefore fixes the position of the centre conductor, as shown in the cross 
section through the design given in figure 3.17. The diameter of the applicator was 
then chosen according to the requirements of the mode. Using the formula given by 
Cronin (1995, p85), the TMoi mode at 7GHz is cut-off in air at a radius of 1.64 cm. 
This means that a circular waveguide with less than this radius will not carry the TMoi 
mode. The cut-off radius for the next mode, the TMn mode, is 2.61 cm. The radius of 
the waveguide was therefore chosen to be mid-way between these two values at 
2.2cm. A Perspex plate was incorporated around half-way down the waveguide as a 
tuning device. The length of the centre conductor extension into the waveguide and 
the thickness and position o f the Perspex plate were then altered manually within 
HFSS to minimise the magnitude of the reflection coefficient at 7GHz. In order to
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ensure patient safety and conform to the relevant electrical safety standards, the 
applicator was covered with a machined uPVC jacket, both inside and out. The base 
of the applicator was covered in moulded silicone rubber. This prevented direct 
patient contact with any metal parts that were connected to the system.
/
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Figure 3.17: Psoriasis applicator. Dimensions in mm
Some theoretical and experimental test results are shown in figures 3.18-3.20
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Figure 3.18: Applicator tolerance analysis in HFSS. Figure 3.19: Applicator magnetic field
The reflection coefficient (SI 1) is given in dB vector as given by HFSS
Figure 3.18 shows the match of the applicator against a range of loss tangents and 
permittivities. This was carried out to give an indication of the tolerance of the 
applicator’s match to changes in skin complex permittivity, thus ensuring that the 
applicator would not be sensitive to small changes in complex permittivity, allowing 
increased safety and reliability in use and comparability to bench test data from 
experiments in PAG. Small changes may arise due to measurement errors of the 
complex permittivity of skin, and also temperature dependence of complex 
permittivity. As can be seen in figure 3.18 the match is predicted to be better than - 
lOdB for almost all combinations. The limits of the tested combinations are fairly 
arbitrary, but were chosen such that they comfortably bracket the permittivities and 
loss tangents of both PAG and skin, which are 49 and 47 respectively, with loss 
tangents of 0.44 and 0.46. In figure 3.19 the magnetic field vector is shown, 
demonstrating that the applicator is operating in TMoi mode.
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Figure 3.20: The applicator heating pattern shown using an LCD sheet overlying a tissue phantom 
(PAG). Blue is 44°C, green is 43°C, yellow is 42°C and red 41°. The heated area is 4.4cm in diameter
Figure 3.20 is a photograph of an LCD sheet, which was placed on the surface of a 
block o f PAG and heated with the applicator in order to give a visual indication of the 
heating pattern. As is to be expected, the TMoi mode results in minimum heating in 
the centre of the waveguide, with the maximum power input to the tissue being 
approximately half way between the centre and the circumference of the applicator. In 
order to ensure that the optical fibre was placed somewhere on this line of maximum 
heating, paper templates were used to mark the position of the tip of the fibre optic 
cable using a pen, and hence the required position of the applicator on the skin before 
treatment.
HFSS model (blue line) com pared  to  analyser o u tpu t (red line) for p so rias is  applicator
Frequency GHz








Figure 3.21: Predicted reflection coefficient (SI 1) against frequency from HFSS compared to measured 
SI 1 against frequency
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The S ll  values between 5 and 10GHz are very similar to the predicted values from 
the HFSS simulations, as can be seen in figure 3.21, but the low S ll  at 7GHz was 
actually found at 6.95GHz. Since conducting all experimentation at 6.95GHz would 
have a negligible effect on the results, all further experimentation was actually 
conducted at 6.95GHz. The finished applicator is shown below in figures 3.22a & b. It 
was then attached to a flexible arm using the machined connection on the side of the 
applicator, in order that it would be self-supporting when in use.
Figure 3.22 a & b: The finished applicator without, and with, insulating jacket
As mentioned earlier, in order to conform to the relevant electrical safety standards 
the applicator was covered with a machined uPVC jacket, both inside and out. The 
base of the applicator was covered in moulded silicone rubber and the connectors 
were covered in a rubber boot. The entire system was tested at the Leicester Royal 
Infirmary Medical Physics Department and passed the electrical safety requirements 
of EN60601.
3.4.4 Temperature control
Temperature control in this system is critical. Over 45°C could cause a bum, but the 
tissue also needs to be at over 42°C to be effective. Furthermore, this temperature 
needs to be reached within several minutes after the start of treatment, and with no 
overshoot. The system is also unpredictable since different power levels will produce 
a different response depending on the amount of energy that has been put in
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previously, and on the blood perfusion level. If the tissue is just warm at the surface, 
then more energy will be required to reach any higher set temperature than if  the 
tissue is thoroughly warmed through already.
A very common form of standard feedback controller is a PID controller, as described 
by Astrom and Hagglund (1988). It was therefore decided to use this as the basis of 
the temperature control algorithm. This is made up of proportional, integral and 
derivative control (hence PID), or any combination of these, except for purely 
derivative control, as described by
Ul(t) = K pe(t) 
U2(t) = Kl je(t)dt
where Kp, Kj, and Kj  are gain constants, e(t) is the error and U(t) is the control 
variable. e(t) is given by r —y, where r is the set point andy is the measured value.
In the case of purely proportional control, the first term of the algorithm alone is used, 
so Ux (/) = K pe(t) . In this case the control variable is simply proportional to the error
between the measured and required values. This has a fundamental disadvantage for 
use in this application, however. This is that as the error goes to zero, the control 
variable also goes to zero. This means that there always needs to be an error in order 
to provide a non-zero control signal. In this application, a constant amount o f power 
needs to be applied to maintain the required temperature. It is possible to adapt the 
proportional control term to include an extra constant, soUx(t) = K pe(t) + C . This
will therefore mean that the control term will be non-zero even when the error is zero. 
However, in this application the required value of the constant is unknown and will 
depend on the steady state power level required for each treatment. The proportional 
control term was therefore not used in this implementation.
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The integral control term gives no set point error (Astrom and Hagglund, 1988) 
making it ideal for this application. When implemented in a situation in which the 
measured values are sampled, the integral term can be approximated from the terms 
shown above according to Astrom and Hagglund (1988) using
where U2 is the control variable, Kt is a gain constant and t„ is the time at discrete time 
interval n.
Finally, the derivative term can be used to speed up the response of the algorithm 
(Astrom and Hagglund 1988). The error term given above is made up of the 
difference between the set point and the measured point
U,(t) = Kd ^  = Kd dr dy 
dt dt
However, set point r is normally constant, and thus will not contribute to the 
derivative term, y  is the measured value. The derivative term can therefore be 
implemented as
two-*, f .
In the discretised case where the measured values are sampled, this can be 
approximated by
Ui {t„) = K d(y„-y„_l ) ,
where U3 is the control variable, Kd is a gain constant, tn is the time at discrete time 
interval n andj^ is the measured value at discrete time interval n.
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Both integral and derivative control was implemented in the control algorithm in 
order to try and obtain fast acting and accurate temperature control.
Setting the gain constants and deciding which terms to include is an empirical 
procedure. Extensive experimentation is therefore vital. In order to speed up this 
process the finite difference thermal analysis program described above was used. This 
meant altering the power input over time by using different combinations of formulae 
and gain constants. Before starting this manual tuning of the gain constants, an 
experiment was performed to check that the results would be meaningful. The 
complete psoriasis treatment system was set-up to warm room temperature PAG using 
a control algorithm with purely integral control. The gain constant was set using the 
computer model such that it was predicted to give a very slow response, but with 
decaying oscillations. The system was then run over the same time period as the 
computer model to allow a comparison of the predicted and measured results. The 
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Figure 333: Modelled feedback algorithm response (pink) against measured response (blue) in PAG
The degree o f overshoot in the simulation is considerably lower than in reality, but the 
similarity was sufficient, especially considering the very long timescale, to allow use 
of the model to try different feedback algorithms and adjust the gain constants. Each
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computer simulation took only a few seconds, saving an enormous amount of 
experimental time and effort.
This initial trial had a very long settling time and a high degree of overshoot. The 
addition of derivative feedback, together with careful tuning of the gain constants, 
allowed the degree of predicted overshoot to be reduced to acceptable limits, and the 
set-point temperature to be reached in an acceptable time period. However, all this 
careful tuning meant that the system was no longer robust. Changing the degree o f 
blood cooling had a dramatic difference on the settling times and overshoot. In figure 
3.24 the response was good, but multiplying the perfusion by a factor of 10 meant that 
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Figure 3.24: Modelled temperature response o f  an integral and derivative (ID) feedback algorithm 
(blue) using a fixed set temperature o f  43°C (pink)
This problem was solved by using a moving set point that ramps up at the required 
rate to the treatment temperature. The ID (integral and derivative) controller is used to 
keep the surface temperature as close as possible to this moving set point. It 
effectively prevents a massive overshoot thus allowing the feedback control to be 
speeded up. In the computer models this was an extremely effective means of 
temperature control. The actual temperature was quickly within about 0.1 of a degree 
of the set point, and was extremely robust to changes in perfusion and temperature, as 
shown in figure 3.25.
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Figure 3.25: The effect o f  high gain and a moving set point temperature on the surface temperature and 
power input
In reality the results were not as good as the simulations, but were a massive 
improvement on having a fixed set point. As shown in the bench test result in figure 
3.26, which was carried out on PAG, a therapeutic temperature can be safely reached 
in around 3 minutes, or even less. The chosen algorithm was,
Pn = P .-, + <.<Tm -TJX -r_ ,) x P„_,






Figure 3.26: Bench tested result in PAG using the optimised feedback algorithm
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The final algorithm varies slightly from the textbook versions given above in that each 
term is multiplied by the power level. This was incorporated so that the feedback 
response would increase or decrease proportionately to the power level. Low power 
levels would therefore have proportionally lower changes in power, for the same 
changes in temperature.
Further investigation showed that the noise in the surface temperature data was 
influencing the algorithm. The Luxtron data varied by around +/-0.5°C. Adding this 
random variation into the feedback in the computer model allowed the modelling to 
be even more representative. This is illustrated in figure 3.27, and allowed further 









Figure 3.27: Comparison between modelled feedback algorithm performance and feedback algorithm 
performance in use
The modelling showed that the power varied considerably during treatment, although 
the temperature stayed constant. To damp out this noise a reduction in both gain 
constants by a factor of 20 was required. However, this also had the unwanted effect 
of preventing the treatment temperature from being reached quickly without any 
overshoot. The solution was to start with the previously chosen gain constants, but to 
reduce them exponentially during the warm-up phase so that the algorithm became
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progressively more damped, as shown in equations 3.4 and 3.5. This allowed both a 
fast warm-up and steady power during treatment.
K t = 0 .19x(2-'/10°) + 0.01 3.4
K d = 0.76 x (2 “"100) + 0.04 3.5
where t is time in seconds.
3.5 Bench characterisation in a tissue phantom (PAG)
3.5.1 Introduction
The system was also characterised on PAG without the temperature feedback control. 
There were three aims to this experiment. Firstly, to find the relationship between the 
power input used in the model and the power input to the applicator. This was 
performed because the heating over the heated region of the applicator is not even, 
meaning that the power input as measured by the power meter cannot be accurately 
related to a power input per unit area at the point at which the optical fibre tip is 
placed. Secondly, once this calibration factor is determined, to check that the 
computer model predictions correlate well over a range of power levels with the 
measured results, and finally to attempt to estimate the likely degree of error inherent
in the system through assessing the degree of error between the model and the system.
3.5.2 Method
The experiment was performed by using a paper template to position both the fibre 
and applicator such that the tip of the fibre was at the point of maximum heating on 
the surface of a sheet of room temperature PAG as shown in figures 3.28 and 3.29. A 
fixed power level in the region that was likely to be approximately appropriate for 
therapeutic heating was then applied. After 2 minutes power was cut and the block 
allowed to cool. This was repeated for a range of appropriate powers. The PAG was 
left to re-equilibrate to room temperature between experiments, and a new position on 
the sheet used each time, but the average starting temperature o f the block did 
increase gradually over the course of the experiments. Once this data was obtained the 
finite difference computer model program was run and the power input adjusted such
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that a calibration factor was obtained that would allow a reasonable fit of all the 
predictions to the results.
%
Figure 3.28: The paper template used to locate the Figure 3.29: The applicator in position on the 
fibre relative to the applicator PAG
3.5.3 Results
All the experimental results, together with the fit from the model that matched them 






















Figure 3.30: Model predictions fitted to experimentally measured temperatures for a range o f  power 
levels
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3.5.4 Analysis
As can be seen there is a good degree of correlation between the model and the 
measured results for both heating and cooling, over the whole range of appropriate 
power levels, and a range of starting temperature. This is despite the fact that the 
model describes the heating and cooling of an infinite plane. The heated area of the 
applicator therefore appears to be sufficiently large not to be grossly effected by this 
approximation. The power level on the model was adjusted to best match the 
experimental results and give a mean error of 0°C. This gives a standard deviation of 
0.555°C. A histogram of the temperature differences is shown in figure 3.31. This 
gives 95% confidence that a modelled temperature will be within +/- 1.1 °C of the 
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Figure 3.31: A histogram o f the temperature differences between the modelled and measured bench test 
results
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3.6 In-vivo testing
3.6.1 Aims
The primary aim of the trial was to assess the possibility of using a frequency of 
7GHz to treat psoriasis. The set-point temperatures were therefore gradually increased 
over the 6 treatments in order to assess the likely range of patient acceptability, and in 
particular, to look for signs of discomfort or deep heating.
3.6.2 Methods
3.6.2.1 Subjects
Subject 1 was a 47 year old woman with chronic plaque psoriasis. Subjects 2 and 3 
were 43 and 37 year old men, also with chronic plaque psoriasis. Subject 1 was 
undergoing tar treatment at the time of the tests, but not in the treated area. Neither of 
the two other volunteers had undergone treatment in the previous 6 months. Ethical 
approval for the study was given by the Leicester Hospitals Trust and all subjects 
gave informed consent to take part.
3.6.2.2 Procedure
Tests were conducted on three volunteers every Tuesday and Thursday for three 
weeks. This treatment interval was determined by the timings of the dermatology out­
patient clinic. Photographs were taken before and after every treatment session. The 
applicator was placed on the chosen area of skin and the position marked so that the 
same area of skin could be treated every time. The algorithm was designed to err on 
the side of caution, which resulted in the mean temperature during a treatment being 
0.2°C below the set temperature. The chosen treatment temperature was reached after 
3 minutes, and then maintained for 20 minutes. The set temperatures are given below 
in table 3.5.
Session 1 Session 2 Session 3 Session 4 Session 5 Session 6
Subject 1 40°C 42°C 43°C 43 °C 43°C 43°C
Subject 2 40°C 42°C 44°C 43°C 43°C 43 °C
Subject 3 41°C 42°C 44°C 43°C 43 °C 43°C
Table 3.5: Treatment set temperatures
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In the first subject, the applicator was placed on the forearm, in the area indicated in 
figure 3.32. In the second subject the applicator was placed as shown in figure 3.33. 
In the third subject, the applicator was placed so as to cover both the plaque and 
healthy skin, as shown in figure 3.34 with the temperature being monitored on the 
healthy skin. The treatment set-up is shown in figure 3.35.
Figure 3.32: The location o f  the applicator on the first subject
Figure 3.33: The location o f  the applicator on the second subject
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Figure 3.34: The location o f  the applicator on the third subject. The temperature was measured on the 
healthy skin
Figure 3.35: The complete system in use
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3.6.3 Results
3.6.3.1 Clinical results
All three volunteers completed the trial, and there were no signs of the deep heating 
that had caused two out of three of the subjects in Keddy-Grant’s (1990) trial at 2.45 
GHz to drop out. Despite the limited number of treatments, an improvement was 
reported by subject 2 after the treatment at 44°C, as shown in figure 3.37. The subject 
reported a reduction in scaliness and itching, and a noticeable increase in skin 
softness. There was also a reduction in surface skin temperature from 36.2°C to 
33.3°C, indicating a reduction in hyperperfusion. The surface skin temperature over 
the course of the 6 treatments is shown in figure 3.36. Unfortunately, this 
improvement was also associated with some blistering within the treated area, as 
shown to the right of the improved area in figure 3.37. Following this, all treatments 
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Figure 3.36: Initial surface skin temperature o f  subject 2 (psoriatic) over the 6 treatments compared to 
the surface skin temperature o f subject 3 (healthy) over the course o f  the treatments. The dotted lines 
are the results o f  applying linear regression to the data points and are to show the general trend o f  the 
data points. A clear downward trend is visible for the psoriatic skin over the course o f the treatments, 
against a slight increase for the healthy skin.
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Figure 3.37: The circled area shows the area o f  improvement in the second subject. The blistering is 
also visible.
The level of power required to maintain the set temperature was widely different 
depending on whether the temperature was monitored on healthy or psoriatic skin, as 
shown in figure 3.38. The difference increased greatly over the temperature range, up 
to a difference of around 5 times the required power at 43.8°C. Furthermore, on the 
final treatment the temperature on both the plaque and the healthy skin of the third 
subject was simultaneously measured during the treatment. This showed that the 
plaque was between 1.5 and 2°C cooler than the surrounding skin. This meant that it 
was at between 41.5 to 42°C, which is just under the therapeutic temperature.
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Figure 3.38: Power level required to maintain a set surface skin temperature
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3.6.3.2 Blood perfusion analysis
Since both the power input and the surface temperature are known, an assessment can 
be made of the skin’s blood perfusion, and its variation with temperature. The known 
power input is applied in the finite difference computer simulation and the blood 
perfusion varied using a feedback algorithm to give the correct surface temperature. 
Since the surface skin temperature for subject 2 was measured on a plaque, and the 
skin temperature for subject 3 was measured on healthy skin, the level of blood 
perfusion for both healthy skin and in a chronic plaque can be assessed.
This analysis predicts a greatly increased level of blood perfusion in psoriatic skin, 
with the differences increasing with temperature, as shown in figure 3.39. Fitting a 
linear trend line through the data gives a level of blood perfusion in psoriatic skin as 
to = 39T - 1510 whilst the level of blood perfusion in healthy skin is given by co = 
2.4T -  90, where co is the blood perfusion in mllOOg 'min'1 and T is the surface skin 
temperature. The overall mean error in blood perfusion values at 95% confidence is 
+/-29%, with a mean error for the blood perfusion in healthy skin at 95% confidence 
o f +/- 32%, and a mean error at 95% confidence in psoriatic skin o f +/- 26%.
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Figure 3.39: Predicted blood perfusion level in both healthy (pink) and psoriatic skin (blue). The dotted
lines are to show the general trend o f  the data points and are based on applying linear regression to the
data points. The equations o f  the lines o f  linear regression are given above in section 3.6.3.2.
This relationship between blood perfusion and surface temperature was then applied 
to a 2D finite difference model (given in appendix 5) in order to model the case of 
subject 3, where the healthy and psoriatic skin were equally heated, but the 
temperature was controlled on the healthy skin. Half the tissue was designated as 
psoriatic and the perfusion was set according to the equation for perfusion in psoriatic 
skin, whilst the other half was set as healthy, with the perfusion levels set accordingly. 
The model was over 10mm along the surface of the skin with the psoriatic to healthy 
interface at 5mm. At the edges of the plane going down into the tissue, symmetry 
boundary conditions were imposed, with a fixed temperature boundary condition 
along the bottom edge of the plane at a depth of 1cm. Power levels were set such that 
a temperature of 43°C would be achieved at 5mm from the psoriatic to healthy skin 
interface, on the surface of the healthy skin. The resulting surface temperatures are 
shown in figure 3.40. The temperatures predicted over the plane are shown in figure 
3.41.
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Figure 3.40: Predicted surface temperature levels for the case where psoriatic skin meets healthy skin. 
The healthy skin was maintained at 43°C












Figure 3.41: Predicted temperatures for the case where psoriatic skin meets healthy skin. The healthy 
skin was maintained at 43°C
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The temperature on the surface of the psoriatic skin is predicted to be 41.1°C, which is 
slightly lower than the temperature measured in reality of between 41.5 and 42°C. 
This could be because the perfusion levels in subject 3 were lower than those of 
subject 2, as his psoriasis was not as severe. The predicted perfusion level for subject 
3 may therefore be something of an overestimate.
In addition, using the same 2D model, the folds of skin shown in figure 3.2 were 
modelled to assess whether the greater blood cooling within the folds would be likely 
to have a significant impact on a microwave therapy. The width of the plaque was 
guess-estimated to be around 1.5cm. This would give a thickness to the epidermis of 
1.7mm with the folds reaching down to around 4.3mm below the surface. The width 
of each fold was around 1.1mm. These values were put into the model with perfusion 
values chosen so that the epidermis would have the same perfusion as healthy skin, 
whilst the dermis would be perfused at the level measured in subject 2. The perfusion 










Figure 3.42: The perfusion levels chosen to simulate the folds o f  psoriatic skin shown in figure 3.2
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Figure 3.43: Predicted temperatures for heavily folded psoriatic skin. The skin surface was maintained 
at 43°C
As can be seen in figure 3.43, the effect of the folds is minimal, and so they are 
predicted to have a minimal impact on any possible therapeutic effect.
3.7 Discussion
Microwave hyperthermia conducted at a frequency of 7 GHz does indeed appear to 
prevent deep heating when tested in-vivo and therefore represents an improvement 
over hyperthermia at 2.45 GHz. However, an improvement in patient condition was 
only reported in the second subject out of the three, and this was associated with 
blistering of another part of the treated area. This lack of improvement may in part be 
due to the treatment interval between the Thursday and the following Tuesday being 
too great. Given that psoriasis can cycle as quickly as every 1.5 days (Coltart & Irvine 
1986), the Tuesday treatment may have been largely treating entirely new cells. 
Overall, the effectiveness of the treatment cannot be accurately assessed due to the 
limited number of subjects, the limited number of treatments at a therapeutic
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temperature and the long treatment interval between the Thursday and Tuesday 
treatments.
2.45 GHz 7 GHz
Efficacy
One subject had complete clearing of 
the plaque and had no relapse in the 
three month follow-up.




Deep heating caused two out of three of 
the subjects to leave the trial.
No deep heating, but blistering in part 
of the treated area in one subject.
Table 3.6. Comparison between hyperthermia induced by microwaves at two different frequencies.
The direct comparison in table 3.6 between the two frequencies implies that there may 
be a trade-off between efficacy and patient acceptability. However, given that two out 
of three o f the previous subjects left the trial, any further microwave hyperthermia 
treatments should clearly be conducted at higher frequencies.
The blistering induced in one of the 7GHz treatments sets an upper limit on treatment 
time o f 20 minutes at a surface temperature of 44°C. However, this complication was 
also associated with the only reported benefit, indicating how accurately the treatment 
parameters need to be set. Further refinement of the treatment parameters are 
necessary, but it appears that a 20 minute treatment at a temperature of between 43°C 
and 44°C could be effective.
The perfusion results calculated from the tests fit reasonably well with previously 
published values from Kemp and Staberg (1983). They predicted 6.3ml lOOg'Wn"1 
for healthy skin, compared to 63.5mll00g'1min‘1 for psoriatic skin. This is well within 
the 95% confidence limits for the predicted perfusions at the lower end o f the 
temperatures at which the tests were carried out. Both sets of results show an 
approximate order of magnitude difference between the blood perfusion in plaques 
and healthy skin. Interestingly, the psoriatic hyperperfusion appears to increase with 
temperature, up to a maximum of around 15 times the perfusion of healthy skin at 
around 44°C. This high level of blood perfusion represents a difficulty when using
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microwave hyperthermia to treat psoriasis, because of the likely non-uniformity of 
any treated area. The chosen therapeutic temperature must be the maximum 
temperature over any treated area. If the treatment area includes any areas o f healthy 
skin, then this will automatically dictate the maximum power output possible. As 
demonstrated in subject 3, this can lead to the plaque falling just below the 
temperature needed to induce a therapeutic effect. One possible solution to this is to 
reduce the blood flow to the treatment area during treatment, either by direct pressure 
or by applying a tourniquet. Whether such methods would reduce the relative 
difference in perfusion between areas is uncertain, and complete occlusion o f the 
blood supply would need to be balanced against patient acceptability. Stress is a well- 
known cause of psoriasis (Ashcroft, Po & Griffiths, 2000), so any treatment that was 
overly stressful to the patient could well prove to be counter-productive.
3.8 Summary
A thermal analysis was performed to determine the optimum degree of penetration at 
which to conduct a treatment microwave hyperthermia treatment for psoriasis. This 
was found to be 7 GHz and a system was designed and built to deliver microwaves at 
this frequency to the skin. Tests using this system were conducted twice weekly for 
three weeks on three volunteers. Temperatures of between 40°C and 44°C for 20 
minutes were used. All the volunteers tolerated the treatments well, and there were no 
signs o f the painful deep-heating that have been associated with a previous attempt to 
treat psoriasis by microwave hyperthemia at a lower frequency. There were only 
limited signs o f improvement in one of the subjects however. An assessment was also 
made of the variation in blood perfusion with temperature in both a plaque and in 
healthy skin, with the plaque showing significantly higher levels of perfusion. This 
difference increased with increasing temperature.
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3.9 Conclusions
Thermal modelling indicates that microwave hyperthermia treatment conducted at 
around 7GHz has the potential to offer a more targeted treatment for psoriasis over 
microwave hyperthermia conducted at lower frequencies. Testing of a system 
operating at this frequency resulted in a positive response in one patient out of three, 
but the limited number of treatments and long time interval between treatments means 
that the effectiveness of the therapy could not be fully assessed. The power levels 
required to maintain therapeutic temperatures of between 40 and 44°C allowed an 
assessment to be made of the level o f blood perfusion in the tissue of both healthy and 
psoriatic skin using a finite difference based thermal model. This gave results that 
fitted well with previously published values and indicates that psoriatic 
hyperperfusion is approximately ten times greater than the perfusion level in healthy 
skin and increases with temperature over this range. The level of psoriatic blood 
perfusion is given by co = 39T -1510 (+/-26%) whilst the level of blood perfusion in 
healthy skin is given by co = 2.4T -  90 (+/-32%), where co is the blood perfusion in 
mllOOg1 miri1 and T is the surface skin temperature. Reducing this difference in 
perfusion would greatly enhance the efficacy and safety of any microwave based 
hyperthermia treatment for psoriasis.
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C hapter 4: V aricose V eins
4.1 Introduction
4.1.1 Background
Varicose veins are a very common condition. Around 10-15% of adult men and 20- 
25% of adult women suffer with them according to Adhikari et al. (2000). Leg veins 
contain one-way valves every few centimetres that help direct blood flow back 
towards the heart when they are functioning correctly (Goldman and Fronek, 1989). 
Varicose veins generally occur when these valves fail, either in a superficial vein 
itself, or in the connecting veins that link the deep to the superficial veins 
(Labropoulos, 1996 and Evans, 1998). This failure o f the valves is known as venous 
incompetence. The exact process that causes this to result in varicose veins is unclear 
(Alexander, 1972), but it appears that normal movement in people with failing valves 
results in chronic increased pressure on the vein walls of the failing vein and those 
around it, known as venous hypertension (Dodd, 1971). This causes the affected veins 
to stretch and gives rise to a variety of complications such as pain, skin changes, 
thread veins, varicose veins and ulcers, as shown in figures 4.1, 4.2 and 4.3. Venous 
ulceration affects one percent of the western population (Cullum, 2003) and is 
estimated to cost the NHS £400,000,000 per annum in the UK alone (Ruckley, 1997).
Figure 4.1: Varicose veins http://medicine.ucsd.edu/clinicalimg/extremities-varicose-veins2.jpg
Chapter 4: Varicose Veins Page 104
Two Applications o f  Microwave Therapy: Psoriasis and Varicose Veins
Risk factors for the development of varicose veins are given by Fan (2003), and 
include age, being of female gender, having a job that involves standing for long 
periods, having a family history of the disease and previously having suffered a deep 
vein thrombosis. Obesity is linked to the development of venous incompetence in 
women, but not men.
Figure 4.2: Skin colouration changes caused by saphenous vein incompetence
Figure 4.3: Ulcer caused by venous incompetence
The greater saphenous vein is particularly prone to failure since it runs all the way 
from the ankle to the groin and is close to the surface over its entire length. The 
shorter saphenous vein is also prone to failure due to its superficial location. Both are 
shown in figure 4.4.
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Figure 4.4: The location o f the greater (long) saphenous vein and the lesser (short) saphenous vein. 
http://www.familydoctor.co.uk/htdocs/varicose/images/vari4.jpg
4.1.2 Current techniques for the treatment of venous incompetence
Many sufferers will simply need to elevate their legs regularly to give their veins, and 
themselves, some temporary relief. Unfortunately however, the progression of the 
disease cannot be reversed. If the disease becomes serious enough, the only way to 
obtain relief is by removing or occluding the saphenous vein altogether. This has no 
negative impact on the patient, as the incompetent vein is failing to perform its 
function correctly anyway. The deep venous system is also more than capable of 
making up for any lost capacity. Removal of the vein from the venous system can be 
performed in a variety of ways. Surgical stripping is the standard technique, but there 
are several alternatives techniques that aim to be minimally invasive. Two are based 
on heating the vein from the inside. This is called endovenous ablation or endovenous 
obliteration, and is performed using a radio-frequency device and with lasers. There is 
also the injection of a corrosive solution directly into the vein, called sclerotherapy. 
Introductions to surgical, RF, laser and sclerotherapy based treatments are given in 
sections 4.1.2.1 to 4.1.2.4.
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4.1.2.1 Surgical stripping
Stripping is essentially pulling the vein out. A general anaesthetic is required, making 
for a more risky and costly operation than anything performed under a local 
anaesthetic. The traditional treatment and current gold standard for long saphenous 
vein incompetence is a high tie of the vein at its junction with the deep system in the 
groin. This is at the point where the saphenous vein meets the femoral vein, called the 
sapheno-femoral junction. The vein is then stripped using a pin stripper to above or 
below the knee (Dwerryhouse, 1999). Separate stab incisions are often also used to 
remove any surface varicosities in a procedure called a phlebectomy (Goren, 1991). 
The stripping is associated with high rates o f both immediate and delayed 
complications. Blood loss can be high and recovery times are long, around 2 to 4 
weeks. This is largely due to post-operative bruising. The rate of recurrence is also 
high, with 20% of treated patients needing further surgery for recurrence according to 
MacKenzie and collegues (2002). This technique therefore leaves considerable room 
for improvement.
4.1.2.2 VNUS® Closure
The use of radiofrequency based techniques to treat venous incompetence by 
endovenous saphenous vein obliteration is fairly well established. It involves 
introducing a catheter, shown in figure 4.5, with sheathable electrodes through an 
introducer or an open cut-down into the vein. An introducer is a plastic tube that is 
inserted into the vein in order to aid insertion of the applicator. An open cut-down is 
where a skin incision is made and the vein pulled up to the surface. An incision is then 
made in the wall of the vein through which the applicator is fed. Whichever method is 
used, the applicator is then fed up to the saphenofemoral junction under ultrasound 
guidance (Rautio et al., 2002). The electrodes are then unsheathed, as shown in figure 
4.6, and embed themselves in the vein wall. The applicator is bipolar with the currents 
running between the collapsible electrodes and the central ball tip. This gives a length 
of wall heating of between 6 and 8mm when the RF current is applied.
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Figure 4.5: The venous closure catheter Figure 4.6: The venous closure
applicator shown both sheathed and unsheathed
Once the applicator is in position the leg is strongly wrapped in a rubber bandage 
called an Esmark bandage (shown in figure 4.7), to exsanguinate the leg, as described 
by Bergan (2002). This is painful, and so a new technique called tumescent 
anaesthesia has been developed for use under local anaethetic, which is based on the 
injection of around 200ml of fluid around the vein (Weiss, 2002). The fluid exerts 
sufficient pressure to cause the vein to collapse. Power is applied from the RF 
generator shown in figure 4.8, and the applicator is slowly withdrawn along the length 
of the vein whilst heating the vein walls to 85°C. A feedback algorithm alters the 
power to maintain the temperature as close as possible to 85°C. The heating causes 
the vein to shrink and die. During treatment heparinised saline is fed through a central 
lumen in the catheter to try and prevent thrombus formation (Weiss, 2002). Heparin is 
an anti-coagulant drug. Occlusion rates at one year are reported as being 88% by 
Sybrandy (2002). The advantages of endovenous obliteration are that it requires no 
general anaesthesia but still gives comparable efficacy to surgical stripping whilst also 
reducing patient discomfort and undesirable side effects.
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Figure 4.7: Esmark bandage Figure 4.8: The venous closure system
Despite the fundamental success of this technique, the pullback rate is very slow, 
around 2.76 cm/min according to Goldman and Amiry (2002). This is due to the need 
for thermal conduction to carry heat out through the full thickness of the vein wall, the 
different layers of which are shown in figure 4.9. Faster drag rates mean that just the 










Figure 4.9: Venous structure
http://www.bmb.psu.edu/courses/bisci004a/cardio/vein.jpg
One more serious problem with radio-frequency based endovenous saphenous 
obliteration is the possibility of causing nerve damage. The saphenous nerve runs 
alongside the vein and is particularly close to it in the lower leg. Paresthesia, defined 
as numbness or tingling lasting for greater than 6 weeks, followed 15% of treatments 
on the upper leg and affected 30% of treated lower legs for Chandler et al (2000).
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Other papers do not mention paresthesia as a problem, such as those by Weiss (2002), 
but it is undoubtedly a serious issue. Another problem reported by Merchant (2002) is 
that of thermal skin injuries. These can be minimised by checking the depth of the 
vein using ultrasound before treatment, cooling the skin with external cooling pads, 
and the use of tumescent anaesthesia (Merchant, 2002), as described earlier.
4.1.2.3 Laser
Endovenous laser treatment is also fairly well established and Navarro, Min and Bone 
(2001) have reported similar success to VNUS. Treatments last around 15 to 20 
minutes. The main supplier of such treatments is Diomed with its EVLT procedure. 
This treatment uses a 0.6mm bare-tipped laser fibre which, like VNUS Closure, is 
inserted into the greater saphenous vein at either the ankle or the knee through a 
percutaneous introducer or an open-cut down and fed up to within l-2cm of the 
sapheno-femoral junction under ultrasound guidance. At this stage a red light is shone 
into the fibre to highlight the exact location of the tip. When the fibre is in position, 
manual compression is applied in order to force the vein against the fibre. 12W is 
delivered to the vein from a 810nm laser, and the applicator slowly withdrawn with 
the laser fired at around 3-5mm increments down the length of vein to be treated 
(Navarro, 2001). This damages the inner lining of the vein wall, called the 
endothelium (shown in figure 4.9), resulting in clotting and hence causing venous 
occlusion. The technique can produce extremely high temperatures. Up to 1334°C has 
been recorded, which in animal models has been shown to cause multiple venous 
perforations by Weiss (2002). Unlike VNUS Closure it seems to have minimal effect 
on the tunica externa (see figure 4.9) of the vein (Proebstle, 2002). However, like 
VNUS Closure, this procedure can be performed under local anaesthetic, especially 
since Esmark bandages are not used. However, there is the possibility that the more 
limited damage to the vein wall could lead to higher levels of re-canalisation, which is 
where the vein re-opens and starts to allow blood flow once more.
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4.1.2.4 Sclerotherapy
Sclerotherapy is most commonly used for spider veins, but is also used for varicose 
ones. It is based on injecting a corrosive solution directly into the vein, that damages 
the lining of the vessel and hence causes the lining of the vein walls to swell, stick 
together, and eventually seal shut (Tisi and Beverley, 2003). The vein should then 
turn into scar tissue. In some cases the vein may need to be retreated. Sclerotherapy 
does not require anaesthesia. A recurrence rate of 43.8% following treatment with 
sclerosants is quoted in a 10 year randomised controlled study compared to 0% in the 
surgery arm o f the study (Belcaro, 2000). The potential cost benefits of not requiring 
surgery when using sclerotherapy are therefore tempered by the need for further 
treatment. There is also the ever-present danger of the sclerosant escaping 
systemically.
New developments in the field of sclerotherapy have concentrated on the use of 
sclerosant foam rather than liquid (Tisi and Beverley, 2003), such as Varisolve®. As 
with RF and laser treatments, the technique involves canulation o f the long saphenous 
vein and constant ultrasound guidance as the foam is injected. The fundamental aim 
of the foam is to fill the superficial venous system and so to cause endothelial damage 
in the same way that traditional sclerosants work, whilst reducing the chances o f the 
sclerosant escaping to the deep venous system.
4.2 Aims of the research
Although both laser and radio-frequency based treatments are available to treat veins 
endovenously, both techniques have some significant complications and inherent 
disadvantages that could be overcome with microwave heating, whilst maintaining the 
efficacy of a thermally based treatment. This is for three main reasons. Firstly, the 
ability o f microwaves to deliver heat into the tissue means that the treatment can be 
speeded up, whilst still maintaining effectiveness as there is no need to wait for the 
heat to penetrate. Secondly, microwaves have the advantage that they heat evenly all 
around the applicator tip, unlike RF based techniques, which should make the 
technique safer as the maximum depth of thermal penetration can be guaranteed. 
Finally, the use o f dielectrics also allows microwave applicators to be made in
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different sizes. Whilst the use of a thick dielectric layer around the tip o f a microwave 
applicator may make the applicator larger and therefore potentially harder to insert, it 
will also allow more power deposition whilst still giving controlled heating. This is 
because o f the larger circumference of the applicator meaning that the thermal 
penetration as measured from the surface of the applicator can be the same as for a 
smaller applicator, but with a greater total power input to the vein. This then offers the 
chance to maximise efficacy whilst maintaining the same level o f thermal penetration 
and hence safety. Another way of looking at this is that with a larger tip, more of the 
vein can be in contact with the applicator, therefore meaning that a larger proportion 
of the vein circumference will be treated. This should therefore maximise treatment 
efficacy.
The primary aim o f this work was to develop a microwave based treatment for 
varicose veins. This broke down into assessing the likely parameters required for a 
successful treatment by looking at the most similar successful endovenous product 
currently available -  VNUS Closure. An applicator and system were then developed 
to deliver a microwave treatment. Characterisation and modelling of this system and 
applicator were performed both on the bench and in a computer modelling exercise, 
and finally the system was compared on the bench to VNUS Closure. This 
demonstrates that the likely effect in-vivo o f the treatment will be very similar to 
VNUS, so giving similar efficacy, whilst still delivering a significantly faster and 
safer treatment.
4.3 Computer modelling by finite difference approximation
4.3.1 Introduction
As with psoriasis, a simple 1-D finite difference program was written to give an 
indication of the heating pattern with different powers, applicator lengths, applicator 
diameters and drag rates (See appendix 6). In particular, the model aims to evaluate 
the heating pattern successfully used by VNUS, and then tries to replicate 
approximately the same heating pattern using microwaves, so giving a first indication 
of the parameters that should be both safe and efficacious.
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4.3.2 Method
The heated volume of tissue was assumed to be a cylinder, so the diffusion equation 
was re-expressed in terms of cylindrical polar coordinates.
The radial part of the diffusion equation in cylindrical polar coordinates is
i m  + iz -& .g L =  - pm
r dr dr1 k dt k
where T(r, t) is the temperature at distance r from the z axis, p is the density, C is the 
specific heat capacity, k is the thermal conductivity and P is the source term (rate of 
heat generation or removal).
This equation was solved using finite differences with a grid spacing in time of 0.01 
seconds and a grid spacing for radial distance of 0.1mm, using the parameters given 
below in section 4.3.2.1.
The source term contains only blood cooling and microwave heating terms. The 
applicator was assumed to be a thermal insulator and so an adiabatic boundary 
condition was imposed at what would be the tissue applicator interface. An adiabatic 
boundary condition means that no heat will be lost from the tissue at this boundary.
4.3.2.1 Parameter derivation
a) Tissue properties
The thermal conductivity was available from published data. The density was initially 
taken as that o f water, and the specific heat capacity was taken as being the same as 
muscle. The properties used are given in table 4.1.
p =  1000 kgm '3 Density of water
C = 3.72Jkg’1K'1 Human cardiac muscle Henriques & Moritz 1947
k = 0.476 W m 'V Human artery (aorta) Valvano & Chitsabesan 1987
Table 4.1: The tissue properties used for the initial finite difference thermal modelling. The properties 
of cardiac muscle and aorta were taken from Duck (1990)
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b) Microwave heating 
As the microwaves are radiating from an infinite cylinder, the energy deposition was 
taken as being as if  from a plane wave, that was reduced in intensity as it spread out 
from the surface of the applicator by a factor of r/ r+x, where r is the radius of the 
applicator and x is the distance from the surface o f the applicator.
Based on the above assumption the power at each node in Wm' is given by the 
formula
Px = Pr . e - 2ca. r_ , 4.1
r+x
where a  is the attenuation coefficient given by equation 2.8, Px is the power lost to the 
tissue at any point x and Pr is the power delivered to the tissue at the surface o f the 
applicator.
The constant Pr can be found from the total radiated power Pt and the heated volume 
whose length is / using
X-oo
Pt = 27d |P X (r + x)dx. 4.2
x= 0
Inserting equation 4.1 above gives
X=oO
P, = 2m-lPr \e~2a,dx.
x=0
Evaluating the integral gives
_ !drPr
x + %t a




P = - ^ ~ .  4.3
Reinserting the constant Pr from equation 4.3 into equation 4.1 gives the power 
density in Wm' as a function of distance from the surface of the applicator.
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c) Blood cooling
In the absence o f specific data on blood cooling, the blood cooling constant was taken 
as 6.9ml lOOg^min'1. This is the average level of blood perfusion over the entire 
human body as calculated from the value given by Hoppensteadt & Peskin (1992) for 
the volume of blood pumped around the body.
4.3.3 Computer program results
Firstly, a VNUS treatment was modelled with the aim of obtaining an appropriate 
thermal profile to emulate. Chandler and colleagues (2000) give details of the VNUS 
parameters used to obtain maximal vein contraction whilst minimising nerve damage. 
The heated region is 6-8mm long, using a power of between 4 and 6 watts and a 
withdrawal rate of around 3cm/min. The electrodes embed themselves about 1mm 
into the walls with a vein size of anywhere between 2 and 12 mm in diameter. The 
temperature is held at 85°C through the feedback mechanism that alters the power 
input.
The fact that the VNUS applicator uses expanding electrodes makes predicting the 
thermal penetration of the VNUS applicator using this model likely to be imprecise. 
This is because the electrodes are unlikely to be evenly positioned around the inside 
wall of a vein, whilst this model is based on a perfect cylindrical applicator. For the 
purposes o f this simulation, a typical vein under compression was assumed to be 
around 4 mm in diameter, so the diameter of the applicator was set at 4mm. A 
frequency o f 15 GHz was used to simulate the very superficial heating that is likely to 
occur from an RF applicator. This equates to a 1/e power penetration depth o f around 
0.8 mm. Using these two assumptions and a power level of 4.5 watts gave the results 
shown below in figure 4.10 for temperature in °C against depth over time. The bottom 
edge of the graph represents the surface of the applicator with radial distance 
extending out over 5mm. The maximum temperature reached is predicted to be 84°C, 
which is almost exactly the temperature that is obtained in reality, and this close 
match between the predicted and actual peak temperatures give credence to the model. 
The predicted thermal profile for VNUS gives a temperature profile to emulate using
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microwave heating, as this thermal profile is known to be both efficacious and have 












Figure 4.10: Simulated RF temperature profile in °C using a frequency o f  15GHz, a withdrawal rate o f  
3cm/min and a power input o f 4.5 watts
Since the finite difference model results appear to be reliable, based on their correct 
prediction o f peak temperature, the model was used to provide initial predictions of 
which parameters would obtain similar temperature profiles, but with faster drag rates, 
as shown in figures 4.11 and 4.12. Adjusting the drag rate and power input by trial 
and error yielded the following set of temperature profiles both with a peak 














Figure 4.11: Simulated temperature profile in °C for a microwave applicator with a withdrawal rate o f  
7cm/min at 9.2GHz with a power input o f  8 watts
Chapter 4: Varicose Veins Page 116












0 10 20 30 40 50 60
time in seconds
Figure 4.12: Simulated temperature profile in °C for a microwave applicator with a withdrawal rate o f  
20cm/min at 7GHz with a power input o f  25 watts
5
4.3.4 Conclusions
In order to increase the drag rate compared to VNUS, the frequency of operation 
needs to be lowered whilst simultaneously increasing the power. This is not 
unexpected as an increase in power will naturally be required as withdrawal rate 
increases to give the same energy dose per unit length. However, this will result in 
high peak temperatures close to the applicator surface if the power is not deposited 
over more tissue. The frequency therefore needs to be lowered as the power and 
withdrawal speed are increased, in order to prevent excessive temperatures and steam 
formation. Another way of looking at this is that lowering the frequency of operation 
reduces the need to rely on thermal conduction to give the required thermal 
penetration. Similar results to those achieved using RF techniques should therefore be 
possible when using microwaves, but with much quicker treatment times. Given the 
encouraging possibilities shown by the initial thermal modelling, an investigation into 
various possible applicator designs and treatment control methods was conducted.
Chapter 4: Varicose Veins Page 117
Two Applications of Microwave Therapy: Psoriasis and Varicose Veins
4.4 Applicator design
4.4.1 Introduction and design requirements
The applicator had to fulfil a variety o f design criteria. It had to be sufficiently 
flexible to allow safe introduction into the vein, whilst not being so flexible as to 
prevent a small amount of force being applied to the cable during insertion. It had to 
be easy to insert, and yet ideally it would also fill the vein, thus allowing power to be 
applied to the entire circumference of the vein wall to improve the likely efficacy of 
the treatment. It also needed to be robust with no possibility of failure in use or the 
chance of parts becoming detached in the body. All the exterior faces needed to be 
medically approved and bio-compatible, with the interior components also being non­
toxic. The tip needed to be rounded to prevent snagging or possible perforation of the 
vein wall during insertion. The exterior also had to be non-stick to prevent clot 
formation on the surface.
4.4.2 Applicator design iterations
The initial computer modelling exercise had indicated that a treatment could be 
performed at a frequency of 9.2 GHz with a similar thermal profile to VNUS Closure, 
but with greater treatment speed. A source was also available at this frequency, so 
prototype applicators were therefore designed using HFSS to operate at 9.2GHz.
Three basic applicator designs were developed for further testing. Stripped coaxial 
cable, a dielectric sheathed monopole radiator with a metal tip, and a dielectric 
sheathed monopole radiator without the metal tip.
4.4.2.1 Stripped coaxial cable
The initial design was simply a stripped piece of coax, cut to the right length to ensure 
an acceptably low degree of reflection when in tissue and coated in a layer o f heat 
shrink. This gave a reflection coefficient (SI 1) o f around -17dB at 9.2GHz and had 
the advantage of being extremely simple, inexpensive and robust.
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4.4.2.2 Dielectric sheathed radiator with a metal tip
This more complex applicator was designed with the aim of continuing to heat the 
vein even as it contracted as the applicator was withdrawn. This was achieved by 
putting a tapering dielectric around the centre conductor together with attaching a 
metal tip at the end of the centre conductor. This provided a rounded profile to reduce 
the chances of snagging on valves, but also produced a reasonable amount o f heating 
at the tip. The final closure of the vein would be ensured by this metal tip that was 
connected to the centre conductor. This performed a dual function as it kept the 
applicator together and also caused intense fields at the very tip o f the applicator. The 
entire applicator was sheathed in a non-stick medical grade heat shrink called FEP 
which provided the non-stick, medically approved robust coating. A variety o f designs 
were tried and the two with the most appropriate field patterns at diameters o f 3.4mm 
(shown in figures 4.14 and 4.15) and 4.8mm (shown in figures 4.16 and 4.17) were 
optimised to give a reflection coefficient (SI 1) o f less than -lOdB. The predicted and 
actual S ll for the 3.4mm applicator between 5 and 10 GHz is shown in figure 4.13. 
The variations in reflection coefficient for the actual applicator are due to the three 
metres o f coaxial cable between the network analyser and the applicator tip. This is 
because there is a slight reflection from the tip as well as slight reflection at the 
connection between the network analyser and the applicator coaxial cable. The two 
reflections will therefore destructively interfere at certain frequencies and 
constructively interfere at others. This effect becomes very apparent with long 
waveguide lengths because the large distance between the tip and the connection to 
the network analyser means that only a relatively small change in frequency is needed 
to add an extra half wavelength and so change constructive to destructive interference, 
and vice versa. The general shapes of the predicted and actual reflection coefficients 
are similar however with a consistent reflection of less than -lOdB between 7.6GHz 
and at least 10GHz.
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Figure 4.13: S l l  reflection coefficient (labelled match) in dB against frequency for the 3.4mm 
applicator from the HFSS model (blue) compared to measured values (red)
The time-average magnitude of the electric field patterns for the two applicators are 
shown below in figures 4.14 and 4.16. They both have the most intense fields close to 
the tip, whilst still showing heating further back. The result of this tip heating is 
shown in surfactant loaded PAG tissue phantom in figure 4.19.
Figure 4.14: The magnitude o f  the time-averaged electric field o f  a 3.4 mm diameter applicator with a 
metal washer tip operating at 9.2 GHz
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Figure 4.15: Cross section o f  a 3.4 mm diameter applicator with a metal washer tip operating at 9.2 
GHz
Figure 4.16: The magnitude o f  the time-averaged electric field o f  a 4.8mm diameter applicator with a 
metal washer tip operating at 9.2 GHz
FR P e rm it t iv i ty  3.4 d ie le c t r ic
m FEP
f~l Coaxial cable
Aluminium f e r r u l e  
I  C e n t r e  c o n d u c t o r  
Hi C opper  t ip
Dimensions in millimetres
Figure 4.17: Cross section o f  a 4.8mm diameter applicator with a metal washer tip operating at 9.2 GHz
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In order to provide feedback on withdrawal, temperature was initially used as a 
control parameter in the same way as it is used by VNUS. A thermocouple was placed 
on the ferrule just behind the ferrule/dielectric interface, in the location shown in 
figure 4.18. A small piece of electrical tape was placed underneath it to help prevent it 
being heat sunk onto the ferrule, as shown in figure 4.24.
Figure 4.18: An exploded diagram o f  the 4.8mm applicator including the coaxial cable, thermocouple, 
ferrule, plastic dielectric, washer and FEP jacket
4.4.2.3 Dielectric sheathed radiator without metal tip
The third type of applicator design to be built had the centre conductor entirely 
sheathed in dielectric, so removing the heating at the tip. The dielectric was simply 
held in place by the FEP sheath. These second generation prototypes showed good
*
Figure 4.19: The heating pattern o f  the 4.8mm 
applicator with metal tip in surfactant loaded PAG
Chapter 4: Varicose Veins Page 122
Two Applications o f  Microwave Therapy: Psoriasis and Varicose Veins
microwave performance and were simpler to build than the applicators with a metal 
tip. A variety of diameters were optimised on HFSS with the aim of providing 
applicators that would be capable of treating veins of different sizes. Applicators of 
3.4mm, 4.0mm, 4.8mm and 6.0mm in diameter were designed and built, as shown in 
figure 4.24. The interior dimensions of the 3.4mm applicator are shown in figure 4.20, 
together with the predicted field pattern in tissue in figure 4.21. The 4.8mm applicator 
is shown in figure 4.22, together with an exploded diagram showing the components 
of the design in figure 4.23. The 4.0 and 6.0mm diameter designs are similar to the 3.4 
and 4.8mm designs.
Perm itt iv ity  25  d ie le c t r ic  
FEP
Coaxial cab le  
Aluminium F erru le  
C e n tr e  c o n d u c t o r
Dimensions in millimeters
Figure 4.20: Cross section o f the 3.4mm diameter applicator without the metal washer tip designed to 
operate at 9.2 GHz
Figure 4.21: Time averaged magnitude o f  the electric field for the 3.4mm diameter applicator without 
the metal washer tip designed for operation at 9.2 GHz modelled in HFSS. This shows significantly 
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Figure 4.22: Cross section o f  the 4.8mm diameter applicator without the metal washer tip designed to 
operate at 9.2 GHz
Figure 4.23: Exploded diagram o f  the second generation 4.8mm applicator including coaxial cable, 
thermocouple, ferrule, e =25 dielectric and FEP jacket
Figure 4.24: Applicators o f  3.4, 4.0, 4.8 and 6mm diameter
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Once the range of applicators was completed, clinical opinion was sought as to the 
ability of the applicators to be introduced into the greater saphenous vein. It was felt 
that the option should be available to allow insertion through a percutaneous 
introducer, as well as an open cut-down. The largest commercially available 
introducer that would be useable with the greater saphenous vein had a internal 
diameter of 4.67mm. The tip of the 4.8mm diameter applicator was therefore reduced 
in diameter slightly to 4.5mm in order to allow use with this introducer. The other 
designs were not taken forward beyond initial bench testing as it was found that the 
4.5mm design gave complete heating of the vein wall of veins up to at least 1.2cm in 
diameter. The design of the 4.5mm applicator is shown in figure 4.25, together with 
its SAR pattern in figure 4.26 and predicted and actual match over the range 7-10 
GHz in figure 4.27.
ppl P e r m i t t iv i t y  25  d i e l e c t r i c
m  fep
[~~1 Coaxial c a b l e  
^  Aluminium f e r r u l e  
|  C e n t r e  c o n d u c t o r
Dimensions in mill imetres 
Figure 4.25: Cross section o f  the 4.5mm diameter applicator designed to operate at 9.2 GHz
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Figure 4.26: SAR o f the 4.5mm applicator as modelled in HFSS
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Figure 4.27: S l l  reflection coefficient (labelled match) in dB against frequency for the 4.5mm 
applicator from the HFSS model (blue) compared to measured values (red)
The variations in reflection coefficient for the actual applicator are due to the three 
metre length of cable between the network analyser and the applicator tip, as 
explained above in section 4.4.2.2. The general shapes of the predicted and actual 
reflection coefficients are roughly similar however with a consistent reflection of less 
than -lOdB between 8GHz and 9.3GHz. The S ll  for this applicator is therefore 
acceptable at 9.2GHz, as at least 90% of the input power will be deposited into the 
tissue.
The 3m flexible coaxial cable that the applicator tip was built onto is shown in figure 
4.28. The first metre was sheathed in FEP for patient contact. The final 2 metres were 
sheathed in polyolefin heatshrink to act as an extension and give sufficient reach from 
the microwave source and system to the operating table when in use.
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Figure 4.28: The complete 4.5mm diameter applicator with cable
The tolerances required on the components of the applicator tip to ensure a high yield 
in production were assessed using HFSS. The results are given in appendix 8.
4.5 Applicator testing
4.5.1 Heat shrink bedded in PAG
4.5.1.1 Aims
A simple and quick way of testing applicator designs was required initially that could 
determine how effectively a design could induce shrinkage, and allow the testing of a 
temperature feedback control method.
4.5.1.2 Method
Low temperature heat shrink was set in PAG to simulate the vein in tissue. This 
shrinks down to half its initial diameter when heated to above 85 °C. The heat shrink 
tube was filled with ultrasound gel to simulate the blood that would be present in the 
vein and to allow an acceptably low level of reflected power. All experiments were 
conducted at room temperature. Both the stripped coaxial cable and the applicators 
with the metal tip were tested in the heat shrink. The power outputs were chosen 
according to the parameters predicted by the finite difference computer model.
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4.5.1.3 Results
When using the stripped coaxial cable, the tube had a tendency to shrink down onto 
the applicator and then become jammed there. As the applicator was withdrawn the 
tube would stay at the same diameter as the applicator. It also had difficulty heating 
heat shrink o f around 4.8mm in diameter due to the small diameter of the applicator.
With the applicators with the metal tip a very high degree of shrinkage could be 
achieved, as was hoped for. However, this required a very slow withdrawal rate of 
around 3cm/min to cause maximum shrinkage of the heat shrink. A faster withdrawal 
rate would result in minimal, if  any, degree of shrinkage. There was a distinct cut-off 
above around 3cm/min where the degree of shrinkage became minimal. This result 
was disappointing as it implied that a high degree of shrinkage was not possible 
without the continued application of heat and meant that some o f the conclusions from 
the finite difference modelling exercise given in section 4.3.3 might not be valid. In 
particular, the ability to obtain the same degree of tissue shrinkage at a faster 
withdrawal rate by increasing power and reducing frequency might not be possible.
4.5.2 Excised vein bedded in PAG
4.5.2.1 Aims
In order to assess whether the results from shrinking heat shrink in set PAG would be 
replicated in tissue, the method was extended by the use o f stripped human saphenous 
vein in place of the heat shrink.
4.5.2.2 Method
As with the heat shrink, the vein was suspended in position with a rod holding it in 
place in the centre o f a small waterproof box. The PAG was then poured in and left to 
set around the vein. The setting of the PAG is an exothermic reaction which raises the 
temperature to around 50°C. It was then left to cool to 37°C, at which point the 
experiment was performed. The vein was once again filled with ultrasound gel to 
simulate blood.
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4.5.2.3 Results
The results are shown in figures 4.29 -4 .31 .
Figure 4.29: A freshly stripped varicose vein Figure 4.30: The same vein after heating
bedded in PAG
Figure 4.31: The cross-sectioned saphenous vein before and after the treatment
The vein shown in figure 4.29 has shrunk so much that it has actually shrunk away 
from the supporting gel, as shown in figure 4.30. Note also that one of the perforator 
veins that joins the greater saphenous has been occluded at the junction. It is not 
known how effectively other modalities occlude junctions. Sealing these junctions as 
well as the vein itself may be a key factor in preventing recurrence.
There were however, some negative aspects to this result. Firstly, if the pullback rate 
was too quick then the heat delivery at the tip was no longer able to apply heat 
directly to the vein wall, exactly as found with the heat shrink. This lead to a vicious 
circle. As the vein was not contracting down to the minimum size at the tip any more, 
it wasn’t heated as strongly, which meant that it didn’t shrink, so that once again heat 
from the tip was not applied. The critical speed to achieve the maximum level of
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shrinkage was similar to RF at around 3cm/min and was slower than the predicted rate 
at 9.2GHz o f 7cm/min. The speed of withdrawal to achieve maximum shrinkage 
therefore appeared to be dictated by the shrinkage rate of the vein, irrespective o f how 
the heat was applied. This important result therefore appeared to limit the speed of 
treatment to the same as VNUS’ RF based treatment. However, although immediate 
venous occlusion would be likely to be preferable from an efficacy point o f view, the 
results o f laser treatment show that instant occlusion is not required to achieve lasting 
results and high efficacy rates. Unlike RF based treatments, microwave heating can 
still cause irreversible tissue damage even at high withdrawal rates over the full 
thickness o f the vein wall. This is because there is no need to wait for thermal 
conduction to carry heat through the tissue alone, as the microwaves will heat the 
tissue directly. This can still be concluded from the initial finite difference modelling 
exercise described in section 4.3, even if  this heating is too rapid to result in 
significant immediate venous shrinkage.
This led to the further testing of applicators without metal tips. The applicators 
described in section 4.4.2.2 were not used in further testing, as applicator designs that 
induced significant heating at the tip to achieve maximum venous shrinkage would 
not be effective at high withdrawal rates. In addition, the effects of the heating were 
now focussed on tissue damage levels and bum characterisation, with no further 
regard for tissue shrinkage. This shift in emphasis from trying to achieve both a 
significant degree of shrinkage and a controlled bum, to just achieving a controlled 
bum, allowed more flexibility in applicator withdrawal rate. In particular, 
considerably higher withdrawal speeds than 3cm/min could now be assessed.
4.5.3 Excised vein in bovine liver
4.5.3.1 Aims
The use of PAG as a model had several disadvantages. Firstly, it caused a temperature 
rise that would result in vein death as it set, meaning that the effect of a treatment 
could not fully be assessed. It also set solid and would not shrink with the vein, if  
required, as heat was applied. Finally it did not show the depth o f thermal penetration 
beyond the vein wall effectively.
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The aim o f the new model of vein in liver was to build on the results o f the veins set 
in PAG, and focus on bum characterisation alone, rather than both shrinkage and bum 
characterisation. In addition, it would address the disadvantages of the PAG and vein 
model and provide a bench model that would be significantly more realistic.
4.5.3.2 Method
An excised long saphenous vein was laid in a sandwich of ox liver and secured at both 
ends o f the vein using sutures. The assembly was wrapped in cling film to simulate 
the fascia of the leg. This block was then placed in a sealed plastic bag and placed in 
the water bath and held at 37°C for several hours. The block was removed from the 
water bath and the plastic bag. The cling film was opened at one end to allow the 
applicator to be inserted into the vein, or gap between the slices of liver. Immediately 
before the applicator was inserted a further temperature was taken from inside the 
block of liver to check that 37°C had been reached. The applicator was inserted into 
the treatment block until the starting point was reached and a compression weight 
applied to the experiment block. This consisted of a flat metal plate approximately 
lcm deep by 15cm by 30cm. After the treatment was finished the block was left for 
around 6 minutes prior to opening to ensure that the maximum thermal penetration 
had occurred.
A range of veins from 1.2cm in diameter down to 3mm in diameter were used in the 
tests. Only the 4.5mm diameter applicator was tested using this model.
4.53.3 Results
The model showed that the 4.5mm applicator was easy to insert in the full range of 
vein sizes tested, whilst also showing a consistent bum over the ftdl thickness o f the 
vein wall even in the 1.2cm diameter veins. This may be due to the compression 
pushing the vein onto the head of the applicator. This model was also used to provide 
validation o f the thermal analysis as described in section 4.9.2.1, as well as a 
comparative test between the 4.5mm applicator and VNUS, as described in section 
4.10.
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4.6 Treatment control
Irrespective o f the applicator, it was vital to provide a method by which the energy 
delivered to the vein could be closely controlled. Several ideas were examined.
4.6.1 Temperature feedback
Initially, the use of temperature as a feedback parameter was investigated, with a 
thermocouple located on the ferrule of the applicator as shown in figure 4.32, to try 
and minimise direct heating.
Figure 4.32: The location o f  the thermocouple on the 4.8mm dielectric sheathed applicator
Unfortunately, obtaining accurate temperature feedback was found to be directly 
related to the contraction problem found in both the heat shrink and the veins in PAG. 
The thermocouple would provide feedback until contact was lost with the vein wall. It 
would then cease to read the temperature of the wall and so fail to provide any sort of 
useful feedback. In fact, it would typically start to read higher when it was no longer 
in contact with the vein wall, causing a quicker withdrawal of the applicator. This 
quicker withdrawal would automatically result in less heating and less contraction of 
the vein. The only way to break this cycle was to ignore the temperature for a short 
while and stop withdrawal, allowing the applicator to regain contact with the vein 
wall, before recommencing withdrawal. This was totally unsatisfactory as a treatment 
control procedure.
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4.6.2 Audible control
In order to remove the temperature feedback problem, a new withdrawal method was 
devised. Coloured bands were marked on the applicator cable at 1cm intervals. The 
basis of this was that the surgeon would need to aim to withdraw the applicator so that 
the bands became visible in time to audible tones from the system. A banded 
applicator is shown below in figure 4.33. This proved to be a very effective way of 
controlling bum depth and allowed initial characterisation of the bums and 
temperatures produced by various withdrawal speeds and power levels. However, 
since one of the aims of the device was to achieve quicker withdrawal rates, the power 
level had to be increased relative to VNUS’ RF treatment. This would give a 
potentially excessive bum to the tissue in the event of failure to withdraw the 
applicator sufficiently. The coloured bands did not therefore offer any means of 
protecting the patient. Some initial investigations were conducted into using the 
thermocouple located on the ferrule to provide a temperature trip, similar to that used 
for MEA (as explained in section 1.3.1). However, an alternative method of control 
based on direct measurement of the applicator withdrawal was developed using an 
optical motion sensor.
Figure 4.33: Coloured bands marked on an applicator cable to allow accurate applicator withdrawal
4.6.3 Optical motion sensor
Due to the inaccuracies of performing accurate temperature measurements of the vein 
wall using a thermocouple or optical fibre, a new method was designed based on
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direct measurement of applicator withdrawal. This was achieved through the use of 
optical mouse sensor technology.
4.6.3.1 Optical mouse position sensing
An optical mouse contains a sensor that identifies its position by image recognition. 
The sensor consists of a light sensitive array, a lens to focus light reflected from the 
surface under the sensor onto the array, an LED to provide illumination of the surface 
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Figure 4.34: A schematic diagram o f the primary components o f  an optical mouse, including their link 
to the computer
The chip identifies features visible to the array. It then assesses the position of the 
same features a fraction of a second later to see if the features have moved. If so, it 
updates its position internally, and searches for new features. It therefore relies on 
surface features that can stimulate the light sensitive array sufficiently to be detected 
by the processing chip. When polled, the chip gives its position in a counts value of 
units in the x and y plane. The exact units are determined by the distance between the 
lens and the surface, the speed of movement of the mouse, and the surface which the 
mouse is placed on. In general, it is to be expected that increasing the distance from 
the surface to the array will result in a drop in the number of counts per distance 
moved.
4.6.3.2 The optical motion sensor
Rather than measuring the location of a mouse relative to a surface, the same 
electronics were used to measure the movement o f the applicator cable as it passed 
through a small housing. This housing was designed to guide the cable through a 
channel past the optical mouse lens. The sensor is based on a commercially available
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optical mouse chip, LED and lens (Agilent ADNK-2620) mounted on custom made 
circuit board. The circuit board shown in figure 4.35, together with the chip, lens and 
LED is mounted above the cable in a plastic sensor unit housing as shown in the 
exploded diagram of figure 4.39. This sensor monitors the location of the cable and 
relays this information to the system when it is polled. The circuit board was designed 
and built by Marchwood Technologies Ltd (2004).
For use in this application, the x value that the 
sensor provides when polled can be disregarded 
as this relates solely to the rotation of the cable.
The update time of the unit is around 2200 times 
per second meaning that a withdrawal of around 
18ms'1 will be required before the sensor fails to 
recognise any features from the previous scan.
Since the number of counts is in arbitrary units, 
it then needs to be related back to real distance 
through multiplication within the system by a 
conversion factor. This is more fully explained 
in section 4.7.3 below. Since the location of the 
cable is determined by image recognition, the 
sensor needs the cable to have surface features that it can read. In this case the 
applicator cable coating is clear, allowing the outer braid of the coaxial cable to be 
read by the sensor. The use of an optical sensor has the major advantage that neither 
debris on the cable, nor cable damage, will prevent the chip from calculating position. 
It is therefore intrinsically reliable.
A variety of design criteria needed to be fulfilled for the housing of the optical mouse 
chip. The first treatment step would be that the percutaneous introducer would be fed 
into the vein. Then the applicator would be fed through the introducer and up the vein 
into position. The housing could then be slid up the cable until it mated with the 
percutaneous introducer. At this stage the housing could be held in position with 
surgical tape. This would help to prevent the introducer being forced further into the
Figure 4.35: Sensor PCB
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vein, and also prevent the sensor from withdrawing along with the cable. The surgeon 
would then hold the sensor housing in one hand, whilst withdrawing the cable through 
the housing with the other as the treatment was performed. In the event o f a treatment 
being performed without the percutaneous introducer, the sensor would simply be 
placed in an appropriate position near the entrance to the vein.
The housing therefore needed to be as small as possible, whilst still large enough to be 
comfortably held in one hand. It also needed to be slightly rounded for patient comfort 
and general aesthetics. The same sensor and applicator combination would be used to 
treat both legs o f a single patient, so the housing also needed to be transferable from 
one leg to another. In addition, both the sensor and housing needed to be disposable.
The housing design was created and prototyped by Kinnier Dufort Ltd (2004), 
working from the treatment description and design criteria given above. To ensure a 
match with the introducer, a short recess o f the same diameter as the end o f the 
introducer was created on the introducer side o f the housing. The final overall housing 
dimensions were approximately 7cm x 4cm, making it small yet easy to hold. In order 
to allow the housing to be taped in position, a clip with tape fed through it was 
designed to be attached to underside of the housing. This meant that the edges of the 
tape were positioned low on the body of the housing where they met the housing, so 
helping to give good adhesion. It also meant that a transfer from one leg to another 
could be carried out if a spare clip and length of tape were provided. After the 
treatment on the first leg, the clip could be detached, so removing the tape at the same 
time and allowing the replacement tape to be clipped on for the second treatment.
The cable was guided through the housing on a series o f plastic ridges that held the 
cable up against the base plate and sensor and minimised lateral cable movements. 
The completed housing design is shown, together with the percutaneous introducer, in 
figures 4.36,4.37 and 4.38.
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Figure 4.36: Underside view o f  the optical motion Figure 4.37: Top view o f  the optical motion
sensor sensor
Figure 4.38: The optical motion sensor showing the mating joint with the percutaneous introducer
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Figure 4.39: Exploded diagram o f the sensor, housing and clip
The exploded diagram in figure 4.39 shows all of the major components of the optical 
motion sensor, and how they fit together. The simplicity of the design and the 
stacking assembly is designed to aid in manufacturing by simplifying the assembly 
process as much as possible.
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4.7 The system
4.7.1 Overview
The system, which is an adaptation of the commercially available MEA system from 
Microsulis Medical, is shown in figure 4.40 and consists of a control unit and 9.2 GHz 
magnetron with a maximum power output of around 50 watts. The pneumatic 
footswitch is used by the surgeon to turn the microwave power on and off. The optical 
motion sensor is plugged into the system on the front panel, and the applicator is 
attached via an N-type connector to the magnetron. The whole system, including the 
applicator, is called the Microwave Venous Occlusion (MVO) system.
The control unit is based on a standard PC with a touch screen user interface and 
custom designed software. The software was created by the software company IPL 
Ltd (2004) working from the specifications described in this section of the thesis 
















Figure 4.40: The complete MVO system
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The applicator is designed to be introduced into the patient with the sensor unit being 
firmly taped or strapped down in an appropriate position near the site of the applicator 
introduction. When treatment starts, the applicator is withdrawn and this movement is 
detected by the sensor. The rate of withdrawal is measured by the sensor and fed back 
to the surgeon via the system to ensure that the required treatment depth is achieved. 
The data from the sensor is time-averaged to make the withdrawal rate data usable by 
the surgeon. In the event that the surgeon moves too slowly, the system cuts power to 
the applicator.
In order to warn the surgeon that the applicator is approaching the skin and the 
treatment coming to an end, coloured warning bands were placed on the cable. Firstly 
a 4cm warning band appears on the cable, followed by 4cm a black stop band. At a 
withdrawal rate of 17.5cm/min this gives the surgeon and theatre staff 14 seconds to 
see the warning band and a further 14 seconds to see the stop band. There are two sets 
of warning and stop bands, as shown in figure 4.41. The yellow and black one is for 
use with a percutaneous introducer whilst the blue and black one provides a warning 
when using the system with an open cut-down.
Figure 4.41: Close-up o f  the tip o f  the 4.5mm diameter applicator
4.7.2 The treatment screen
The treatment screen, shown in figure 4.42, indicates the speed of withdrawal on a 
speedometer. The background is divided into 4 areas with three different coloured 
zones, to indicate the optimal, sub-optimal and unacceptable rates of withdrawal. The 
rates that correspond to each band were determined through the computer modelling 
detailed in sections 4.7 and 4.8 of this chapter. In the event of the averaged
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withdrawal rate dropping into the unacceptable region of below 1 Ocm/min, power is 
cut to the applicator and the treatment screen replaced with a screen asking the 
surgeon to withdraw the applicator 8mm. This withdrawal is monitored by the 
software and the number of remaining millimetres required to complete the 8mm 
appears on the screen. Once the 8mm has been covered the treatment screen re­
appears and treatment can re-commence. This should have no clinical implications as 
the length of untreated vein will be very short relative to the overall treated length.
M IC R O W A V E : ON Total D is tan c e : 0 .0 cm  T re a tm e n t T im e (m m :ss): 00 :00







Figure 4.42: The user interface screen during a treatment
4.7.3 Speed averaging
During use the sensor returns a position value when polled in counts, relative to where 
it was last re-set. Before the start of every treatment the sensor is reset and then polled 
every 0.1 seconds once the footswitch is depressed and power is applied. The 
difference in the counts value between each poll is then multiplied by a conversion 
factor to give the rate of motion in cm per minute.
The polling interval is important in determining accuracy and is related to the speed of 
motion of the cable. If the polling interval is so short that very few counts have been 
accumulated between polls, then discretisation errors will occur as the measured rate 
will appear to be one of several discrete values. The polling interval was chosen 
through trial and error to make such errors unrecognisable.
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In order to make the feedback useful to the surgeon, the response of the speedometer 
had to be made sufficiently damped to make the speed that appears on the system 
screen move smoothly and not cause unnecessary trips. At the same time the response 
must not be so slow that the system does not trip within an acceptable time period and 
the speed presented to the surgeon is to screen so delayed that the feedback is not 
useable. In order to fulfil these criteria a rolling average calculation was used which 
presents the mean value of the preceding 26 polling intervals. In other words, the 
mean value from the previous 2.6 seconds of speed measurement. This gives a smooth 
response to changes in speed, whilst also giving an effectively instantaneous response 
to any change in speed. The maximum length of time which the applicator can remain 
stationary for is therefore the length of the averaging time, i.e. 2.6 seconds. A typical 
treatment is shown in figure 4.43. The mean averaged withdrawal speed in this 
treatment is 17.5cm/min with a standard deviation of 2.2cm/min. The minimum 
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Figure 4.43: The actual withdrawal speed of the applicator as measured every 100ms (blue) together 
with the averaged withdrawal rate over 2.6seconds (black) for a typical treatment
A potential user problem was coping with the response of the speedometer at the start 
of the treatment. Starting from the minimum value of 7.5cm/min would entail
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removing the 1 Ocm/min trip level and only imposing it again after a certain length of 
time. Instead, the treatment screen starts with the needle at the optimum treatment rate 
of 17.5cm/min with the algorithm assuming that a perfect withdrawal had been 
maintained even before the start of treatment. The surgeon has to withdraw the 
applicator before the needle reaches the trip level. This system is quite intuitive and 
easy to use and ensures that the same safety conditions are imposed throughout the 
treatment. In the event of no withdrawal at all from a standing start the trip time is 
((17.5-10)/17.5) x 2 .6=  1.1 seconds.
4.7.4 System testing
4.7.4.1 The lead screw based withdrawal device
In order to allow accurate withdrawal of the applicator for characterisation of the 
sensor and system a withdrawal device based on a lead screw was built. The lead 
screw is driven by a computer controlled stepper motor which rotates accurately at a 
chosen number of rotations per second. The drive nut runs along the screw and is 
fitted with a clamp into which the cable can be fitted, as shown in figure 4.44. The 
sensor is clamped near the end of the lead screw and the cable fitted into the clamp on 
the drive nut. The cable can then be withdrawn at a constant pre-determined speed 
when the stepper motor is driven.
Figure 4.44: The mechanics o f the lead screw device
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4.7.4.2 Motion sensor characterisation
The speed value shown is dictated by the accuracy of the sensor and the calibration 
factor. This in turn determines the bum induced in the patient. The accuracy of the 
sensor is therefore crucial.
Initially a single sensor was randomly chosen and withdrawals at various speeds using 
the lead screw were carried out over a fixed length of 20.9cm. This allowed an 
assessment of the effect of different withdrawal speeds on distance measurement. The 






























Figure 4.45: Percentage measurement error in distance over 20.9cm against withdrawal speed for one 
randomly chosen sensor. The error bars are 95% confidence intervals
The number of counts measured per unit distance will therefore decrease by 
approximately 0.5% from the value measured at 1 Ocm/min with increasing 
withdrawal speed in the likely range of interest of up to 27.5cm/min.
The conversion factor was then assessed through testing ten completed sensors. Each 
one had an applicator pulled through it at 27.5cm/min and 1 Ocm/min. The mean 
number of counts from these 20 values was then chosen to calculate the conversion
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factor. The results are shown in scatter diagram in figure 4.46 as an error in distance 
measurement relative to the mean. The standard deviation is 1.2% and the 95% 
confidence interval for the mean is +/-0.5%
---------------.------------♦♦---------------------  < J K i -♦ -----♦ ------♦------------- .---------------
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Figure 4.46: Percentage error in distance measurement for 20 values from 10 sensors
4.8 Thermal analysis by Green’s function integration
4.8.1 Introduction
The finite difference model described in section 4.3 gave an initial treatment 
characterisation for VNUS and allowed a first assessment of the likely parameters that 
would potentially give an effective treatment using microwaves. However, as 
explained in section 2.1, the fact that this is a medical treatment means that accurate 
characterisation o f potential tissue damage is required, both to minimise risks to 
patients by allowing accurate setting of treatment parameters, and also to fully explain 
how the tissue will be affected by the treatment. A more accurate thermal analysis was 
therefore required, upon which analysis o f tissue damage could be built. A Green’s 
function model was used as this approach lends itself well to modelling this treatment. 
Firstly, finite difference and finite element based approaches do not lend themselves 
as well to modelling moving sources. Furthermore, the tissue temperatures reached by 
this treatment will not be sufficient to cause steam generation, and heating is applied 
for a relatively short time. The chances of significant changes in tissue properties 
occurring are therefore minimised. In addition, the applicator is removed from the 
tissue as soon as heating has occurred, minimising the effect of the applicator itself on 
the thermal profile. The heated volume is also very small relative to the body. All of 
these factors support the assumptions required for a Green’s function model to be 
appropriate, which are that the medium is homogenous, isotropic and infinite.
Chapter 4: Varicose Veins Page 145
Two Applications o f  Microwave Therapy: Psoriasis and Varicose Veins
4.8.2 SAR fitting
An analysis was conducted with the aim of characterising the treatment and placing 
limits on the withdrawal speed of the applicator. The first step was to transfer the 
SAR predicted by HFSS to the Green’s function model. The SAR was therefore 
recorded along various lines parallel to, and radiating outward from, the applicator 
surface as shown in figure 4.47.
The SAR variation along the length of the applicator was modelled using a Gaussian 
distribution, as shown in figure 4.48, whilst an exponential decay was used to describe 
the decay of the SAR as it radiates outwards from the surface, as shown in figure 4.49. 
The two approximations were multiplied to give the approximate SAR at any point in 
cylindrical polar coordinates
where SARpeak is the maximum value of SAR at the surface of the applicator.
Figure 4.47: The MVO applicator tip modelled in HFSS showing the lines along which the SAR o f the
applicator was recorded
SAR(r, z ) - e 1000(r-2 .25x l0~ 3) 4.4
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Figure 4.48: The SAR calculated from HFSS (blue) compared to the approximation used in the Green’s 
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Figure 4.49: The SAR calculated from HFSS (blue) compared to the approximation used in the Green’s 
function analysis (red) along a line running radially outward from the applicator surface
The expression for SAR was convolved with the Green’s function kernel as described 
in section 2.3.3 over space and time to give the temperature against time for any 
chosen depth. The Mathcad worksheet used is given in appendix 7.
Multiplying the expression for SAR in equation 4.4 by the density, gives an 
expression for power deposition in Wm'3. Integrating this over the volume of which 
significant heating occurs gives the total power deposition into the tissue. The value
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SARpeak can then be adjusted to give the required power output P, which sets the value 
for S A R ^  using
where p t is the density of the tissue.
The temperature rise T fa  t) at time t and at a point in space ro(ro, 6, zo), due to an 
impulse applied to the applicator at t = 0, is given by the convolution of the Green’s 
function with the applicator SAR, integrated over the volume over which the SAR 
applies. The source points are defined by the SAR(r, 6, z). For the case in which the 
applied SAR is an impulse heat source, applied at t = 0, defined in cylindrical polar 
coordinates, T(tq, t) is given by,
where ro is the field point, ro\r ’ is the distance between the source point and the field 
point and v is the volume over which the SAR applies.
The distance between the source and field points for the case where the system is 
described in cylindrical polar coordinates is given by trigonometry, as shown in figure 
4.50 and is given by
where the source points SAR are given in cylindrical polar coordinates and the field 
point ro is located at (ro, 0, zq) c.
8x10"3 10.25x1 (T3
-1000(r-2.25xl0-3) x p ( x 2.7T.r)drdz
-8x10-3 2.25x10-3
T(ra,t) = r \ t)SAR(r, 0 , z)rdOdzdr 4.5
yj(r sin#)2 +(r0 - r  cos#)2 + ( z - z 0)2 ,
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-■ field point (ro ,0 ,2 o^
rrt - rcos Distance
source point (r, 0  ,z)
rsin
rcos 0
Figure 4.50: The relationship between the source and field points and the distance between them 
calculated using cylindrical polar coordinates
For a case of a stationary SAR which is applied for a certain time then the temperature 
rise T(ro, t )  after time f  is given by the integral over time of equation 4.5
T(r0, n  = | ^\(3(r0\r',t)SAR(r,9,z)rd0dzdrdt.
0 v
However, in order to evaluate the temperature rise after power stops being applied, the 
integral must evaluate the contribution from the Green’s function that would come 
from the first instance at which power was applied, as well as all the other 
contributions that come after power was first applied until it was turned off. If power 
was applied for x seconds, and the temperature rise at t ' is required, then the integral 
will have to evaluate contributions from t ’- x  until t ’
T(r0,t')=  |  |||G (r0|r',t)SAR(r,0 ,z)rdGdzdrdt
t '- x  V
where jc is the length of time power is applied for.
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To model a moving source, the integral must account for the changing distance 
between the field point and the source points, as well as the integrating over the 
correct time. If the source is moving at a constant rate u along the z axis, then the 
distance will be a function of time, and the time can be specified in terms of distance 
moved along the z axis from zstart to the final location at time t, zo(t). The integral can 
then be performed over distance, with the time specified in terms of the distance
1 *o(0
T(r0,t) = ~J JJjG(r0\r\t(z0))SAR(r,0 , .
z  start v
As shown in figure 4.51, let / be the length of time since the start of the simulation, at 
which point the temperature rise is required. If the simulation starts with the source 
points at some position zstart when i =0, the distance moved after / will therefore be,
Z(i) = ui + zstart.
Setting the time so that when Z(0) = 0 gives a new variable,
T(i) — i  +  Zgtart.
U
Source points adjacent to
field point at z =  0 and i = - z sla)t
T(D = 0 —
source points
Leaves here at z . .start
Time i = 0
field point
start
Figure 4.51: The relationship between the source and field points over time T(i) and / relative to 
distance z0
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Each integral is evaluated with i fixed, so for every calculation / is effectively a 
constant. The integral needs to evaluate the contribution of the source points to the 
field point going back over time from time T(i) and position Z(i). This means that the 
contribution of the source points to the temperature rise at any fixed point in time / 
will be given by the contribution from the Green’s function at position Z(i) with time 
within the function set to 0, added to the contributions from the locations o f the 
previous positions of the source points, with the times at which each of these 
contributions increasing to take into account that these contributions were 
progressively further and further back in the past.
The distance moved at time T(i) will be Z(i), and the time used within the Green’s 
function must be 0 at time T(i) with time increasing as the integral is evaluated over 
positions going back in time. This gives an expression for the time used within the 
Green’s function to relate position to the length of time in the past that the applicator 
was at that position
The final integral, with limits based on the results shown in figure 4.48 and 4.49 is,
r(i)  10.25xl0-3 8x10-3 n4  * 1 * 7 o m u  
T(rQ,i) = ~  J { J \G(r0\r\T (i)—±)SAR(r,z)rdMzdrdz0 .
U Zstart 2.25xl0-3 -8x10-3 —X  U
In order to speed up the calculation, after the SAR is far enough away that any further 
contribution from the SAR is negligible, it is possible to evaluate the integral up until 
a stop point zstop
4  ^Stop
T(r0 , i ) ~ — |  Jj*j*G(>o |r \ z0 )SAR(r, 0, z)rd6ldzdrdz0 .
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4.8.3 Model validation in PAG
4.8.3.1 Aims
The aim is to validate the temperatures predicted by the model by comparing the 
predicted temperatures that would be created in PAG with temperatures measured in 
PAG over a range of relevant withdrawal speeds. This will demonstrate that the model 
is an appropriate one to use for characterising the treatment.
4.8.3.2 Method
The temperatures predicted by the model were validated against the tissue phantom 
PAG. A PAG block was created with a 4mm diameter channel running down the 
centre of it. Optical fibre temperature measurement probes were buried at depths of 
approximately 1mm, 2mm, 3mm and 4mm from the channel. The exact distance of 
the centre of each fibre from the edge of the channel was then measured using a 
travelling microscope. This was focused on the centre o f the tip of the fibre, and the 
position recorded. The microscope assembly was then moved sideways along a track 
until the centre of the image was on the edge of the channel and the new position 
recorded. This allowed a more accurate measurement of the position of the fibre 
relative to the channel to the made. The fibres were measured as being at distances of 
0.75mm, 1.5mm, 3.35mm and 4.25mm. The applicator was inserted into the channel 
and power applied as the applicator was withdrawn past the fibre at a constant speed 
using the lead screw based withdrawal device. The temperature profiles were recorded 
for speeds of 1 Ocm/min, 12.5cm/min, 17.5cm/min and 22.5cm/min, so a total o f 16 
temperature profiles were recorded. The experimental set-up is shown in figures 4.52 
to 4.55.
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Figure 4.52: The PAG temperature validation experimental set-up showing the lead screw withdrawal 
device together with its computer control, the PAG block and fibre, the magnetron power source, the 
luxtron optical fibre temperature measurement device and the data logging computer
Figure 4.53: The PAG block with an optical fibre running into it
Figure 4.54: A close-up o f  the applicator tip and optical fibre within the PAG block.
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Figure 4.55: The travelling microscope used to measure the depth o f  the fibre in the PAG relative to the
channel
4.8.3.3 Initial results
A small modification was made to the integral that was used to evaluate the 
temperatures. Rather than integrating around the entire circumference of the 
applicator from -n  to 7t, the integral was only evaluated from -nJ2 to nJ2. This 
therefore meant that only heat sources on the side of the channel nearest to the point at 
which the temperatures were being predicted were taken into account. This was to 
allow for the fact that heat sources from the other side of the channel would not be 
able to reach the fibre due to the air gap caused by the channel. The properties of PAG 
given in table 2.2 were used in the modelling. The initial results for a withdrawal 
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Figure 4.56: Comparison between measured (blue) and modelled (pink) values for temperature at a 
depth o f  0.75mm in PAG at a withdrawal rate o f  22.5cm/min when first measured
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Figure 4.57: Comparison between measured (blue) and modelled (pink) values for temperature at a 
depth o f  1.5mm in PAG at a withdrawal rate o f  22.5cm/min when first measured
The model is clearly a good fit the experimental results. However there is a 
discrepancy between the modelled and measured results for the peak temperatures 
close in to the applicator. Unfortunately, this discrepancy is important because these 
high temperatures are largely responsible for creating the bum. It was therefore 
important to understand from where this difference arose. A static finite element 
analysis in ANSYS was conducted to investigate the source of this discrepancy.
4.8.4 ANSYS analysis
4.8.4.1 Aims
In ANSYS both the PAG and the fibre were modelled in order to obtain the best 
possible understanding of the source of the difference. The optical fibre temperature 
probe used to take the measurements was a Luxtron STB. A close-up of the tip is 
shown in figure 4.58. Figure 4.59 shows the internal structure of the fibre, as given by 
the manufacturers.
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Approximately 0.5 mm
Figure 4.58: Close-up o f  the optical fibre temperature Figure 4.59: Internal structure o f  the temperature 
measurement probe. measurement probe.
http://www.polytec.com/ger/_files/PH_OS_LUX_m3300_.pdf
Although optical fibre measurement probes have the advantage that microwave fields 
do not directly affect them, their temperature response can potentially lag slightly in 
regions of high thermal gradient. This is because the fibre itself is microwave 
transparent, and therefore does not heat up with the surroundings. Instead it relies on 
thermal conduction to heat the fluorescent dye. However, the dye is located within a 
plastic jacket, which naturally acts as insulation. Furthermore, the dye is directly in 
contact with the relatively high thermal conductivity silica core of the optical fibre 
and therefore has a natural tendency to lag behind temperature changes. This lag is not 
normally significant, but it was investigated as a possible explanation of the 
discrepancy between the predicted and recorded temperatures as the MVO applicator 
passes the fibre.
4.8.4.2 Method
A hollow cylinder of 30mm in diameter and 20mm deep was created in ANSYS to 
represent the PAG used in the validation experiments. The central lumen had a 
diameter of 4.5mm. Within this cylinder two further cylinders of the same dimensions 
as those given by Luxtron were embedded to represent the core and cladding of the 
optical fibre. The material properties given below in table 4.2 were then applied.
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Polyacylamide gel
Density 1030 kgm'J
Specific heat capacity 4187 Jkg'K '1
Thermal conductivity 0.41 Wm-'K'1
Plastic
Density 940 kgm'3
Specific heat capacity 1900 Jkg'K '1
Thermal conductivity 0.47 Wm-'K'1
Silica
Density 2200 kgm'j
Specific heat capacity 740 Jkg'K '1
Thermal conductivity 1.38 Wm-'K'1
Table 4.2. The thermal properties applied to the three components o f  the ANSYS simulations
In the simulation the fibre was placed at 0.75mm. This was because a noticeable 
temperature lag between the measured and modelled temperatures was only visible 
when the fibre was close to the channel. The set-up is shown in figures 4.60a and 
4.60b.
0A13M
Figure 4.60a. The symmetry plane o f  the geometry Figure 4.60b. A side-on view o f  the geometry 
o f  the ANSYS simulation with the fibre at 0.74mm. o f  the ANSYS simulation.
Adiabatic boundary conditions were applied to the symmetry plane of the model (the 
XY plane) and the internal lumen of the cylinder. The outer surfaces were all given 
fixed temperature boundary conditions of 20°C. The initial starting temperature was 
also chosen as 20°C. This is effectively an arbitrary starting temperature, as it is the 
temperature rise (AT) that is important.
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The field generated by the MVO applicator was applied to the PAG for two seconds, 
and the resulting temperatures at the point within the tip of the fibre where the 
fluorescent dye is located were determined over 200 seconds. Then the material 
properties of the fibre were changed to those of tissue, and the SAR was applied both 
to the PAG and to the fibre for two seconds. Once again the temperature at the same 
point at the tip of the fibre was determined over 200 seconds. The same mesh was 
used for both simulations and the node at which the temperature was recorded is 
shown in figure 4.61.
Figure 4.61. A close-up o f  the meshed model with the fibre at 0.75mm. The node at which the 
temperature was recorded is circled.
Two seconds was chosen as the period of time for which the SAR from the stationary 
applicator was applied, since this is approximately equivalent to the SAR likely to be 
experienced by the fibre from an applicator moving at the optimal rate of 17.5cm/min.
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4.8.4.3 Results
The initial results showed only a very small difference between the temperature at the 
point of the fluorescent dye, and the temperature in the PAG without the fibre, as 
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Figure 4.62. Graph o f  temperatures recorded over 200secs at a depth o f  0.75mm by a temperature 
measurement fibre in perfect thermal contact with its surroundings (red) and in PAG alone without a 
fibre (blue).
However, this difference was not sufficient to explain the difference seen between the 
model and the measured results. A second set of simulations was then carried out. An 
adiabatic boundary condition was applied to the walls of the fibres, leaving only the 
tip in contact with the PAG. The adiabatic boundary condition prevented energy flow 
between the fibre and the PAG anywhere except on the flat of the tip. This was to 
simulate the effect of an insulating air gap around the fibre. This did produce a 
significant discrepancy between the temperature of the dye and the temperature o f the 
PAG alone, as shown in figure 4.63, which matched very well with the experimental 
data.
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Figure 4.63 Graph o f temperatures recorded over 200 secs at a depth o f  0.75mm by a insulated fibre 
and in PAG without a fibre.
This effect can be seen below in figures 4.64 and 4.65, both recorded at 8secs after 
heat was first applied. Figure 4.64 shows a cross section of the fibre and PAG with all 
the correct properties, whilst figure 4.65 shows a cross section of the PAG alone.
A N S Y S
Figure 4.64. Temperature profile after 8secs with Figure 4.65. Temperature profile after 8 secs
the insulated fibre. without the fibre.
The fibre can be seen to be cooler than the surrounding PAG in figure 4.62, whilst in 
figure 4.65, the thermal contours are passing through the former location of the fibre.
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4.8.4.4 ANSYS model validity
This model was intended to qualitatively demonstrate that when the fibre is used to 
measure temperatures in regions of high thermal gradient, such as those experienced 
at a depth of 0.75mm from the applicator, the intimate contact of the fibre surface 
with the material in question becomes very important. Validity can be given to the 
model by comparing the predicted temperatures that would be measured by the fibre 
when only in contact at the tip, with the actual temperatures measured as part of the 
Green’s function model validation. This comparison is valid because of the relatively 
fast movement of the applicator past the fibre, and the proximity of the fibre to the 
applicator. As shown in figure 4.66, the measured temperature profile is very similar 
to that predicted for the stationary case. Since the temperature predictions are so 
similar to the measured values, credence can be given to the model that incorporates 
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Figure 4.66. Predicted temperatures experienced by the fibre at 0.75mm from a stationary applicator 
compared to the recorded temperatures from a moving applicator for the case where the fibre shaft is 
insulated from the tissue
4.8.4.5 Conclusions
An ANSYS model has been produced of a stationary MVO applicator heating PAG 
for 2 seconds with and without a temperature measurement fibre located at 0.75mm.
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The simulations were carried out with and without adiabatic boundaiy conditions 
applied to the fibre-PAG interface along the length of the fibre shaft. This model 
indicates that the discrepancy in peak temperature measurements between the 
measured results and the Green’s function model predictions in regions of high 
thermal gradient is due to the intrinsic nature of the fibre, and additionally, 
insufficient contact between the fibre and the PAG. It explains why there is a 
difference between the Green’s function temperature predictions and the measured 
results, particularly for the short period when the fibre is within a high thermal 
gradient.
4.8.5 Final temperature validation results in PAG
Despite the similarity o f the ANSYS analysis results to the measured results at 
17.5cm/min, the thermal analysis was still conducted using Green’s functions. This is 
because the ANSYS results do not incorporate movement, so slower withdrawal rates 
are likely to have an increasing discrepancy between the predicted and measured 
values. There is also likely to be a growing discrepancy between the predicted and 
measured values as the fibre moves away from the applicator channel.
However, based on the results of the ANSYS analysis, the temperature measurements 
were re-done with ultrasound gel injected around the tip of the fibre to try and 
maximise contact with the PAG. This gave improved results compared to the Green’s 
function analysis predictions, as shown in figures 4.67-4.70 for the results measured 
using a withdrawal rate o f 22.5cm/min.
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Figure 4.67: Comparison between measured (blue) and Green’s function analysis (pink) values for 
temperature at a depth o f  0.75mm in PAG at a withdrawal rate of22.5cm/m in
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Figure 4.68: Comparison between measured (blue) and Green’s function analysis (pink) values for 
temperature at a depth o f  1.5mm in PAG at a withdrawal rate o f  22.5cm/min
Chapter 4: Varicose Veins Page 163




Figure 4.69: Comparison between measured (blue) and Green’s function analysis (pink) values for 




Figure 4.70: Comparison between measured (blue) and Green’s function analysis (pink) values for 
temperature at a depth o f  4.25mm in PAG at a withdrawal rate o f  22.5cm/min
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4.9 Burn depth analysis by use of the Arrhenius equation
4.9.1 Aims
Once confidence had been established in the temperatures predicted by the model, the 
Arrhenius equation was applied to the temperature results given by the model in order 
to assess the degree of cellular damage that would result, and in particular, the depth 
of cell death. The Arrhenius equation and the parameters used are given in section 2.6.
4.9.2 Method
This gives the resulting level of tissue damage at the depth at which the temperature 
profile was calculated over time as an omega value. Q = 1 is the value at which 
permanent tissue damage is taken to have occurred, as explained in section 2.6.2. The 
maximum values that omega reaches are then recorded at intervals of 0.1mm as 
shown in figure 4.71 for a withdrawal rate of 22.5cm/min. The exact point at which Q 
= 1 can then be interpolated. The maximum value o f omega was taken as the final 
value after 360 seconds for withdrawals of 5 and 7.5cm/min, and 240 seconds for all 
other results. The growth of omega over time is shown in figure 4.72 for the 5cm/min 
results and the 1 Ocm/min results. These represent the results that are most likely not to 
have reached their final values by the end of the simulated time period. As can be 
seen, the final omega value is clearly close to the omega value that would be recorded 
at infinity.
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Figure 4.71: Omega values plotted against depth for a withdrawal rate o f  22.5cm/min, allowing the 
point at which O = 1 to be interpolated. The dotted lines shows a linear interpolation between the two 
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Figure 4.72: Omega value growth against time for the two results that are most likely not to have 
reached their maximum value by the end o f  the simulation
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4.9.3 Burn validation in liver
4.9.3.1 Aims
In order to validate the model predications for tissue damage, a validation was carried 
out in bovine liver.
4.9.3.2 Method
An applicator was sandwiched between two pieces of liver that had been heated in a 
water bath to 37°C, as described in section 4.5.3.2. Power was applied and the 
applicator was then withdrawn using the lead screw based withdrawal device at 
lOcm/min, 12.5cm/min, 17.5cm/min and 22.5cm/min. The liver was then left for six 
minutes to allow the bum to reach the maximum possible extent. The heated track in 
the liver was cross-sectioned and close-up photographs taken against a scale. The 
depth of visible thermal damage was then measured at 0.5cm intervals along the 
heated length and the mean level of visible tissue damage calculated. A typical bum is 
shown in figure 4.73.
Figure 4.73: The bum in liver resulting from a withdrawal rate o f  22.5cm/min
The model was then run using the properties listed in table 4.3.
p  =  1060 kg m'3 Mean density o f  human liver Duck, 1990
C = 3.370 Jkg'K *1 ' Specific heat capacity o f  bovine liver Robinson, 1972
k = 0.488 W m  'K’1 Thermal conductivity o f  bovine liver Poppendiek at al, 1966
Table 4.3: The tissue properties used for the validation o f  the results from the bum analysis. These 
were all taken from Duck (1990)
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4.9.3.3 Results
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Figure 4.74: Modelled bum depths (pink) compared to measured mean bum depths (blue) in ex-vivo 
bovine liver with 95% confidence intervals for the means
The gradients of the predicted and measured bum depths are very similar, and the 
predicted and measured bum depths are similar. The predicted bum depths are all 
slightly greater than those measured, though. However, this is not unexpected as only 
the level of gross tissue damage is visible and it is probable that the likely depth of 
tissue necrosis will extend slightly further than that visible in the liver.
4.9.4 Predicted results in-vivo and system parameter choice
Following on from the results of the bum validation, the Green’s function model was 
re-run using the parameters for the human vein given in table 4.4, for withdrawal 
speeds of 5, 7.5, 10, 12.5, 15, 17.5, 20, 22.5, 25 and 27.5cm/min, at the ideal, 
maximum and minimum power levels possible from the applicator. The Arrhenius 
equation was then applied using the values for E and A given in section 2.4 and 
validated in the liver, in order to calculate the maximum and minimum depths o f cell 
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p =  1056 kg m'3 Density o f  human veins Duck, 1990
C = 3.528 J k g 1 K'1 Specific heat capacity o f  human aorta Valvano & Chitsabesan, 1987
k = 0.46 W m 'K"' Mean o f two values for human aorta Valvano & Chitsabesan, 1987 
Van Gemert et al., 1986
Table 4.4: The tissue properties used for the thermal analysis in human veins. These were all taken 
from Duck (1990)
The maximum power level is given by the maximum uncertainty on the magnetron 
power output, which is + 7.15% and assumes a perfectly matched applicator. This 
gives an output of 16.9 watts at the tip. The minimum power output is given by the 
minimum uncertainty on the magnetron power output, which is -7.15%, together with 
the worst-case match into tissue. The minimum acceptable applicator match measured 
at the end of the cable is -16.6dB, which taking into account the loss in the cable 
gives a minimum power output of 11.5 watts into the tissue.
♦  15 watts 
■ 16 9 watts 
A 11.5 watts
10 15 20
W ithdraw al s p e e d  in cm /m in
25 30
Figure 4.75: Predicted bum depth against withdrawal rate for the MVO applicator and system in a vein
These results shown in figure 4.75 were used to assess the safe and recommended 
limits for applicator withdrawal rate, which are given on the treatment screen as 
described in section 4.7.2. The model shows that the bum grows greatly for
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withdrawal rates under lOcm/min. This was therefore chosen as the safety limit, with 
the recommended withdrawal rate being between 12.5 and 22.5cm/min. This is 
equivalent to a bum of between 1.1 and 2.6mm at the target power output of 15 watts. 
The optical sensor characterisation given in 4.7.4.2 gives a standard deviation of 
1.2%. Taking three standard deviations as the maximum degree of error gives an error 
of +/-3.6%. Based on this error and the maximum and minimum power output levels, 
the worst case bum with a constant withdrawal is predicted to be 3.0mm depth. At a 
nominal withdrawal of 22.5cm/min, the minimum bum is predicted to be 0.6mm in 
depth. If the surgeon stays within the recommended treatment band the bum should be 
well within 0.6 to 3.0mm as a constant steady withdrawal at lOcm/min is impossible 
to perform manually. These bum depths are within the levels previously published as 
being typical o f a VNUS Closure treatment, but greater than the thickness o f a vein 
wall, which is around 0.5mm. This should therefore give a safe and effective 
treatment.
4.10 Comparative bench testing with VNUS
4.10.1 Aims
In order to evaluate the MVO treatment as effectively as possible before a clinical 
study, a bench model was created to directly compare the established treatment VNUS 
Closure with MVO.
4.10.2 Method
A stripped human greater saphenous vein was sandwiched between two layers of ox 
liver. The liver represented the fascia and muscle that surround the vein in-vivo and 
allowed the extent of the thermal penetration through the vein to be assessed. The vein 
was sutured to the liver at both ends and the entire sandwich was wrapped in cling 
film and heated in a water bath to body temperature. The sandwich was then removed 
and a pressure of 200mmHg applied to represent bandaging and exsanguination of the 
leg with an Esmark bandage. Treatments were carried out on this model using both 
VNUS and MVO according to their normal protocols.
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4.10.3 Results
4.10.3.1 Macroscopic
A typical comparative result is shown below in figures 4.76. As can be seen, the 
appearance of the bums is similar. Similar levels of efficacy can therefore be expected 
to VNUS, but much more quickly.
Figure 4.76: The bum on the right results from MVO, whilst the bum on the left results from VNUS
Closure treatment
Figure 4.77: Cross section o f  the liver from Figure 4.78: Cross section o f  the liver from
the bench test o f  the VNUS treatment the bench test o f  the MVO treatment
The depth of visible thermal penetration through the vein wall into the surrounding 
liver is minimal for both VNUS and MVO as shown in figures 4.77 and 4.78.
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4.10.3.2 Histological
Initial histological analysis of the VNUS bum has also been conducted. An 
experiment was designed and carried out by Metcalfe (2004) to allow an assessment 
of the bum resulting from VNUS. Rather than surrounding the vein with liver, a 
stripped varicose vein was cut into sections and the sections placed one inside the 
other. The vein was treated within 20 minutes of being removed from the patient in 
order to make the results as realistic as possible. This allowed heating to be carried 
out on still live tissue and an assessment of the degree of cell damage through 
birefringence to be made, as explained in section 2.5.9. This was not carried out with 
MVO, as microwaves fix tissue, making histological analysis of relatively subtle 
bums such as these difficult.
Figure 4.79: A cross-section o f  three lengths o f  vein placed one inside the other followed by treatment 
with VNUS closure and histological analysis (Metcalfe, 2004)
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Interestingly, this shows an asymmetric bum with dark areas at the top and bottom of 
figure 4.79. The lighter areas show viable tissue. This asymmetry is probably due to 
the compression applied to the vein causing the electrodes to be crushed together. 
They therefore no longer fill the vein and do not apply heat evenly to the inside wall. 
The vein in figure 4.79 was therefore probably crushed from either side, so the actual 
orientation of the vein in the experiment was probably at 90° to its current orientation 
on the page. The maximum depth of the bum is uncertain, but it certainly appears to 
be greater than 1.5mm, as it has penetrated through 3 veins, each of which is around 
0.5mm thick.
This result implies that the complete circumference of the vein wall does need to be 
necrosed in order to cause occlusion. This is important because this situation is similar 
to the results that can be expected from a smaller, round applicator, such as the MVO 
applicator, which may also only apply maximum heat to the areas where the vein is 
directly in contact with the applicator. With very large veins, there may be areas 
around the applicator that do not get heated, as the applicator does not fill the vein. 
The VNUS result implies that this may have no impact on treatment efficacy.
4.11 Discussion
Ideally VNUS would have been modelled more extensively in order to evaluate its 
thermal profile more realistically than with a simple finite difference model. In 
particular, an investigation of the interesting histological results shown in Metcalfe’s 
(2004) bench test on VNUS Closure may have justified the use of smaller diameter 
MVO applicators. However, the histological results do not fit well with the 
macroscopic bums visible in both the veins and surrounding liver treated by VNUS 
and this result may well be due to the birefringence analysis not being sufficiently 
subtle to detect the changes that would result in cell death. In addition, the use o f a 
smaller MVO applicator would mean that the maximum power input would need to be 
reduced in order to keep the thermal penetration from the surface of the applicator 
constant. This would probably result in reduced efficacy, but further work would be 
required to assess this. Linked to this is the question o f the range of vein sizes that can 
be treated by the 4.5mm diameter microwave applicator. All the bench testing has
Chapter 4: Varicose Veins Page 173
Two Applications of Microwave Therapy: Psoriasis and Varicose Veins
shown a bum to the complete wall of veins up to 1.2cm in diameter, but there is likely 
to be an upper limit on treatment size. There is also likely to be a lower limit on 
treatable vein diameter, but the 4.5mm applicator has been shown to be capable of 
insertion into veins o f only 3mm in diameter. A smaller applicator may gain very little 
in terms of ease of insertion, but may well be less effective at treating large veins.
Another uncertainty is in the predicted maximum and minimum depths o f thermal 
penetration. The modelling exercise conducted was effectively a worst-case analysis, 
as no perfusion, or fluid effects were considered. In-vivo there may well be fluids 
present, both in and around the vein. These fluids, such as blood, could remove heat, 
and so reduce the thermal penetration. This problem should not occur when the vessel 
and surrounding tissues are completely ex-sanguinated through compression, but this 
may well not be completely possible in-vivo. The level o f residual blood will be a 
function of the ability of the clinician to ex-sanguinate the tissues, and can therefore 
only be assessed through clinical testing.
The manual pullback and feedback control mechanism also means that there will be 
some variation in pullback rate during the treatment. However, so long as the clinician 
stays within the recommended treatment band, the range o f bum depths should be 
smaller than that predicted in the modelling. This is because the mean pullback rate 
will influence the temperature of the applicator, so tending to rob heat from the tissue 
when moving too slowly and add heat when moving too fast, relative to a steady 
pullback rate.
Although ultimately the efficacy and safety of the treatment can only be definitively 
answered through clinical testing, the bench test comparisons with VNUS do provide 
a very strong degree of confidence in the system.
4.12 Summary
An applicator for the treatment of varicose veins through the occlusion of the greater 
saphenous vein above the knee has been developed through an iterative development 
process. A finite-difference model of endovenous heating has been constructed to
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show that a microwave applicator could increase the withdrawal rate o f an 
endovenous thermally based treatment from the current 3cm/min using an RF 
technique, to around 20cm/min whilst still maintaining a similar temperature profile. 
Due to the ready availability of a source at 9.2 GHz, the possibility of designing an 
applicator to operate at this frequency was investigated. The resulting applicator has a 
design frequency of 9.2GHz and is intended for introduction either directly into the 
vein or through a percutaneous introducer. The bum is controlled by the withdrawal 
speed of the applicator. This applicator has been integrated into a system which uses 
an optical motion sensor to measure the withdrawal rate o f the applicator by the 
surgeon. Characterisation of the temperatures induced in the tissue by the applicator, 
and the resulting bum, has been carried out for a range of speeds. A validated model 
based on the use of Green’s functions to assess the temperatures induced in the 
surrounding tissue, and the Arrhenius equation to assess the resulting level o f tissue 
damage, was used. This information has been used to determine the most effective 
and safe range of withdrawal speeds. Comparative bench tests on human veins have 
been carried out with an established and successful RF based treatment system to 
confirm that the bums resulting from the use of the applicator and system are likely to 
be both safe and effective. The first microwave treatment for varicose veins has 
therefore been developed.
4.13 Conclusions
A finite difference model has been able to show the potential of a microwave based 
endovenous technique for the treatment of varicose veins. The use of the HFSS finite 
element package, together with bench testing has allowed the development of a 
microwave applicator operating at 9.2GHz. Thermal modelling by Green’s function 
analysis, together with the application of the Arrhenius equation has then allowed the 
depth o f thermal penetration of the applicator to be assessed to within the range 1.1 to 
2.6mm. This modelling, together with the use of an optical motion sensor to measure 
applicator withdrawal rate has the potential to allow both a fast treatment and tight 
limits on the thermal penetration of the system. The resulting bums appear similar to 
those from an established but much slower RF treatment. The use of all three 
computer models, together with validation testing, has allowed the development of a 
system that should give similar levels o f efficacy to the RF treatment, but with
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increased safety and speed. This is the first microwave treatment for varicose veins 
and one of very few minimally invasive treatments, and it has the potential to offer 
greater speed, efficacy and safety than any other treatment for venous incompetence.
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Chapter 5: Conclusions and future work
5.1 Summary
5.1.1 Introduction
This thesis provides a general overview of the major thermal medical treatment 
modalities, including microwave therapy. A survey of four successful microwave 
based therapies was given as an introduction to how microwaves can be successfully 
used to treat medical conditions. The analysis techniques required to develop 
treatments were also covered, such as an introduction to tissue complex permittivity 
and microwave absorption, the practical use of finite element packages, thermal 
analysis by finite difference approximation, Green’s functions, the ANSYS finite 
element package, the Arrhenius equation, bench testing and the use of tissue 
substitutes.
The analysis techniques given in the introduction were applied in the development 
and testing of two novel microwave based treatments that are designed to treat two 
very different conditions: psoriasis and varicose veins.
5.1.2 Psoriasis
A review of the history of the use of hyperthermia in the treatment of psoriasis was 
conducted. This identified the possibility of improving on the result of one previous 
microwave trial involving three patients at 2.45GHz by Keddy-Grant (1990) that 
successfully treated one patient, but caused painful deep heating in the other two. The 
aim of this work was to build on Keddy-Grant’s promising result and optimise the 
treatment of psoriasis by microwave therapy. The system would be designed to retain 
the therapeutic effect shown by the use of microwaves at 2.45GHz, whilst removing 
the deep heating.
A one dimensional finite difference thermal model was developed for a theoretical 
investigation into the likely performance required by a microwave applicator to be 
used for treating psoriasis. Data on blood perfusion from Klemp and Staberg (1983), 
and the thermal properties of skin from Duck (1990) were used in the model. The 
surface cooling parameter was assessed experimentally through the use of a tissue 
phantom on the bench, and the microwave properties of skin were taken from Clegg
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(2000). According to Orenberg (1986) the most efficacious treatment would be given 
by a therapeutic temperature of between 42 and 44°C over the superficial 3mm of the 
skin. The finite difference model developed indicated that to give a temperature of 
43°C at a depth of 3mm required a frequency of 5GHz and forced air surface cooling 
at an ambient air flow rate of around 0.5m/s. In order to err on the side o f caution, the 
parameters required to obtain a temperature of 42°C at 3mm were also assessed. 42°C 
at 3mm was found to be achievable using a frequency of 7GHz, and with no surface 
cooling required.
Based on these results an applicator operating at 7GHz, and without surface cooling, 
was designed using the finite element package HFSS and built. Its microwave 
performance was characterised using a network analyser, and it was integrated into a 
system. The heating produced by the applicator was characterised on the bench using 
a tissue phantom and compared to the model results in order to obtain a level of 
confidence in the model. This system was then applied to three patients for two 
treatments per week over three weeks.
In terms of efficacy, the clinical results were disappointing, with a mild improvement 
visible in only one of the patients. This improvement was also associated with a 
complication, which was blistering of the skin in part of the treated area. The resulting 
surface temperature data and power input data, together with the computer model, 
allowed an assessment to be made of the perfusion levels in healthy and psoriatic 
skin, and their relationship to skin temperature. This gave novel results on the 
variation of skin perfusion with temperature at hyperthermic temperatures. A best fit 
to the results gave the level of psoriatic blood perfusion as co = 39T -1510, whilst the 
level o f blood perfusion in healthy skin was found to be co = 2 .4T - 90, where co is the 
blood perfusion in mllOOg^min1 and T is the surface skin temperature. These results 
are valid for temperatures of between 40 and 44°C, with a mean error in predicted 
blood perfusion of +/-29%.
5.1.3 Varicose Veins
As with psoriasis, a review of current treatments was conducted, and the possible 
means of treating varicose veins using microwaves was assessed. A minimally
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invasive, radio-frequency based treatment called VNUS Closure demonstrated that a 
minimally invasive endovenous treatment based on heating could provide an effective 
treatment. A one dimensional finite difference model was developed to allow an 
analysis of VNUS’ thermal effects in tissue. Based on this modelling exercise a 
microwave applicator was constructed and bench tested. The design went through a 
number of iterations until a design was settled on. This was characterised using a 
thermal analysis model based on the use of Green’s functions, and validated against a 
tissue phantom on the bench. A discrepancy between the results was explained 
through the use of static finite element analysis using the package ANSYS. The 
Green’s function analysis was then expanded to include an analysis o f the bum likely 
to result from the heating by applying the Arrhenius equation to the temperatures 
predicted by the Green’s function model. As before, the model results were validated 
against a bench model. This model gave a characterisation of the bum resulting from 
different applicator withdrawal speeds, showing that with a power output of 15 watts 
and a frequency of 9.2GHz, a bum of between 2.6 and 1.1mm would result if  the 
withdrawal speed was kept between 10 and 22.5cm/min. These limits on withdrawal 
speed were incorporated into a system that monitors the withdrawal speed through the 
use of an optical motion sensor, and presents this as feedback to the surgeon in order 
to achieve a safe and effective treatment. This novel optical motion sensor uses 
standard optical mouse components to measure relative position of the applicator 
cable as it passes through a custom designed housing, so allowing the speed of 
withdrawal to be calculated. The complete applicator and treatment system were 
compared against VNUS using stripped human saphenous vein on the bench to 
demonstrate the similarity between the effects of the two systems, and hence the 
likely efficacy and safety of the microwave based system in-vivo.
5.2 Discussion
5.2.1 Thermal models
The characterisation and modelling of both applicators by computer has proved to be 
effective and successful. The finite difference model was simple and quick to run. It 
also had the advantage that it was flexible as it was written from the ground up. On 
the negative side, it could not easily be made to describe complex or curved 
geometries and could become unwieldy as it was made more complex. The Green’s
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function model was ideal for modelling moving sources but had the disadvantage that 
homogeneity of the modelled volume needed to be assumed. Finite element packages 
have the potential to offer extremely accurate results, as demonstrated by HFSS. The 
consistent accuracy of the results from HFSS meant that the any discrepancy between 
the simulation and the measured values was likely to be due to incorrect translation of 
the model into reality. When conducting thermal analysis using ANSYS the effect of 
the temperature measurement probe itself could even be included, as explained in 
section 4.8.3. However, modelling of moving sources can become complex and 
computationally expensive.
5.23 Psoriasis
The clinical results were disappointing with only a minor improvement seen in one 
patient. There are a variety of possible reasons for this. Firstly, the thermal modelling 
may have been inaccurate. Secondly, the twice-weekly treatment scheduling may 
have left too great a gap between treatments, allowing complete cell replication to 
take place during the interval and resulting in each treatment being effectively the 
same as the first. However, the most likely problem was due to the extreme variation 
in blood perfusion found between healthy and psoriatic skin. This meant that if 
healthy skin reached a therapeutic temperature, then the psoriatic skin would not 
reach it, whilst if the psoriatic skin reached a therapeutic temperature, then a bum 
would result in any healthy skin within the treatment area. This meant that only the 
patient with large area plaque psoriasis was effectively treated, and this was the same 
patient that did show some benefit. However, the safety implications of using a 
microwave treatment without some means of controlling blood flow are clear.
It therefore appears that whilst the possible efficacy of microwave therapy at 7GHz 
remains unresolved, the difficulty of controlling dosage using microwave therapy at 
any frequency without control of blood flow has been shown.
5.2.4 Varicose veins
The modelling exercises described in chapter 4 provide a convincing characterisation 
of the treatment due to the validation of both the thermal and bum depth analysis on 
the bench. The probable efficacy of the treatment as a whole is also strongly
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supported by the bench comparison of the MVO treatment against an existing 
treatment with known efficacy and safety in-vivo.
5.3 Suggestions for further research
5.3.1 Fundamental research
There is considerable scope for improving our knowledge of both the microwave and 
thermal tissue properties, and their relationship with temperature. A comprehensive 
set of results for complex permittivity and its relationship to temperature in a range of  
tissue types would also ideally be derived, extending the work of Clegg (2002). 
Another key parameter is knowledge of blood perfusion levels in different tissues. 
One possible way of achieving this would be through the use of a probe that was 
fundamentally similar to that used for the psoriasis experiments. A smaller waveguide 
could be constructed and a known level of microwave heating applied to the tissue, 
whilst the surface temperature was measured. The entire device could be modelled in 
ANSYS and if the thermal and microwave properties of the tissue were accurately 
known, the perfusion level could be accurately calculated.
5.3.2 Thermal analysis
Improved knowledge of both microwave and thermal tissue properties could be 
applied to computer modelling in ANSYS to start to utilise its full capabilities. In the 
first instance, a loosely coupled microwave and thermal solutions could be performed 
on static models. This effectively means iterating the electromagnetic and thermal 
solutions over time within ANSYS. This would allow a quantitative analysis of the 
cooling effect of the tip as well as heating from the applicator shaft. If required, 
expansion of the various components of the applicator could also be undertaken. If the 
changes in material properties with temperature were known, this could be 
incorporated at this stage. The changing SAR pattern and power input during a 
treatment as the bum evolved could therefore also be predicted. Ideally, this solution 
would be closely coupled, meaning that the electromagnetic and thermal solutions are 
generated simultaneously, rather than through an iterative process. Another 
particularly interesting step would be to quantitatively describe heat transfer as a 
result of fluid movement. Finally, a moving source could be modelled with all the 
relevant changes in tissue properties taken into account.
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5.3.3 Psoriasis
For psoriasis, there are several possible approaches for continuing the research. One 
would be to continue with surface microwave irradiation and to examine the 
possibility of temporarily reducing or removing the blood supply to the area to be 
treated, as mentioned before in section 3.10. It may be possible to achieve this 
through direct compression or the use of a tourniquet, or even through the application 
of drugs. The aim of this would be to remove the temperature differences over the 
treated area caused by the widely varying levels of blood perfusion in conjunction 
with the uniform deposition of energy over the skin. However, this may be difficult to 
achieve without inducing counter-productive levels of patient stress.
Another possible avenue to explore for treating psoriasis with microwaves would be 
through the application of heat using a Veinwave™ style device, as described in 
section 1.5.3. This would be inserted into the plaque and heat applied with the aim of 
occluding the blood supply within the plaque. This may provide relief through two 
methods of action. One would be to simply reduce the redness of the plaque by 
reducing the blood supply to the plaque. It may also provide longer term relief by 
reducing the supply of nutrients delivered by the blood to the cells, and so directly 
hinder their replication.
5.3.4 Varicose Veins
For veins, the first step would be to examine the results of the treatment as it stands 
in-vivo in a clinical trial. Follow-up of the patients would allow the effectiveness of 
the treatment to be quantified, but ideally histological analysis of in-vivo treated 
vessels would also be conducted. This would allow a direct comparison to the results 
of the bench tests, Green’s function and the Arrhenius analysis.
The treatment could also be expanded to treat other vessels, such as the lesser 
saphenous vein and small perforator veins. These would require a considerably 
smaller applicator. The lesser saphenous vein would also require an even more 
targeted treatment, due to the close proximity of the saphenous nerve to the vein in the 
lower leg.
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An altogether different treatment technique could also be investigated. Rather than a 
continuous pull-back down the length of the vessel, the applicator could be kept static 
and a pulse of heat applied. The applicator could then be withdrawn without any 
power, and left static in a new position adjacent to the previous one. Another bum 
could then be put in at this point. As with the current method, the withdrawal could be 
monitored by the optical sensor. This technique would be a cross between the laser 
endovenous technique and MVO, and may be ideal for short veins such as perforators.
5.4 Conclusions
The use of the finite element computer modelling package HFSS together with 
accurate data on microwave properties has allowed the construction, testing and 
refinement of two very different microwave applicators, with the aim of treating two 
very common, difficult to treat, and chronic diseases: psoriasis and varicose veins.
The first conclusion is that treatment of psoriasis using microwave hyperthermia is 
possible, but is limited by large variations in blood perfusion between different 
regions of the skin. The variations in blood perfusion between healthy and psoriatic 
skin has been shown to be particularly large, with levels of blood perfusion in 
psoriatic skin of co = 39T -  1510 (+/-26%), compared to levels of blood perfusion in 
healthy skin of co = 2.4T-  90 (+/-32%), where co is the blood perfusion in mllOOg 
!min1 and T is the surface skin temperature. These results are valid for temperatures 
of between 40 and 44°C, and fit well with previously published values for blood 
perfusion in healthy and psoriatic skin derived by a different method. They are also 
the first results for the temperature dependence of skin perfusion at hyperthermic 
temperatures.
Secondly, varicose veins can be treated using microwaves with a device and system of 
the type described. The resulting treatment effect appears to be very similar to an 
established and effective venous occlusion device, but with a significantly faster 
treatment time. This is the first microwave based treatment for varicose veins, and one 
of only a handful of minimally invasive varicose veins treatments.
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Finally, modelling can play an important and successful role in the design and 
characterisation of medical microwave treatments. Thermal analysis of the treatments 
has been conducted by three different methods, with accuracy sufficient to allow 
significant characterisation and refinement of the applicators and their use.
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Appendix 1: Derivation of Pennes’ Bio-Heat Equation
Heat flux is inversely proportional to temperature gradient so
1
where a is a constant and F is the thermal flux.
Also, the energy retained over distance Sx in the body is directly proportional to the
temperature at x. The rate of change of temperature with respect to time is determined 
by the rate of energy change at x giving
where p is a constant and E is energy.
This rate of energy change can be broken down again into two parts. Firstly there is a 
source term, P(x, t), that represents power input (or removal) due to internal heat 
generation (or heat removal). This is directly proportional to temperature. Secondly, 
there is also energy change due to the rate of change of heat flux with respect to 
distance. This is inversely proportional to temperature giving
3
dt dx
Inserting 3 into 2 gives,
4
and inserting 1 into 4 gives,
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— a &r_
dx
Substituting k for a and 1/pC for /?, where k is the thermal conductivity, p is density 
and C is the specific heat capacity gives,
a r _ j _ a Y  _p_
8t pC dx2 pC
Rearranging, this gives,
82T p cd T  _ P  
dx2 k 8t k
For microwave medical thermal analysis purposes the source term, P , can now be 
broken into three parts. Firstly there is the deposition microwave energy. This is 
commonly expressed as a standard absorption rate (SAR (x, t)) in watts/kg. Secondly, 
there is blood cooling. Finally there is the internal heat generation due to metabolic 
processes.
Therefore,
P = P,SAR -  p ,p bcbm{T -T b) + p ,Q , 6
where p t is the density of the tissue, p b is the density of blood, Cb is the heat capacity
of blood, m is the volumetric flow rate of blood per unit mass of tissue, 7* is the 
temperature of the perfusing blood and Q is the metabolic heat generation.
Inserting equation 6 into 5 and re-arranging gives Pennes’ (1948) bio-heat equation, 
which in 3 dimensions is
E t£ i- —  = 'V 2T - - ! — ^ ' - , n ( T - T b) + — S A R  + ^ ^ -  . 
k 8t k b k k
Appendices Page 199
Two Applications of Microwave Therapy: Psoriasis and Varicose Veins
Appendix 2: PAG formulation





TMEDA (T etramethylethelenediamine) 1.92g
Surfactant (optional) 5g
Add de-ionised water to 450ml 
Part 2
AP (Ammonium persulfate) 0.65g
Add de-ionised water to 50ml
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Appendix 3: ID  finite difference thermal model of skin for assessment of blood 
perfusion levels (BASIC)
20 PRINT "Enter no of seconds"
30 INPUT S
60 PRINT "Enter watts on power meter"
70 INPUT W
80 PRINT "Enter starting temp"
90 INPUT STEMP
91 PRINT "Enter set temperature"
92 INPUT SETTEMP 
95 BP = .000001
97 W = W * 100000 
100 S = S* 100 
110 L = 500 
115 TLAST = 36.5 
120 DIM T(L, 2)
130 OPEN "CiRESULTS.TXT" FOR OUTPUT AS #1
140 FOR N = 1 TOL
150 T(N, 1) = STEMP
160 NEXT N
165 T(L, 2) = STEMP
170 FOR N = 1 TOS
180 FORN1 = 2 TO (L -1)
190 P = W * (2.71828 A (-442.5 * N1 / 10000))
210 T(N1,2) = ((T((N1 + 1), 1) - (2 * T(N1, 1)) + T((N1 - 1), 1)) * .0931) + T(N1, 1) + (P / 
387202750) + ((STEMP - T(N1, 1)) * BP)
220 NEXT N1 
230 T(l, 2) = T(2,2)
235 T(l, 2) = (.0052 * (20 - T(l, 2))) + T(l, 2)
240 FORN1 = 1 TOL 
250 T(N1, 1) = T(N1, 2)
252 NEXT N1
253 BP = ((T(l, 1) - SETTEMP) * BP * .001) - ((T(l, 1) - TLAST) * BP * .002) + BP
254 TLAST = T(l, 1)
255 IF BP < .000001 THEN BP = .000001
256 IF N / 100 = INT(N / 100) THEN GOTO 275 ELSE GOTO 300
260 REM FOR N1 = 1 TO 50
261 REM PRINT #1, CSNG(T(1, 1)); CHR$(9);
270 REM NEXT N1
273 REM PRINT #1, CHR$(13);
275 PRINT N / 100;
276 PRINT T(l, 1);
277 PRINT BP 
300 NEXT N 
350 END
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Appendix 4:1 D finite difference thermal model of skin with hill-climbing 
algorithm for treatment optimisation (BASIC)
100 DIM VAR(3,2)
170 PRINT "Enter starting power"
180 INPUT VAR(1, 1)
190 PRINT "Enter starting frequency in GHz"
200 INPUT VAR(2, 1)
210 PRINT "Enter starting surface cooling constant"
220 INPUT VAR(3, 1)
260 L = 200
263 OPEN "CiRESULTS.TXT" FOR OUTPUT AS #1 
265 DIM T(L, 2)
270 VAR(1, 2) = VAR(1, 1)
280 VAR(2,2) = VAR(2, 1)
290 VAR(3,2) = VAR(3, 1)
300 PRINT "Enter no of generations"
310 INPUT Y 
320 Q = 1 
330 GOSUB 470 
340 Q = 2 
350 GOSUB 470
360 REM ***** START OF MAIN LOOP *****
370 FOR X = 1 TOY 
380 GOSUB 410 
390 NEXT X 
400 GOTO 900
410 IF DIF(l) >= DIF(2) THEN Q = 1 ELSE Q = 2 
420 IF DIF(l) >= DIF(2) THEN R = 2 ELSE R = 1 
430 DIF(Q) = 0
440 VAR(1, Q) = VAR(1, R) * ((RND / 10 - .05) + 1)
450 VAR(2, Q) = VAR(2, R) * ((RND / 10 - .05) + 1)
460 VAR(3, Q) = VAR(3, R) * ((RND / 10 - .05) + 1)
470 G = VAR(2, Q) * 10 A 9 
480 EO = 8.854187* 10 ^ -12 
490 U =  1.256637* 10 A-6 
500 ER= 50
510 OM = 2 * 3.14159 * G 
520 SIG = 27 * OM * EO
530 Z = ((((SIG / (OM * EO * ER)) A 2) + 1) A .5) - 1 
540 G = 1 /((((Z * U * EO * ER )/2) A .5) * OM)
550 W = VAR(1, Q) * 100000 
555 G = G / 2
570 IF X = 0 THEN PRINT "Skin depth is"; G * 1000; "mm"
590 FOR N = 1 TOL
600 T(N, 1) = (((1.572875 * 10 A -9) * (N A 5)) - (8.081823 * (10 A -7) * (N A 4)) + (.0001468 * (N A
3)) - (.010876 * (N A 2)) + (.2101256 * N) + 42.96808)
610 NEXT N
620 T(L, 2) = 35
640 FORN1 = 2 TO (L -1)
650 P = W * (2.71828 A (-(1 / G) * N1 /10000))
660 T(N1,2) = ((T((N1 + 1), 1) - (2 * T(N1, 1)) + T((N1 - 1), 1)) * .09507) + T(N1, 1) + (P /
431261000) + ((35 - T(N1,1)) * .00012)
670 NEXT N1 
680 T(l, 2) = T(2, 2)
690 T(l, 2) = (VAR(3, Q) * (20 - T(l, 2))) + T(l, 2)
700 FORN1 = 1 TOL
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710 T(N1, 1) = T(N1, 2)
720 NEXT N1 
740 FORN = 1 TOL
750 DIF(Q) = ((T(N, 2) - (((1.572875 * 10 A -9) * (N A 5)) - (8.081823 * (10 A -7) * (N A 4)) + 
(.0001468 * (N A 3)) - (.010876 * (N A 2)) + (.2101256 * N) + 42.96808)) A 2) + DIF(Q)
760 NEXT N
770 PRINT DIF(R); VAR(1, R); VAR(2, R); VAR(3, R)
775 PRINT #1, CSNG(DIF(R)); CHRS(9); CSNG(VAR(1, R)); CHR$(9); CSNG(VAR(2, R)); 
CHRS(9); CSNG(VAR(3, R));
776 PRINT #1,CHR$(13);
780 IF X = Y THEN GOTO 790 ELSE GOTO 890 
790 PRINT "Continue training?"
800 INPUT E$
810 IF E$ = "N" GOTO 820 ELSE GOTO 300 
820 PRINT VAR(1, R); "W"
870 PRINT VAR(2, R); "GHz"
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Appendix 5: 2 D finite difference thermal model of skin (BASIC)
20 PRINT "Enter no of seconds"
30 INPUT S 
100 S = S * 100
118 DIM Tl(100, 95)
119 DIM T2(100, 95)
120 DIM BP(100, 95)
121 OPEN "CiRESULTS.TXT" FOR OUTPUT AS #1
123 FOR N = 1 TO 100
124 FORN1 = 1 TO 95
125 T1(N, N l) = 37
126 T2(N, N l) = 37
127 BP(N, N l) = 1
128 NEXT Nl
129 NEXT N
130 FORN = 50 TO 100
131 FORN1 = 1 TO 20
132 BP(N, N l) = 0
133 NEXT Nl
134 NEXT N 
150 W = 5000000 
160 OPW = 100
170 FORN = 1 TOS
180 FOR Nl =2  TO 99
185 FOR N2 = 2 TO 94
190 P = W * (2.71828 A (-542 * N2 / 10000))
195 IF BP(N1, N2) = 0 THEN GOTO 196 ELSE GOTO 198
196 BPR = ((4.475 * (10 A-6)) * T1(N1, 1))-.0001699
197 GOTO 210
198 BPR= ((7.87714 * (10 A -5)) * T1(N1, 1)) - .0030586
210 T2(N1, N2) = ((T1((N1 + 1), N2) - (4 * T1(N1, N2)) + T1((N1 - 1), N2) + T1(N1, (N2 + 1)) + 
T1(N1, (N2 - 1))) * .093104) + T1(N1, N2) + (P / 387202750) + ((36.5 - T1(N1, N2)) * BPR)
220 NEXT N2
225 NEXT Nl
226 FORN1 = 1 TO 100
229 T2(N1, 1) = T2(N1,2)
230 T2(N1, 1) = (.0052 * (20 - T2(N1, 1))) + T2(N1, 1)
231 NEXTN1
232 FOR N2 = 1 TO 95
233 T2(l, N2) = T2(2, N2)
234 T2(100, N2) = T2(99, N2)
235 NEXT N2
240 FORN1 = 1 TO 100 
245 FOR N2 = 1 TO 95 
250 T1(N1, N2) = T2(N1, N2)
260 NEXT N2
261 NEXTN1
280 IF N / 80 = INT(N / 80) THEN GOTO 285 ELSE GOTO 300 
285 T3 = 43
291 OPT = T2(100, 1)
292 OPW = OPW + ((T3 - OPT) * OPW * (.19 * (2 A (-(N / 80) / 100)) + .01)) - ((OPT - TLAST) * 
OPW * (.76 * (2 A (-(N / 80) /100)) + .04))
293 IF OPW < .3 THEN OPW = .3
294 IF OPW > 100 THEN OPW = 100
295 TLAST = OPT
296 W = OPW * 400000
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300 PRINT N; CHR$(9); W; CSNG(T2(100,1)); CHR$(13);
310 NEXT N
320 FOR N2 = 1 TO 95
330 FOR Nl = 1 TO 100
340 PRINT #1, CSNG(T2(N1, N2)); CHR$(9);
350 NEXT Nl
360 PRINT #1,CHR$(13);
370 NEXT N2 
380 END
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Appendix 6:1 D Finite difference thermal model of an infinite cylinder (BASIC)
20 PRINT "Enter drag rate in cm/min"
30 INPUT DR 
40 DR = D R /6000
50 PRINT "Enter radius of applicator in mm"
60 INPUT R 
65 R = R /1000
70 PRINT "Enter length of applicator in mm"
80 INPUT LENGTH
85 LENGTH = LENGTH /1000
100 HEAT = LENGTH / DR
130 S = 6000
140 L = 100
150 DIM T(L, 2)
160 PRINT "Enter total number of Watts going into tissue"
170 INPUT W
180 PRINT "Enter frequency in GHz"
190 INPUT G
195 REM ***** Calculate Skin Depth *****
200 G = G* 10 A 9 
210 EO = 8.854187* 10 A-12 
220 U = 1.256637* 10 A-6 
230 ER = 50
240 OM = 2* 3.14159 *G 
250 SIG = 27 * OM * EO
260 Z = ((((SIG / (OM * EO * ER)) A 2) + 1) A .5) - 1 
270 G = 1 / ((((Z * U * EO * ER) / 2) A .5) * OM)
280 PRINT "Uncorrected skin depth is"; G * 1000; "mm"
290 REM ***** Evaluate power input constant *****
300 G = 2 / G
420 K = (W * G) / (R * 2 * 3.14159 * LENGTH)
430 OPEN "C:RESULTS.TXT" FOR OUTPUT AS #1
435 REM ***** s et Boundary Conditions *****
440 FORN = 1 TOL 
450 T(N, 1) = 37 
460 NEXT N 
470 T(L, 2) = 37
475 REM ***** Main loop *****
480 FORN = 1 TOS 
490 FORN1 = 2 TO (L - 1)
500 P = K * (2.71828 A (-G * (Nl / 10000))) * ((R+ (Nl / 10000))A -1) * R 
510 I FN>  HEAT* 100 THEN P = 0
520 T(N1,2) = (T((N1 + 1), 1) - (2 * T(N1, 1)) + T((N1 -1), 1)) / 7.4 + (T((N1 + 1), 1) - T((N1 - 1), 
1)) / (148000 * (Nl + (R * 10)) * .0001) + T(N1, 1) + (P / 370000000) + ((37 - T(N1, 1)) * .000013) 
530 NEXT Nl 
540 T(l, 2) = T(2, 2)
550 FORN1 = 1 TOL 
560 T(N1, 1) = T(N1, 2)
570 NEXT Nl
580 IF N / 50 = INT(N / 50) THEN GOTO 590 ELSE GOTO 630
590 FORN1 = 1 TO 50
600 PRINT #1, CINT(T(N1, 1)); CHR$(9);
610 NEXT Nl
620 PRINT #1,CHR$(13)
630 NEXT N 
6 5 0  E N D
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Appendix 7: Green’s function thermal analysis program for the MVO applicator 
(Mathcad)
m
k:=0.46 peak — 875015 par:=00t
= £ £ . 10 5 Conversion of dimensions
60
a  —  Thermal diffusivity
pi-cl
SARfRUO :=e-  iooo(ri-2.2s .o_3).(peak)exij(_1(^ 2l2)
n-3 . .  ._-3H O  f l0 .2 5 1 0  '
Power.= | J S AR(R, z) R 2x dRdzl000 Powef.
- 8 - 1 0 ' 2 .2 5 1 0 -
Power= 15
D^Rl,0,zl,R,Z) :=[(Rfsui(8))2 + (RI-cos(o ) -  R)2 + (zl -Z )2]
source-fieid distance
factor:- pt ( ;  First part of greens function
k(4-ica)
factor = I 4 6 7x 1<?
-P2(RI,0.zl.R.Z)
♦ a l
(jj(RI,0,zl,R .Z,l):=------------------------ Second part of Greens Function
period := 240 u =  166710 Speed in m/S dcplh:=2.SI0"
i:=0.. period
d -depth + 2 2510
Zstaft~-16ld"3 Zalop-1610"3




(  rZ(i)-0.1-10"3 p 0-2510"3 rt- ltr3 fit \  f  cZstop fl0.2510"3 r*IOT3 f*
T(i)S——^.F2- a  Rl,0,zl,d,z,T(i)-  -  | Rl-SAR(Rl,zI)dOdzldRidz , 1-F2 O Rl,0,zl,d,z,T(i) |-RISAR(Rl,zI)d8dzldRldzu l - L  W  uJ J I L L o -3 LA-^ u)




omegan := 8.5 IQ79 ^  ex[ 
j= 0
-506411^ 
8 .3 1 4 (3 l0 .1 5 f T E M P)
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Appendix 8: MVO applicator engineering tolerance analysis
In order to define the acceptable tolerances on the components of the applicator, 
tolerances of +/- 0.05mm were placed on the diameter and length of the dielectric, the 
hole for the centre conductor in the dielectric, and the centre conductor length. All 
combinations of the tolerance extremes were simulated on HFSS. None of the 
simulations gave a result under -lOdB, and the predicted match for 80% of them was 
under -15 dB, as shown below.
Number
o
40 60 100 120
-5
-10






Match results for all the extreme combinations o f  tip dimensions with a tolerance o f  +/-0.05mm
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